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ABSTRACT 
 
The research described in this thesis investigated the microencapsulation of omega-3 oil 
and probiotic bacteria together in a protein-polysaccharide complex coacervate matrix. The 
synergistic or competitive interactions between the probiotic bacteria and omega-3 fatty 
acids when packaged in a single microcapsule was determined including how best to utilise 
such interaction to achieve improved oxidative stability of omega-3 fatty acid and better 
survival of the probiotic bacteria. 
 
Encapsulation and co-encapsulation of tuna oil (O) and Lactobacillus casei 431 (P) as 
models of omega-3 and probiotic bacteria, respectively, were carried out and the works is 
described in this thesis in five distinct sections. (1) The optimisation of the complex 
coacervation process between whey protein isolate (WPI) and gum Arabic (GA).  (2) 
Microencapsulation of tuna oil (O) in WPI-GA complex coacervates followed by spray and 
freeze drying to produce microcapsules (WPI-O-GA).  (3) Microencapsulation of probiotic 
bacteria L. casei 431 (P) in WPI-GA complex coacervates followed by spray and freeze 
drying to produce microcapsules (WPI-P-GA).  (4) Co-encapsulation of omega-3 oil and L. 
casei 431 together in WPI-GA coacervate matrix followed by spray and freeze drying to 
produce co-microcapsules (WPI-P-O-GA). (5) In-vitro digestion evaluation of co-
microcapsules and microcapsules to indicate bioavailability. 
 
iii 
 
The viability of L. casei was significantly higher in WPI-P-O-GA co-microcapsules than in 
WPI-P-GA microcapsules in both spray and freeze dried microcapsules. The oxidative 
stability of tuna oil was significantly higher in spray dried co-capsules. Also, co-
microencapsulation increased the survivability of L. casei during simulated digestion. 
There was no significant influence observed on the release properties of omega-3 oil due to 
co-microencapsulation. However, the total omega-3 fatty acids in the released oil during 
in-vitro digestion were found to be higher, when co-microencapsulated. Hence, co-
microencapsulation was shown to protect the L. casei and deliver both viable cells and 
omega-3 oil to human intestine without any significant adverse effect on their functionality 
and properties.  
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Chapter 1 
Introduction 
 
1.1. Background 
Consumers expect health benefits and disease prevention, beyond basic nutrition, from 
their diet, and this requires the development of foods with specific physiological function 
(Hilliam, 1996). Accordingly, functional foods have become an important category within 
the food industry (Stanton et al., 2001). Novel and innovative nutraceuticals and functional 
food products are being designed and manufactured to fulfil this growing demand (Earle, 
1997; Jones et al., 2007). Two of the most widely used bioactive ingredients used in 
functional foods due to their unique health benefits are probiotic bacteria (Nazzaro et al., 
2012) and omega-3 fatty acids (Verbeke et al., 2005; Verbeke et al., 2009) (Table 1.1). 
Microencapsulation technology has been successfully used to incorporate these bioactive 
ingredients in food matrices. Microencapsulation can be defined as the technology of 
packaging solid, liquid and gaseous materials in small capsules (micro level) that release 
their content at controlled rates over a prolonged period of time with suitable designs of 
wall materials and processing conditions. 
 
Probiotic bacteria are a group of bacteria which are defined as ‘live microorganisms which 
when administered in adequate amounts confer a health benefit on the host’ (FAO/WHO, 
2002). Many studies report on the incorporation of probiotic bacteria in a range of food 
products (Farnworth et al., 2006). However, a major challenge in relation to the application 
of probiotic cultures in functional foods is the maintenance of viability during processing 
and host’s natural barrier such as gastrointestinal transit (De Prisco et al., 2016). 
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Microencapsulation technologies are a promising prospect for introducing viable probiotic 
bacteria in foods because the encapsulation matrix can provide a certain degree of 
protection against physical and chemical stressors until it reaches the gastrointestinal tracts 
(Mattila-Sandholm et al., 2002, Del Piano et al., 2011).  
 
Table 1.1: Health benefits of omega-3 fatty acids and probiotic bacteria 
Bioactive ingredients Health benefits  References 
      
Omega- 3 fatty acids Reduce the risk of cardiovascular diseases, decrease 
the overall mortality rate, minimize  mortality owing 
to myocardial infarction 
Bucher et al., 2002;           
Wen et al., 2013 
      
  Immunomodulatory and anti-inflammatory effect  Wall et al., 2010;        
Tousoulis et al., 2014 
      
  Reduce the risk of cancer  Rossmeisl et al., 2014; 
Berquin et al., 2008 
      
  Help brain development and overall function McNamara et al., 2006; 
      
  Ease depression  Su et al., 2014 
      
  Prevention and curing of Alzheimer’s disease Luchtman et al., 2013 
      
Probiotic bacteria Improve gastrointestinal health  Gorbach, 2000 
      
  Reduce infection and improve immune response  Nayak, 2010 
      
  Help in the treatment of diarrhoea Wanke et al., 2013 
      
  Prevention of eczema Abrahamsson et al., 
2007 
      
  Help and improve good functionality of brain  Davari et al., 2013 
      
  Anti-cancer effect de LeBlanc et al., 2010 
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Omega-3 fatty acids are defined as polyunsaturated fatty acids (PUFAs) with their first 
carbon-carbon double bond present at the third carbon from the terminal methyl group and 
they are considered as essential fatty acids (Shahidi, 2015) and hence it is essential to take 
omega-3 fatty acids through food (Kris-Etherton et al., 2003). The increased consumption 
of omega-3 rich foods is hindered by their poor compatibility in water-based products and 
susceptibility to oxidative degradation due to their polyunsaturated nature, which can lead 
to off-flavours, off-odours, and loss of bioactivity (Barrow et al., 2007). Therefore, 
stabilisation of omega-3 rich oils using suitable microencapsulation technology is essential 
for successful incorporation of omega-3 rich oils in a broad spectrum of food products and 
beverages (Augustin et al., 2015). An increased trend of enriching food products with 
omega-3 fatty acids has been observed in the last few decades specifically for food 
products such as milk, bread, and pasta (Augustin et al., 2015). 
 
Complex coacervation is a liquid-liquid phase separation phenomenon that occurs when 
electrostatically opposite charged biopolymers are brought together under certain specific 
conditions. Barrow et al (2007) reported that it is one of the most effective methods of 
microencapsulating omega-3 fatty acids rich oils, primarily using gelatine as the wall 
material. Broadening the range of suitable wall material for the microencapsulation is 
important for expanding the scope and applicability of this important technique. Hence, 
this thesis explores the process of complex coacervate formation between cationic whey 
protein isolate and anionic gum Arabic. WPI is prepared from whey which is a by-product 
of cheese making and it has been widely used in the food processing industry due to its 
nutritional qualities and unique physio-chemical properties such as emulsion stabilization 
and gel formation (Adhikari et al., 2007). GA is a complex polysaccharide which shows a 
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negative charge above pH 2.2 and it is one of the most commonly used stabilizers in the 
food and pharmaceutical industries (Nie et al., 2013).  
 
A review of current literature suggested that the microencapsulation of omega-3 fatty acids 
and probiotic bacteria has, so far, been carried out individually (Barrow et al., 2009; 
Oliveria et al., 2007; Arslan et al., 2015; Gómez-Mascaraque et al., 2016 ). Co-
encapsulation of omega-3 fatty acids and probiotic bacteria in a single matrix has not been 
described. Halwani et al. (2008) reported that co-encapsulation of more than one core 
materials in an encapsulation system can enhance the bioactivity of individual components. 
Co-encapsulation has been widely used in pharmaceutical delivery systems; however, the 
co-encapsulation of more than one bioactive component with different characteristics such 
as omega-3 oil (hydrophobic) and probiotic bacteria (hydrophilic) is challenging, 
particularly using complex coacervation. 
 
Probiotic bacteria and omega-3 oils are known as unstable entities. When probiotic 
bacteria and omega-3 fatty acids are co-encapsulated in a single product, there may be 
synergistic and mutual stabilisation effect as well as increased health benefits. Interactions 
of these two inherently unstable entities when they are packaged together in a single 
microcapsule have to be studied to a considerable detail. Such interactions and resulting 
effects on the stability of either one or both entities can depend on the processing 
parameters against which the capsule formation process have to be optimised. A 
comparison of efficacy of complex coacervation followed by spray drying and complex 
coacervation followed by freeze drying must also be systematically assessed as these two 
drying processes are used industrially to produce food and pharmaceutical powders. This is 
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essential in quantifying the effect of the drying process on the particle formation process of 
wet microcapsules to enhance the storage life and to broaden the industrial applicability. 
 
This work aims at investigating the fundamental science underpinning microencapsulation 
using complex coacervation to optimise the formation of composite microcapsules 
containing omega-3 fatty acids and probiotic bacteria. This work further aims at 
investigating the process of formation of solid microcapsule from liquid microcapsule 
using both spray and freeze drying. The advances made in this study on the fundamentals 
of synergistic interaction between the probiotic bacteria and the omega-3 fatty acids and 
the effect of such interactions on the efficacy of microencapsulation (payload, 
encapsulation efficiency, oxidative stability etc.) will provide the technological basis for 
food industries to develop and manufacture composite liquid and/or solid microcapsules 
containing live probiotic bacterial cells and omega-3 fatty acids. 
 
In this context, this project involves investigation of the underpinning science of four 
research components. The first component involves the microencapsulation of omega-3 
rich tuna oil in WPI-GA complex coacervates followed by spray and freeze drying. The 
second component involves the microencapsulation of probiotic bacteria Lactobacillus 
casei (L. casei) in WPI-GA complex coacervates followed by spray and freeze drying. The 
third research component involves microencapsulation of the omega-3 rich tuna oil 
together with probiotic bacteria in a single WPI-GA complex coacervate microcapsule 
followed by spray and freeze drying. The release and digestion of the co-encapsulated tuna 
oil and survival of probiotic bacteria in simulated intestinal digestion are studied in the 
final section of this research. 
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1.2. Research Hypotheses  
The research hypotheses that underlines this thesis is as follow: “Synergistic interaction 
occurs between the probiotic bacteria and omega-3 fatty acids in a single microcapsule to 
achieve better stability of omega-3 fatty acids and better survival of the probiotic bacteria.” 
 
This thesis addresses the following research questions to test the research hypotheses 
systematically: (1) How can the process parameters be optimised to produce WPI-GA 
complex coacervates? (2) What is the best way to encapsulate omega-3 fatty acids in WPI-
GA complex coacervate? (3) How can the probiotic bacteria and omega-3 fatty acids be 
best co-encapsulated in WPI-GA complex coacervate? (4) Finally, can multicore complex 
coacervates be used to better microencapsulate and stabilise probiotic bacteria and omega-
3 fatty acids in a single complex coacervate until it reaches the human gastrointestinal 
tracts? 
 
1.3. Research Objectives 
This work involves understanding the synergistic or competitive interactions between 
probiotic bacteria and omega-3 fatty acids when packaged in a single microcapsule and 
how best to utilise such interaction to achieve improved stability of omega-3 fatty acid and 
longer survival of the probiotic bacteria. 
The specific objectives of the project are: 
1. To encapsulate omega-3 fatty acids in whey protein isolate-gum Arabic complex 
coacervate including developing the optimal complex coacervation process parameters. 
2. To encapsulate probiotic bacteria in whey protein isolate-gum Arabic complex 
coacervate including optimising the encapsulation process parameters. 
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3. To encapsulate omega-3 fatty acids and probiotic bacteria in a single (complex 
coacervate) microcapsule including optimising the encapsulation process parameters and 
determining stability of oil and survival of probiotic bacteria during storage. 
4. To conduct the comparative in vitro digestion studies on all the above microcapsules. 
 
1.4. Outline of Thesis  
This thesis is organized into eight chapters as outlined below. Six chapters (Chapter 2 to 
Chapter 7) have been peer reviewed as research manuscripts. The research described in 
Chapter 3 to Chapter 6 has been published while the contents compiled in Chapter 2 and 
Chapter 7 are currently undergoing peer review as manuscripts (Table 1.2). 
 
Chapter 1: This chapter provides the background of the thesis and presents the updated 
status of science and gaps in knowledge in the area covered by the thesis. The rationale 
behind the research theme and the research questions which this thesis addresses are also 
documented. The research hypotheses, objectives of this project and approaches to the 
work are documented in this chapter.  
Chapter 2: This chapter critically reviews the literature relevant to the thesis and covers 
fundamental concepts of complex coacervation process. It also covers microencapsulation 
and characterization of the individual ingredients, omega-3 fatty acids and probiotic 
bacteria, through complex coacervation. The bioavailability of these bioactive ingredients 
from the microcapsules has also been reviewed. Furthermore, recent advances on the co-
encapsulation of different bioactive ingredients and current technological hurdles 
associated with this technology are also reviewed. 
8 
 
 Chapter 3: This chapter documents the optimisation of the complex coacervation process 
between WPI and GA. The electrostatic complexation between two biopolymers as a 
function of different WPI to GA ratios, pH and morphology, was studied using 
turbidometric, zetapotential and confocal measurements. The microencapsulation of 
omega-3 oil was carried out with optimised WPI-GA complex coacervates. The two drying 
processes freeze drying and spray drying were used to produce powdered microcapsules. 
Microcapsules formed though there two processes were compared for surface oil, total oil, 
microencapsulation efficiency and oxidative stability.  
Chapter 4: This chapter documents the detailed protocol for the microencapsulation of 
probiotic bacteria L. casei in WPI-GA complex coacervates as well as the co-encapsulation 
of omega-3 oil and probiotic bacteria in WPI-GA complex coacervates. The two drying 
processes freeze drying and spray drying were used to produce powdered microcapsules. 
The physico-chemical and surface characteristics of microcapsules were studied.  
Chapter 5: Optimisation of spray drying to determine the best inlet and outlet air 
temperatures to produce co-microcapsules containing omega-3 oil and probiotic bacteria 
were investigated. Three sets of inlet and outlet air temperatures were used in nine 
combinations to produce powdered co-microcapsule. The viability of probiotic bacteria (L. 
casei), oxidative stability of omega-3 oil, surface oil, oil microencapsulation efficiency, 
surface elemental composition and morphology of the powdered samples were investigated 
and the results described in this chapter. 
Chapter 6: The main hypothesis of this thesis has been tested in this chapter. The 
interaction between probiotic bacteria and omega-3 oil in co-microcapsules, particularly in 
terms of oxidative stability of omega-3 oil and vitality/viability of probiotic bacteria and 
any synergistic outcome, were measured and possible mechanisms for synergy are 
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discussed. The effect of storage temperature and time on the survival and fermentation 
activity of L. casei and oxidative stability of tuna oil in the microcapsules/co-
microcapsules were determined. 
Chapter 7: The release behaviour of co-microencapsulated omega-3 oil and viability of co-
microencapsulated probiotic bacteria were studied to understand the applicability of 
complex coacervation-based co-capsules as a controlled release delivery system. 
The in-vitro digestibility of co-microcapsules (WPI-P-O-GA) and microcapsules (WPI-P-
GA and WPI-O-GA) on sequential exposure to simulated salivary, gastric and intestinal 
fluids were examined.  
Chapter 8: In this chapter, key conclusions drawn from current study are summarised. This 
chapter details the contributions made by this study to the field of microencapsulation and 
the advancement made in the co-encapsulation concept in food science. This chapter also 
provides future research directions based on the findings obtained and experience gained in 
this study.  
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Table 1.2: Publication summary of chapters 
Chapter 
number Title of the paper Journal  Status  
Contribution 
of candidate 
(%) 
2 Recent advances in the microencapsulation 
of omega-3 oil and probiotic bacteria 
through complex coacervation: A review  
Trends in food 
science and 
technology 
    Submitted 80 
          
3 Complex coacervation with whey protein    
isolate and gum Arabic for the 
microencapsulation of omega-3 rich tuna oil  
Food and Function Published 80 
          
4 Co-encapsulation and characterization of 
omega-3 fatty acids and probiotic bacteria        
in whey protein isolate-gum Arabic complex 
coacervates 
Journal of Functional 
Foods 
Published 80 
          
5 Survival, oxidative stability and surface 
characteristics of spray dried 
co-microcapsules containing omega-3 fatty 
acids and probiotic bacteria  
Drying Technology Published 80 
          
6 Survival and fermentation activity of 
probiotic bacteria and oxidative stability of 
omega-3   oil in co-microcapsules during 
storage 
Journal of Functional 
Foods 
Published 80 
          
7 In-vitro digestion of co-microencapsulated 
probiotic bacteria and omega-3 oil in whey 
protein isolate-gum Arabic complex 
coacervates 
Food Chemistry Published 80 
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Chapter 2 
Recent advances in the microencapsulation of omega-3 oil and probiotic bacteria 
through complex coacervation: A review 
 
Abstract  
Background: Functional foods are one of the fastest growing sectors of the food industry. 
The development of functional foods comprising omega-3 fatty acids and probiotic 
bacteria, through complex coacervation process is an emerging area of research and 
product development.  
Scope and approach: We reviewed relevant literature concerning the use of complex 
coacervation in microencapsulation, focusing primarily on the inclusion of probiotic 
bacteria and omega-3 oils into a single delivery format. This review covers advantages and 
disadvantages of the complex coacervation process to microencapsulate bioactive 
ingredients, viability of probiotic bacteria and oxidative stability of omega-3 oil during the 
complex coacervation process, the bioaccessibility of omega-3 oil and probiotic bacteria 
during simulated gastrointestinal conditions and in-vivo testings.  
Key results and conclusions: The review describes the advantages of co-encapsulation 
using complex coacervation followed by spray drying. It also describes the technological 
hurdles that need to be resolved for further development of industrial applications of co-
microencapsulation of probiotic bacteria and omega-3 lipids. The co-encapsulation concept 
has been widely used in pharmaceutical delivery systems, but is a relatively new concept in 
food ingredient stabilisation and delivery. 
Key words: Functional foods, co-microencapsulation, omega-3 oil, probiotic bacteria, 
complex coacervation 
17 
 
 
2.1. Introduction 
There has been a substantial increase in the demand for delivering bioactive ingredients 
through everyday foods over the last few decades, particularly due to the increased 
awareness of healthy life and the impact of food on health (Goldberg, 2012). 
Consequently, the functional food industry has become a rapidly growing sector of the 
food industry (Pulz et al., 2004). Novel and innovative nutraceuticals and functional food 
products are being designed and manufactured by incorporating different bioactive 
ingredients to fulfil growing consumer demand (Neethirajan et al., 2011).  
 
The industrial production of functional foods requires the addition of stable bioactive 
ingredients (Champagne et al., 2007). Incorporation of bioactive ingredients to produce 
functional foods presents numerous challenges, particularly with respect to the stability of 
the bioactive compounds during processing and storage. It is also essential to prevent 
undesirable interactions with the carrier food matrix and to ensure their stability without 
losing functionality until they reach the human gastrointestinal tract and finally release the 
bioactive ingredients to the targeted site (Champagne et al., 2007). Microencapsulation of 
bioactive ingredients could address some of these requirements (Desai et al., 2005).  
 
Microencapsulation technology has been defined as the technology of packaging solid, 
liquid and gaseous materials in small capsules that release their contents at controlled rates 
over prolonged periods of time (Champagne et al., 2007). Microencapsulation technology 
is commonly used in pharmaceutical and food industries (Mastromatteo et al., 2010). 
Shahidi et al (1993) proposed six significant reasons for applying microencapsulation in 
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food industry: to decrease any undesired reaction of core material with environmental 
factors such as heat, moisture, air, and light; to reduce or prevent the loss of the core 
material to outside the environment; to promote easier handling; to minimize or prevent the 
release of the core material until encountering the right stimulus; to mask the taste and 
odour of the core; and finally to dilute the core material when it is intended to use in very 
small amounts and to separate components in a mixture that would otherwise react with 
each another.  
 
According to Gouin (2004), microencapsulation technology is not only used to produce 
value added food products but also used to produce entirely new and stable functional food 
components with desirable properties. This technology helps imparting improved 
controlled release properties. The applicability of a microencapsulation process in the food 
industry depends on the cost of the product given the pressure to keep the price low 
without compromising its health benefits (Gouin, 2004; Desai et al., 2005). Therefore, the 
factors that needed to be considered in the design of any functional food ingredient through 
microencapsulation in industrial scale are the cost of production, applicability in a wide 
range of products and ease of scale-up. 
 
Two of the leading bioactive ingredients used in functional food products are probiotic 
bacteria (de Pinho Ferreira Guine et al., 2012) and omega-3 fatty acids (Kim et al., 2006). 
The functional foods developed from probiotic bacteria and omega-3 fatty acids have 
proven health benefits (Nazzaro et al., 2012; Wildman et al., 2016). Over the last few 
decades, a large number of food products have been fortified with probiotic bacteria and 
omega-3 oil, as illustrated in Table 2.1 
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Table 2.1: Food products fortified with omega-3 fatty acids and probiotic bacteria 
Bioactive 
ingredients 
Source of bioactive 
ingredient  
Food 
category 
Commercial 
product name 
Manufacturer/Country 
Probiotic 
bacteria 
  
  
  
  
  
  
  
  
  
L. casei immunitas 
(DN-114001) 
Yogurt DanActiva Dannon (France) 
L. ramnosus GG 
(ATCC 53103) 
Infant 
formula  
Mead Johnson 
Nutrition 
(Enfamil 
Nutramigen) 
Valio (Finland) 
Lactobacillus 
plantarum (LP299V®) 
Juice drink GoodBelly 
probiotic juice 
drink, Probi’s 
probiotic drink 
GoodBelly (USA) 
L. acidophilus NCFM 
(ATCC SD5221) 
Infant 
formula  
Heinz Nuture 
Toddler 
DuPont Danisco 
Danisco probiotic 
strains-Howaru 
Dophilus and Howaru 
Bifidioacidophilus 
Chocolate Attune Foods 
Probiotic Bar 
Attunefoods (USA) 
 Lactobacillus casei 
Shirota 
Fermented 
milk drink 
Yakult Yakult (Japan) 
Bifidobacteria Baby 
formula 
Good Start 
Natural Cultures 
Nestle (Canada) 
S. salivarius BLIS K12 Chewing 
gum 
Probioticgum CulturedCare (Canada) 
Bifidobacterium 
longum BB536  
Milk Caldus milk Morinaga Milk Industry 
Co. Ltd. (Japan) 
Lactobacillus 
plantarum (LP299V®) 
Fruit drink ProViva Dannon (France) 
Omega-3 
fatty acids 
  
  
  
  
  
  
_ Bakery 
products 
F Plus fortified 
biscuits  
Cuetara (Spain) 
Tuna oil Bread Tip Top® The 
One 
Coles (Australia) 
_ Eggs DHA Gold eggs  Omega Tech (USA) 
_ Spread Blue Gaio Arla (Denmark) 
Menhaden oil Buttery 
spread 
SmartBalance 
OmegaPlus 
GFA Brands Ltd.(USA) 
Flax seed oil Dairy Fortified 
skimmed milk 
Natrel (Canada) 
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Probiotic bacteria are a group of bacteria which are defined as live microorganisms which 
when administered in adequate amounts confer a health benefit on the host (FAO/WHO, 
2002). Some of the health benefits associated with probiotic bacteria are alleviation of 
unwanted gastric and abdominal symptoms (Gomi et al., 2015), an improved immune 
response (Bogsan et al., 2014), reduction of total cholesterol (Ejtahed et al., 2011), and 
enhancement of intestinal microbiota (Wang et al., 2012). Probiotic bacteria require 
protection from metabolic inactivation due to their sensitivity to environmental factors 
such as heat, oxygen and humidity (Peighambardoust et al., 2011). There are several 
criteria that probiotic bacteria must satisfy, if they are to contribute in a positive way to 
human health, including their viability during manufacturing, storage and delivery. It is 
essential that the probiotic bacteria survive during the passage through the upper 
gastrointestinal tract in order to preserve their ability to function in the gut environment 
(De Prisco et al., 2016). Microencapsulation improves survivability of probiotic bacteria 
during processing as well as during the passage through the gastrointestinal tract 
(Champagne et al., 2007).  
 
Omega-3 fatty acids provide well established and clinically proven health benefits to 
humans (Surette, 2008). Omega-3 fatty acids are defined as polyunsaturated fatty acids 
(PUFAs) with their first carbon-carbon double bond present at the third carbon from the 
terminal methyl group (Qi et al., 2004). The main bioactive omega-3 fatty acids are cis-
5,8,11,15,17-eicosapentaenoic acid (EPA) and cis-4,7,10,13,16,19-docosahexaenoic acid 
(DHA), as shown in Fig. 2.1. They are considered physiologically essential fatty acids and 
have numerous physiological roles (Barrow et al., 2013). Omega-3 fatty acids are 
recommended for decreasing the risks of cardiovascular disorders, Alzheimer’s disease, 
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immune response disorders, diabetes and cancer (Luchtman et al., 2013; Wen et al., 2014; 
McNamara et al., 2006; Rossmeisl et al., 2014). There is a high commercial need for 
omega-3 fatty acids; for example, the estimated global demand for omega-3 ingredients 
was worth USD 1595 million in 2010 and is estimated to exceed USD 4000 million in 
2018 (Transparency Market Research, 2012). Fish oil usually contains a higher proportion 
of omega-3 fatty acids than seed oils and algal oil (Rubio-Rodríguez et al., 2010). 
However, oil containing high amount of omega-3 fatty acids are highly sensitive to 
oxidation due to their polyunsaturated nature, which not only results into loss of nutritive 
value but also develops off-flavours (Karlsdottir et al., 2014). When encapsulated, the 
omega-3 fatty acids are more stable in food matrix (Smith et al., 2015). 
 
 
 
Fig. 2.1: Chemical structure of EPA and DHA. (Adapted from Kralovec et al., 2012)  
 
There are several microencapsulation methods that have been used or at least studied for 
microencapsulation of omega-3 oil and probiotic bacteria. These methods include complex 
coacervation (Barrow et al., 2009, Liu et al., 2010, Oliveria et al., 2007 and Conto et al., 
2013), spray drying (Quispe-Condori et al., 2011; Arslan et al., 2015), emulsion followed 
by spray granulation, fluidized bed drying, freeze drying (Anwar et al., 2011), 
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electrospraying (Coghetto et al., 2016; Gómez-Mascaraque et al., 2016). This review 
focuses on complex coacervation microencapsulation techniques as applied to encapsulate 
omega-3 oil and probiotic bacteria.  
 
This review considers the emerging field of co-encapsulation in the food industry. To date, 
published reviews address microencapsulation of either probiotic bacteria or omega-3 fatty 
acids. Within this review, the complex coacervation method of microencapsulation will be 
discussed followed by an overview of research works reported on microencapsulation of 
omega-3 oil, probiotic bacteria and their co-encapsulation using complex coacervation. A 
brief overview of the digestion of probiotic cells and omega-3 fatty acids in the gastro-
intestine system in-vitro and in-vivo models will then be presented. To close, future trends 
in the microencapsulation field will be discussed with reference to implication for the food 
industry. 
 
2.2. The complex coacervation process of microencapsulation 
A brief overview of complex coacervation process of microencapsulation is presented in 
this section. The electrostatic interaction between oppositely charged biopolymers results 
into the formation of soluble complexes, which further aggregate to decrease the free 
energy of the system until their size and surface properties render them insoluble. 
Subsequently, a liquid–liquid phase separation occurs which is known as complex 
coacervation (Schmitt et al., 2011).  De Kruif et al. (2004) defined complex coacervation 
as a liquid–liquid phase separation phenomenon that occurs when electrostatically opposite 
charged biopolymers (protein/polysaccharides) are brought together under certain specific 
conditions. Some of the important and specific conditions influencing this process are pH, 
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ionic strength, polymers concentration, ratio of biopolymers, molecular weight of 
biopolymers, temperature, and the degree of homogenization (Fig. 2.2). Many authors have 
endeavoured to optimize the complex coacervation parameters between protein-
polysaccharide pairs (Eratte et al., 2015, Kaushik et al., 2016; Timilsena et al., 2016; Wang 
et al., 2013; Schmitt et al., 2011).  
 
There has been strong interest over the last thirty years to develop different protein-
polysaccharide complex coacervates to microencapsulate unstable bioactive ingredients for 
industrial applications (Turgeon et al., 2007). The microcapsules that use complex 
coacervates as shell material generally have diameters ranging from nanometres to few 
millimetres. Depending on the size of the capsules, they can be classified as microcapsules 
(micron size) and nanocapsules (submicron size). Typical particle diameters of 
microcapsules are in the range of 1 μm to 1000 μm; whereas nanocapsules typically have 
diameters < 0.2 μm. Desired properties for these biopolymeric complex coacervate based 
capsules are biocompatibility, nontoxicity and biodegradability and controlled release 
capability (Kaushik et al., 2015). Furthermore, complex coacervation is a well-adapted and 
benign method since neither any organic solvents nor extreme reaction conditions are 
required. Frequently used proteins to produce complex coacervates are gelatine, albumin, 
whey protein, beta-lactoglobulin and various plant proteins. Common polysaccharides are 
gum Arabic, chitosan, pectin, alginates, xanthan gum, carrageenan, and carboxymethyl 
cellulose. Recently, plant gums such as flaxseed gum (Kaushik et al., 2016) and chia seed 
gum (Timilsena et al., 2016) have also been used to successfully encapsulate flaxseed oil 
and chia seed oil, respectively. 
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Fig. 2.2: Factors affecting the protein-polysaccharide complex coacervation process 
 
2.3. Microencapsulation of omega-3 oil through complex coacervation 
Microencapsulation of omega-3 oil through complex coacervation presents advantages and 
disadvantages of this technology for the food industry. In-vitro and in-vivo digestion 
studies on microencapsulated omega-3 oil must also be considered to determine the 
appropriateness of this methodology. 
2.3.1. Complex coacervation to microencapsulate omega-3 oil 
Omega-3 polyunsaturated fatty acids, particularly eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA) have clinically proven health benefits (Simopoulos, 1991). 
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However, the daily consumption of these fatty acids is generally too low, a fact attributed 
for the risk of some chronic diseases in humans (Kaushik et al., 2015). Hence, increased 
intake of omega-3 fatty acids is highly recommended, particularly in Western countries 
with a low intake. An approach to increasing consumption, without making major changes 
to eating habits, is to enrich frequently consumed and common food products with omega-
3 fatty acids. However, omega-3 oils are very unstable due to their polyunsaturated nature 
and become rapidly oxidized leading to the formation of primary and secondary oxidation 
products such as peroxides, aldehydes and ketones. These oxidation products not only 
cause unpleasant odour and taste but also degrade the functional values of the omega-3 oils 
(Decker et al., 2010). The use of antioxidants can delay lipid oxidation (Logani et al., 
1980). However, the availability of food grade antioxidants is quite limited. For example, 
cinnamic and benzoic acid derivatives, oregano, rosemary, parsley, flavonoids and 
phenolic compounds have been used to increase the stability of omega-3 oils against 
oxidation (Espinosa et al., 2015). However, the use of antioxidants alone is generally not 
adequate to enable sensory stabilisation of these oils for addition to many foods and 
beverages (Kralovec et al., 2012). Moreover, the antioxidant mechanisms in multi-
component and multiphase food systems are complex and hence it is difficult to predict the 
behaviour and efficacy of an antioxidant in preventing lipid oxidation in food materials 
(Jacobsen et al., 2008). Therefore, the application of emulsifiers (proteins or/and 
polysaccharides) in combination with antioxidants has been studied to increase the stability 
of omega-3 oils (Baik et al., 2004). Microencapsulation of omega-3 oils using 
emulsification followed by spray drying has been successfully used to increase the shelf-
life of this type of ingredients (Barrow et al., 2007). It has been reported that this 
technology can be successfully used in large variety of foods such as infant formulas and 
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bread mixes (Schrooyenet al., 2001), cream filled sandwich cookies (Borneo et al., 2007), 
and instant foods such as soups, cocoa drinks, potato puree, milk products etc. 
(Kolanowski et al., 2007).  
 
Barrow et al. (2007) reported that complex coacervation is one of the most effective 
methods for microencapsulating omega-3 fatty acids and delivering them into foods. The 
complex coacervates using gelatine-gum Arabic to microencapsulate omega-3 oil has been 
commercialised by Ocean Nutrition Canada (Barrow et al., 2007). The complex 
coacervation-based microencapsulation produces agglomerates/assembles of micron sized 
single cores  by primary (inner) as well as secondary (outer) shells and impart greater 
mechanical and oxidative stability to omega-3 oils (Barrow et al., 2009; Wang et al., 2014; 
Eratte et al., 2014). The complex coacervation-based oil microencapsulation process 
generally involves three key steps (Wang et al., 2014). The first step involves preparation 
of a stable oil-in-water emulsion. The second step is the complex coacervation step in 
which the emulsified oil droplets are coated by protein-polysaccharide complex coacervate 
layer. This step involves optimization of pH, protein-to-polysaccharide ratio and the size of 
the oil droplets. The final step usually involves introducing crosslinkers and lowering of 
temperature so that a robust primary and secondary shells are formed and aggregates of 
fully coated oils droplets are produced. Enzymatic or chemical crosslinking of the shell 
matrix is carried out and the microcapsules are hardened in this step so that the shell 
material redissolve easily with mechanical forces. Microcapsules formed by this method 
have shown excellent controlled release characteristics (Jun-xia et al., 2011).  
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The liquid microcapsule obtained from the complex coacervation process is dried using 
suitable drying methods such as spray drying or freeze drying. However, this step of the 
process is to remove the water and not to form the microcapsule. This is a major difference 
between microencapsulation using spray drying and microencapsulation by complex 
coacervation followed by spray drying. In complex coacervation, the size and type of 
particle formed is controlled during the wet process and not by the drying process. 
Microcapsules produced through complex coacervation followed by spray drying or freeze 
drying possess higher payload and improved stability compared with spray dried or freeze 
dried microcapsules prepared through simple emulsion (Barrow et al., 2007).  
 
Table 2.2 summaries work to date on the microencapsulation of omega-3 oil using 
complex coacervation followed by drying. Gelatine-gum Arabic is the most commonly 
used protein-polysaccharide combination in the complex coacervation process. The 
variation of charge density of gelatin with pH and its unique gelling behavior makes it 
particularly suitable for complex coacervation process compared to other proteins. 
Moreover, the coiled structure of gelatin maintains sufficient charge density on its chains 
to avoid precipitation irrespective of the anionic compound used. On the other hand, gum 
Arabic also has a coiled configuration which preserves the charges and allows considerable 
quantity of water to be occluded between the chains to avoid precipitation (Ducel et al., 
2004). The food industry sees the development of new protein-polysaccharide complex 
coacervates as shell materials that does not involve gelatine as desirable. For this, the 
complex coacervation process of each protein-polysaccharide combinations has to be 
optimized. Interestingly, many studies have characterised the physiochemical properties of 
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complex coacervates; however, their performance in food formulations have received very 
little attention (Table 2). 
 
Table 2.2: Complex coacervation to microencapsulate omega-3 oil. 
Omega-3 oil Wall materials  Drying 
techniques 
Oxidative 
stability 
Incorporation 
into foods 
References 
Eicosapentaenoic 
acid ethyl ester 
Gelatine and acacia Spray 
drying 
Increased  No Lamprecht et 
al., 2001 
Fish oil  Gelatine and 
polyphosphate 
Spray 
drying 
Not tested No Barrow et al., 
2009 
Omega-3 marine 
lipids 
Whey protein 
isolate and gum 
Arabic 
Not applied Not tested No Zhang et al., 
2009 
Flax seed oil Gelatine and gum 
Arabic 
Freeze 
drying 
Increased  No Liu et al., 
2010 
Microalgal oil Gelatine and gum 
Arabic 
Oven dried Not tested No Zhang et al., 
2012 
Fish oil ethyl 
ester 
Soy protein isolate 
and gum Arabic 
Freeze 
drying 
Increased  No de Conto et 
al., 2013 
Cod liver oil Sodium caseinate 
and gum Arabic 
Freeze 
drying 
Freeze 
drying 
Commercial 
mixed fruit 
juice 
Ilyasoglu et 
al., 2014 
Tuna oil Gelatine and 
sodium 
hexametaphosphate 
Freeze 
drying 
Increased  No Wang et al., 
2014 
Tuna oil Whey protein 
isolate and gum 
Arabic 
Freeze 
drying and 
spray 
drying 
Increased  No Eratte et al., 
2014 
Linseed oil Gelatine and gum 
Arabic 
Not dried Not tested No Ach et al., 
2015 
Stearidonic acid 
soybean oil 
Gelatine and gum 
Arabic 
Freeze 
drying  
Increased  No Ifeduba et al., 
2016 
Flax seed oil Flax seed protein 
and gum  
Spray 
drying and 
freeze 
drying 
Increased  No Kaushik et al., 
2016 
Chia seed oil Chia seed protein 
and gum  
Spray 
drying and 
freeze 
drying 
Increased  No Yakindra et 
al., 2016 
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Astaxanthin-
containing lipid 
extract from 
shrimp waste 
Gelatine and 
cashew gum 
Freeze 
drying  
Increased  Plain yogurt Gomez-
Estaca et al., 
2016 
 
Compared to conventional microencapsulation methods such as spray drying of oil-in-
water emulsion, this “multicore” complex coacervation process achieves greater than 50% 
payload. This process also produces a thicker outer shell compared to the emulsion method 
thereby decreasing the surface oil and improving the oxidative stability of omega-3 oil. 
The complex coacervate-based shells provide microcapsules with good sensory properties 
and storage stability (Barrow et al., 2007; Wang et al., 2014). This process helps the 
production of microcapsules in the desired size range (1 to 1000µm) and successfully 
prevents the migration of oil to the particle surface and gives greater protection to the 
encapsulated omega-3 oil (Kaushik et al., 2014). The higher payload in microcapsules 
obtained by complex coacervation followed by spray drying makes it more cost effective 
for delivering of omega-3 oils (Kralovec et al., 2012).  
 
There are few limitations with the complex coacervation technology. The protein-
polysaccharides complex coacervates formed are stable on a very narrow range of pH, 
ionic strength and temperature. Therefore, reaching the correct endpoint and stabilizing the 
coacervate formed before cross-linking requires careful monitoring of the process (Zhang 
et al., 2009; Kaushik et al., 2014). As stated above, gelatine is ubiquitously used by 
industry as wall material to produce complex coacervates. This protein is not suitable for 
the vegetarian population and has poor sensory properties in some food applications 
(Kralovec et al., 2012). Alternative shell materials are required for use in the complex 
30 
 
coacervation process; however, the development of alternative protein-polysaccharide 
complex coacervates requires rigorous optimisation (De Kruif et al., 2004). 
2.3.2. Bioaccessibility of EPA and DHA from omega-3 microcapsules 
Bioaccessibility has been defined as the fraction of an ingested nutrient that is released 
from the food matrix and is available for absorption in the gut after digestion (Ilyasoglu et 
al., 2014). The relationships or links between food properties, human digestion processes, 
and final health outcomes have to be established to design a successful functional food. 
The initial assessment of any new microencapsulated product to test these relationships is 
to use in-vitro tests. This is because the in-vitro test incurs less cost, is rapid and avoids the 
need for ethics approval (Polli, 2008; Minekus et al., 2014). These in-vitro studies enable 
the food industry to design foods to modulate lipid digestion and absorption within the 
human gastrointestinal tract using simple simulated tests (Zhang et al., 2015). Therefore, it 
is useful to test the stability/survival and release behaviour of omega-3 and probiotic from 
these microcapsules during salivary and gastrointestinal transit prior to proceeding to full-
fledge in-vivo trials. 
 
The digestion and absorption of dietary omega-3 lipids in the human gastrointestinal tract 
are complex processes involving numerous physicochemical and biochemical events (Fave 
et al., 2004). Extensive reviews on fat digestion in gastrointestinal tracts are available 
(Embleton et al., 2007; Singh et al., 2009). In humans, the first step of fat digestion takes 
place in the stomach. Gastric lipases secreted in the gastric juice hydrolyse oils under 
acidic conditions (Ilyasoglu et al., 2014). Subsequently, the digestion of fat is completed in 
the small intestine, where absorption of lipolytic products occurs. The digestion of 
encapsulated oils is activated after adsorption of lipase to the oil–water interface of 
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emulsified oil droplets (Ilyasoglu et al., 2014). It has been reported that the digestion of oil-
in-water emulsions is influenced by several factors: (a) size of the oil droplet; (b) the 
nature of the interfacial layer (Mun et al., 2007); (c) the physical state of the lipid; (d) the 
presence of other ingredients in the emulsion systems such as fibers and polysaccharides; 
and (e) the composition of digestion fluids (Chung et al., 2011). A substantial body of 
literature exists on various aspects of in-vitro digestion studies omega-3 oil emulsions 
(Klinkesorn et al., 2009; Farvin et al., 2010; Christophersen et al., 2016); however, only 
limited information exists on the in-vitro evaluation of oil release from the solid 
microencapsulated omega-3 oil. Ilyasoglu et al. (2014) reported the bioaccessibility of 
EPA, DHA and EPA + DHA as 56.16, 36.25 and 47.37 percent, respectively, from solid 
microencapsulated cod liver oil in sodium caseinate-gum Arabic complex coacervates. The 
authors suggested three main reasons for this low bioaccessibility values. Firstly, the 
lamination of fish oil with two interfacial complex coacervate layers might have led to a 
decrease in lipid digestibility. Secondly, the protein moiety of gum Arabic can strongly 
interact with the oil-water interface, possibly blocking the available interface thereby 
preventing the release of the non-esterified fatty acids generated at the droplet surface. 
Finally, some of the fish oil could reach the colon without lipolysis. It has been reported by 
Shen et al. (2011) that lipolysis of microencapsulated omega-3 oil powder during in-vitro 
digestion can be affected by the food matrix, its structure (e.g., solid versus liquid), and 
also by its composition. For example, after sequential exposure to simulated gastric and 
intestinal fluids, much higher extents of lipolysis of both EPA and DHA were obtained. 
For example, 73.2-78.6% of EPA and DHA were lipolyzed in neat microencapsulated tuna 
oil powder, fortified orange juice, and yogurt and 60.3- 64.0% were in the fortified cereal 
bar. The authors concluded that fortified cereal bar contained the highest content of fat and 
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polysaccharide (e.g., dietary fibers) and had the largest relative oil droplet size exposed to 
simulated intestinal fluids and thus having the least bioaccessibility of EPA and DHA. The 
complexity of all the above factors are the technological hurdles that need to be resolved 
for the introduction of omega-3 oil in wide range of daily life food matrices. 
 
The microencapsulated bioactive ingredients will be beneficial, only if these are 
bioavailable and hence, testing the bioequivalence of encapsulated bioactive ingredients 
from microcapsules by conducting in-vivo studies are of prime importance. Barrow et al. 
(2007) reported a comparative human bioavailability study of microencapsulated omega-3 
fish oil and standard fish-oil soft-gel capsules and concluded that the fish oil 
microencapsulated using complex coacervation is bioavailable and bioequivalent to dietary 
supplementation with soft-gel capsules. On the contrary, Raatz et al. (2009) reported that 
there was increased absorption of omega-3 fatty acids, EPA and DHA and a reduction in 
the omega-6/omega-3 fatty acid ratio as evidenced by changes in plasma phospholipid fatty 
acids (PLFA) composition from a preparation of emulsified fish oil compared to the fish 
oil capsules as well as parent oil in human trials. Arterburn et al. (2007) reported that two 
different algal oil capsule supplements and an algal oil-fortified snack bar represent 
bioequivalent and safe sources of DHA in human trial. Patten et al., (2009) reported that 
the nature of the protein–carbohydrate encapsulation matrix used to prepare spray-dried 
fish oil powders influenced the digestibility of the encapsulated oil in the gastrointestinal 
tract of rats.  
 
A detailed understanding of the digestion of long chain polyunsaturated omega-3 fatty 
acids in different microencapsulated oil formulations and food matrices during in-vitro and 
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in-vivo digestion is lacking. Overall, research into factors that determine the choice of 
functional food is limited, and no studies to date have investigated the specific factors 
affecting the use of foods enriched with omega-3 fatty acids thorough clinical human 
studies to support the health claims, which are some of the spaces for future studies. 
 
2.4. Microencapsulation of probiotic bacteria through complex coacervation  
In this section we discuss the necessity for encapsulating probiotic bacteria, review 
probiotic microcapsules produced explicitly through complex coacervation, and provide a 
brief overview of in-vitro and in-vivo studies on encapsulated probiotic bacteria. 
2.4.1. Complex coacervation to microencapsulate probiotic bacteria 
Probiotic bacteria have been used as pharmaceutical products and as nutraceuticals and 
functional food ingredients (Martin et al., 2015). It has been generally accepted that the 
viability of probiotic bacteria in a food matrix should be more than 106 cfu/g, in order to 
impart effective health benefits (FAO/ WHO, 2002). There are various aspects that affect 
the viability of these bacteria in food matrices, irrespective of strains and genus (Burgain et 
al., 2011). These factors include physical and chemical properties of food products such as 
moisture content, acidity, temperature, buffering capacity in addition to the processing and 
storage conditions such as shear, temperature, humidity, and atmosphere (Martin et al., 
2015). As the ultimate objective is to deliver these bacteria through daily life foods and 
absorb into the human body, the food matrices in which probiotic bacteria are incorporated 
should support them to survive through the gastrointestinal tract and regulate the 
colonization of the gastrointestinal tract. Hence, the selection of suitable food systems to 
deliver viable probiotic bacteria to the targeted site is an important consideration in 
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developing functional probiotic foods (Martin et al., 2015). Microencapsulation is a 
promising and development approach that has been shown to improve the viability of 
probiotic bacteria in some food matrices. In fact, numerous food products containing 
encapsulated probiotic bacteria have been introduced and accepted by consumers (Burgain 
et al., 2011). 
 
Different methodologies and various wall materials have been tested for the 
microencapsulation of probiotic bacteria (Burgain et al., 2011; Kent et al., 2014; Tripathi et 
al., 2014; Martin et al., 2015; De Prisco et al., 2016). Here, we summarize the studies on 
the microencapsulation of probiotic bacteria, particularly by complex coacervation and 
subsequent drying and incorporation into food products. Ribeiro et al., (2014) reported that 
complex coacervation based microencapsulation does not expose microorganisms to as 
harmful condition as other prevailing techniques. Moreover, complex coacervation is 
particularly useful for the microencapsulation of probiotic bacteria that are required to be 
released when exposed to higher pH in the large intestine (Rathore et al., 2013). Table 2.3 
summarizes the significant work on complex coacervation to microencapsulate probiotic 
bacteria.  
 
The probiotic bacterial microcapsules produced through complex coacervation are usually 
dried so that they can be easily handled and stored. Drying methods include spouted bed 
drying, vacuum drying, freeze drying and spray drying (Cook et al., 2012). Spray drying is 
commonly used in the food industry since it is fast, economical and has a high throughput 
and yield (Keshani et al., 2015). It is also a mild technique compared to other convective 
air drying methods because of its very short product residence time (Kim et al., 2008).  
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Spray drying is 4-7 times less expensive than freeze drying (Klinkesorn et al., 2006). 
However, the viability of heat sensitive food components such as probiotic bacteria 
through spray drying can be a major challenge (Ghandi et al., 2012). Since spray drying is 
cost effective, scalable and efficient, many studies have investigated optimising spray 
drying and product formulations of probiotics towards increasing viability and minimising 
activity losses (Knorr, 1998; Tripathi et al., 2014; Eratte et al., 2016). 
 
Table 2.3: Complex coacervation to microencapsulate probiotic bacteria. 
Probiotic 
bacteria 
Wall 
materials  
Drying 
techniques 
Viability Incor
porati
on 
into 
foods 
References 
Bifidobacteri
um lactis 
and Lactobac
illus 
acidophilus 
Casein/pectin Spray drying  Preserved viability during 
drying and simulated gastric 
conditions 
No Oliveira et 
al., 2007 
Bifidobacteri
um lactis 
and Lactobac
illus 
acidophilus 
Casein/pectin Spouted bed 
drying 
Greater viability at a storage 
temperature of 7°C, but did 
not protect during simulated 
gastrointestinal conditions 
No Oliveira et 
al., 2007 
Lactobacillus  Gelatine/polyp
hosphate 
Not dried Preserved viability at storage 
temperature 10o C 
No Liu et al., 
2009 
Lactobacillus 
rhamnosus 
Pectin/whey 
protein 
Freeze drying Preserved viability during 
simulated gastrointestinal 
conditions 
No Gerez et al., 
2012 
 Lactobacillu
s acidophilus  
Pectin/whey 
protein 
Not dried Did not confer additional 
protection during simulated 
gastrointestinal conditions. 
No Gebara et al., 
2013 
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 Lactobacillu
s acidophilus  
Pectin/casein Freeze drying Preserved viability when 
stored under refrigerated 
conditions, but did not protect 
during simulated 
gastrointestinal conditions 
Buffal
o milk 
yogurt 
Shoji et al., 
2013 
Lactobacillus 
plantarum 
Whey protein 
isolate/ κ-
carrageenan  
Not dried Greater viability during 
simulated gastrointestinal 
conditions 
No Hernández-
Rodríguez et 
al., 2014 
L. 
acidophilus 
Pectin/whey 
protein 
Not dried Preserved viability on 
refrigerated storage for 35 
days 
Yogur
t 
Ribeiro et 
al., 2014 
Lactobacillus 
casei 
Whey protein 
isolate/gum 
Arabic 
Spray drying 
and freeze 
drying 
Greater viability when freeze 
dried 
No Eratte et al., 
2015 
 
A large number of articles have been published on the development of probiotic 
microcapsules and their application in food. However, this needs further and continuing 
investigations because many of the encapsulation technologies have practical difficulties 
for the food industry. For example, both intrinsic (culture selection, state of growth, 
subcellular injuries by heat or osmotic stress)  and extrinsic factors (composition of food 
matrices, pH value, oxygen level, food manufacturing conditions) are important for the 
retention of desired viability of probiotic bacterial cells in the final end product. 
Establishing relationships between any of these factors to bacterial viability is challenging. 
Also, each food matrix poses different and new challenges to different strains of probiotic 
bacteria, and hence generalization is problematic. In addition, the monitoring of cell 
viability and vitality along the entire food production chain, including storage is still 
challenging due to the time and resource consuming microbial assays. Further, the 
assessment of metabolism and fermentation activity of the microencapsulated probiotic 
bacteria require further investigation (De Prisco et al., 2016). Finally, a need for more 
stringent quality control in the preparation of probiotic formulations is required (Martin et 
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al., 2015). Current probiotic functional foods available through microencapsulation 
strategy are primarily focused on milk based products, leaving more technically 
challenging foods such as bakery, meat products, and vegetable based products to be 
developed. 
2.4.2. In-vitro and in-vivo studies on probiotic microcapsules 
The resistance of various probiotic bacteria microencapsulated through complex 
coacervation, to simultaneous changes in pH and in the presence of salivary and gastro-
intestinal (GI) enzymes has been examined. For example, Oliveira et al., (2007) studied the 
influence of casein/pectin complex coacervates for the protection of B. lactis and L. 
acidophilus in simulated GI conditions. In this study the authors concluded that complex 
coacervation, followed by spouted bed drying was adequate for microencapsulation of L. 
acidophilus during storage conditions at 7o C. However, this method was not efficient in 
protecting these microorganisms at pH values similar to those found in the human stomach. 
In another study, the same authors found that casein/pectin complex coacervate imparted 
better protection to both B. lactis and L. acidophilus, when microencapsulated in complex 
coacervate followed by spray drying during simulated GI conditions. Thus, the selection of 
the downstream drying process after complex coacervation is important in determining the 
performance of probiotic microcapsules (viability/vitality) during storage and 
gastrointestinal delivery. Possible cellular damage during the drying process can result in 
lower resistance of the encapsulated microorganisms to acidic conditions. Ghandi et al., 
(2013) reported that upstream processing conditions during spray drying such as the mode 
of atomization, rate of shear and presence or absence of antioxidants in the dryer feed 
affected the viability and vitality of dried bacterial cells. 
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Gebare et al. (2013) produced Lactobacillus acidophilus microcapsules in whey 
protein/pectin complex coacervates. This microencapsulation system conferred greater 
protective effect to Lactobacillus acidophilus as compared to the free cells. However, the 
whey protein/pectin did not confer additional protection to probiotic cells when exposed to 
simulated gastrointestinal conditions. In contrast, Gerez et al. (2012) found an 
improvement in the survival of probiotic bacteria, when they were microencapsulated in 
pectin particles coated with whey protein, after exposure to gastric conditions (pH 1.2), 
compared to free cells. Thus, this lack of confirming results make it difficult to select the 
most appropriate encapsulation process, parameters and wall materials, particularly for 
delivering viable microbial cells to the targeted sites (Liserre et al. 2007).  
 
In vivo testing of probiotics microencapsulated using complex coacervation is limited. 
Rodents are the most commonly used laboratory animals used in probiotics research, 
although only a limited number of studies have been published. Wurth et al. (2015) found 
neither sodium caseinate (SC) nor newly developed SGF-resistant fat SC (FSC) capsules 
could increase two Lactobacillus strain’s survival in the murine gastrointestinal system 
after 3 or 24 h of oral uptake, even though both showed good in-vitro effects. In contrast, 
Liu et al., 2016 reported that grafted alginate-sodium polyacrylate microcapsules enhanced 
the viability of probiotic Lactobacillus plantarum in the small and large intestinal fluids in 
both in-vitro and in-vivo analysis tests in rats. In-vitro evaluation followed by in-vivo 
studies on bioavailability of probiotic bacteria will enhance more insight of the 
applicability of the process to food industry.  
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2.5. Progress in the co-encapsulation of omega-3 oil and probiotic bacteria 
The co-encapsulation concept has been widely used in pharmaceutical delivery systems. 
Co-encapsulation of more than one bioactive components with different characteristics is a 
challenging and is a relatively new concept, particularly for nutritional purposes. Recently, 
Wang et al., (2015) reported that complex coacervates of gelatine and sodium 
hexametaphosphate could effectively microencapsulate tuna oil fortified with the multiple 
functional lipophilic ingredients, vitamin A, D3, E, K2, curcumin and coenzyme Q10.  
Further, it was reported that complex coacervates of whey protein isolate-gum Arabic 
could successfully microencapsulate lipophilic omega-3 oil and liphophobic probiotic 
bacteria (Eratte et al., 2015). A detailed illustration of the co-encapsulation process and 
produced structures is shown in Fig. 2.3A and Fig. 2.3B, respectively (Eratte et al., 2015). 
These studies show that microencapsulation using complex coacervation is suitable for 
stabilizing multiple bioactive lipophilic and liphophobic food ingredients. In-vivo testing is 
needed to confirm the simulated studies. Food companies are under pressure to develop 
functional foods with higher nutritional value, lower dose of synthetic preservatives and 
better organoleptic features within a budget. Co-encapsulation of multiple unstable 
ingredients decreases processing costs per ingredient, improving efficiency, but can also 
result in a more stable or improved product, as observed for the co-encapsulation of 
omega-3 and probiotics.  
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Fig. 2.3A: 1) Schematic representation of co-encapsulation of omega-3 oil (O) and 
probiotic bacteria (P) in whey protein isolate (WPI)-gum Arabic (GA) complex 
coacervates; (2) Optical micrographs of WPI-P-O-GA co-capsules formation: (A) Coarse 
tuna oil emulsion i in WPI; (B) Microfluidized tuna oil emulsion in WPI; (C) Complex 
mixture of bacterial cells and tuna oil in WPI-GA solution; (D) WPI-P-O-GA 
microcapsules formed at optimized conditions; (3) Spray dried WPI-P-O-GA 
microcapsules. Scale bar 5 µm for the spray dried microcapsules images 
(1) 
(2) 
(3) 
A 
 
B 
 
C 
 
D 
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Fig. 2.3B: Graphical representation of WPI-P-O-GA microcapsules inferred from SEM 
analysis. (Adapted from Eratte et al., 2015). 
 
2.6. Conclusions and future directions 
Microencapsulation of omega-3 oils and probiotic bacteria are technically and 
commercially viable for the delivery of these bioactive ingredients into foods. However, 
testing of compatibility of these microcapsules in a range of food and beverage products is 
required to determine impact on the shelf-life and sensory properties of these products. At 
present, there exist several functional foods fortified with either omega-3 oils or probiotic 
bacteria, but not both. There is commercial need of co-encapsulation of multiple 
ingredients within a single microcapsules, due to decreased cost and improved product 
quality. Complex coacervation has been shown to be a useful method for the co-
encapsulation of multiple unstable ingredients. 
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Complex coacervation followed by spray drying has shown to produce co-microcapsules 
of omega-3 oil and probiotic bacteria with improved oxidative stability and cell viability. 
The mechanism for improved performance over ingredients encapsulated individually is 
unclear, although the effect appears to be a synergistically beneficial to both active 
ingredients. Future work could focus on more specifically controlling the release of 
bioactive ingredients from these capsules, for targeted delivery including enteric delivery 
to the intestine. Currently, the majority of published data contains no information on the 
nature and mechanism of release of bioactive ingredients from co-microcapsules. Although 
in-vitro systems provide useful bioavailability information, additional animal and human 
bioavailability trials are needed to determine the effectiveness of bioactive release, 
particularly for microcapsules containing multiple bioactive ingredients. 
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Chapter 3 
Complex coacervation with whey protein isolate and gum Arabic for the 
microencapsulation of omega-3 rich tuna oil 
 
Abstract 
Tuna oil rich in omega-3 fatty acids was microencapsulated in whey protein isolate (WPI)-
gum Arabic (GA) complex coacervates, and subsequently dried using spray and freeze 
drying to produce solid microcapsules. The oxidative stability, oil microencapsulation 
efficiency, surface oil and morphology of these solid microcapsules were determined. The 
complex coacervation process between WPI and GA was optimised in terms of pH, and 
WPI-to-GA ratio, using zeta potential, turbidity, and morphology of the microcapsules. 
The optimum pH and WPI-to-GA ratio for complex coacervation was found to be 3.75 and 
3:1, respectively. The spray dried solid microcapsules had better stability against oxidation, 
higher oil microencapsulation efficiency and lower surface oil content compared to the 
freeze dried microcapsules. The surface of the spray dried microcapsules did not show 
microscopic pores while the surface of the freeze dried microcapsules was more porous. 
This study suggests that solid microcapsules of omega-3 rich oils can be produced using 
WPI-GA complex coacervates followed by spray drying and these microcapsules can be 
quite stable against oxidation. These microcapsules can have many potential applications 
in the functional food and nutraceuticals industry.  
Keywords: Omega-3 fatty acids, Microencapsulation, Complex Coacervation, Whey 
protein isolate, Gum Arabic, Spray drying, Freeze drying 
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3.1. Introduction 
The health benefits associated with the consumption of omega-3 fatty acids are well 
known, particularly for maintaining normal brain function (McNamara et al., 2006), 
reducing the risk of cancer (Rose et al., 1999) and preventing cardiovascular disease 
(Bucher et al., 2002). The lower actual versus recommended daily intake (RDI) of omega-3 
fatty acids in many countries has been the major driving force for the development of 
functional foods and nutraceuticals containing eicosapentaenoic acid (EPA, C20:5n3) and 
docosahexaenoic acid (DHA, C22:6n3). Fish oil is the major source of EPA and DHA for 
fortified foods and nutritional supplements (Kris-Etherton et al., 2003; Dey et al., 2012). 
However, fish oils are highly susceptible to oxidation due to the highly unsaturated 
structure of long-chain omega-3 fatty acids. Oxidation of polyunsaturated fatty acids 
(PUFAs) produces peroxides and other harmful secondary oxidation products, which 
ultimately decreases the nutritional value of omega-3 fatty acids and negatively impacts the 
sensory properties (Hsieh et al., 1989; Frankel, 1989). Hence, the need for omega-3 rich 
oils to be microencapsulated in suitable wall materials to preserve their nutritional and 
organoleptic quality is ascertained (Heinzelmann et al., 1999; Velasco et al., 2003). 
 
Complex coacervation is a liquid-liquid phase separation phenomenon that occurs when 
electrostatically opposite charged biopolymers are brought together under certain specific 
conditions (Ducel et al., 2004). Barrow et al (2007) reported that it is one of the most 
effective methods of microencapsulating omega-3 fatty acids rich oils, primarily using 
gelatine as the wall material. Broadening the range of suitable wall material for the 
microencapsulation of omega-3 fatty acids is important for expanding the scope and 
applicability of this important technique. Hence in the present study we explored the 
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process of complex coacervate formation between cationic whey protein isolate and 
anionic gum Arabic to microencapsulate tuna oil which is rich in omega-3 fatty acids. WPI 
is prepared from whey which is a by-product of cheese making and it has been widely used 
in the food processing industry due to its nutritional qualities and unique physio-chemical 
properties such as emulsion stabilization and gel formation (de Wit et al., 1998). As a 
natural protein, WPI exhibits positive charge below its isoelectric point (IEP). WPI is 
effective in lowering interfacial tension at the oil-water interface, quite promptly migrates 
to the interface from bulk solution, and possesses good skin forming ability when it is dried 
(Adhikari et al., 2007). GA is a composite edible polysaccharide which shows a negative 
charge above pH 2.2 (Butstraen et al., 2014). It is one of the most commonly used 
stabilizers in the food and pharmaceutical industries (Nie et al., 2013). GA mainly consists 
of six carbohydrates moieties and less than 2% proteins (Islam et al., 1997; Garti et al., 
2001). Hence, complex coacervation between WPI and GA can occur by adjusting the pH 
and the WPI-to-GA ratio of their mixture.  
 
However, there are only limited studies on the microencapsulation of oils using WPI-GA 
complex coacervates. Weinbreck et al (2004) encapsulated sunflower oil, lemon and 
orange oil flavours with WPI-GA coacervates. However, this work did not proceed to 
produce dried microcapsules and was confined in producing liquid microcapsules. Zhang 
et al (2009) investigated the encapsulation of fish oil using WPI-GA complex coacervates. 
This work focussed mainly on studying the effect of different GA and WPI types in 
forming complex coacervates and microcapsules. So far, the optimization of complex 
coacervation process between WPI and GA aiming to better microencapsulate omega-3 
rich oils has not been systematically studied.  
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Dried microcapsules produced through complex coacervation could offer omega-3 rich oils 
better shelf-life and wider applicability (Ponsart et al., 1996). Both spray and freeze drying 
are commonly used in the food industry to produce powder or solid microcapsules. 
However, the application of different drying techniques can influence the stability and 
other characteristics of powdered microcapsules even at the same optimal complexation 
and emulsification conditions. For example, the freeze dried products are more porous due 
to the sublimation while spray dried powders containing biopolymers are usually irregular 
and contain surface folds (Anandharamakrishnan et al., 2010; Gharsalloui et al., 2007). 
However, the effect of spray and freeze drying processes on the microencapsulation 
efficiency, surface oil and oxidative stability of solid microcapsules produced using WPI-
GA complex coacervates is poorly understood. 
 
In this context, there were three key objectives in this study. Firstly, to determine the 
optimum process parameters at which complex coacervation between WPI and GA can 
occur. Secondly, to produce and characterise the liquid microcapsules of omega-3 rich tuna 
oil produced by using these WPI-GA complex coacervates as the shell of the 
microcapsules. Finally, to produce and characterise spray and freeze dried solid 
microcapsules in terms of oxidative stability, microencapsulation efficiency, and surface 
oil content and morphological analysis through scanning electron microscopic (SEM) 
examinations. 
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3.2. Materials and methods 
3.2.1. Materials  
Whey protein isolate (WPI 895TM -93.9% protein by dry weight basis) was donated by 
Fonterra Cooperative, New Zealand. Gum Arabic was purchased from Sigma-Aldrich Ltd 
(New South Wales, Australia). Tuna oil (HiDHA), containing 39.03% omega-3 fatty acids 
(Table 3.1), was a gift from NuMega Ingredients Ltd. (Victoria, Australia) and stored at 4 o 
C until use. All other chemicals were purchased from Sigma–Aldrich Australia (New 
South Wales, Australia) and were of analytical grade and used without further purification. 
Table 3.1: Omega-3 fatty acids composition of tuna oil   
Omega-3 fatty acids Percentage (%) 
16:3w3 0.97 
18:3w3         ALA 0.40 
18:4w3 0.60 
20:4w3 0.46 
20:5w3         EPA 5.98 
22:5w3 1.20 
22:6w3         DHA 29.42 
Sum   Omega-3 –PUFAS 39.03 
         NuMega Ingredients Ltd. (Victoria, Australia)  
 
3.2.2. Optimization of the complex coacervation process 
The zeta potential, yield of complex coacervates and turbidity data were used to determine 
the optimum pH and WPI-to-GA ratio for the formation of complex coacervates. 
3.2.2.1. Optimization of pH 
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Zeta potential values as a function of pH were used to determine the optimal pH range at 
which complex coacervation between WPI and GA was formed. Zeta potential values for 
WPI (1.5% w/w) and GA (0.5% w/w) were measured in the pH range of 3.0 -7.0 at 25o C 
by using a zetasizer (Zetasizer NanoZS 90, Malvern Instruments Ltd. Worcestershire, 
WR14 1XZ, UK), which determines the electrophoretic mobility and then calculates the 
zeta potential using appropriate conversion equations (Espinosa-Andrews et al., 2013; 
Yuan et al., 2014). 
 
The absorbance of the mixture of WPI (0.1%) and GA (0.03%) was measured within 
3.0-5.0 pH range using a UV spectrophotometer (UV-1800, Shimadzu, Kyoto, Japan) at 
750 nm. The absorbance (or turbidity) of WPI (0.1%, w/w), GA (0.03%, w/w), and the 
mixture of WPI and GA at different ratios, were measured at 750 nm. The pH value at 
which the maximum absorbance (turbidity) was observed was considered the optimal pH 
for complex coacervation between WPI and GA. 
3.2.2.2. Optimization of the WPI-to-GA ratio   
The turbidities of various mixtures of WPI and GA at different ratios (1:1, 3:1, 3:2, 4:1 and 
5:1) were determined using the light absorbance of these mixtures at 750 nm using a UV 
spectrophotometer as detailed above. 
 
The optimum WPI-to-GA ratio which resulted in the highest coacervation yield was also 
measured. For this purpose, aqueous dispersions containing WPI and GA at the above 
mentioned ratios were prepared at ambient temperature and the pH of these dispersions 
was adjusted to the optimum value (Section 3.2.2.1). These pH adjusted dispersions were 
allowed to stand for 5 h to facilitate the precipitation of the gel-like complex coacervates. 
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Then, the coacervates were carefully separated and dried at 105o C until a constant mass 
was reached. The coacervate yield was then calculated by using equation (1) given below. 
Coacervate yield (%) =                                         (1) 
 
3.2.3. Confocal laser scanning microscopic (CLSM) analysis 
The microstructure of tuna oil microencapsulated with WPI-GA using complex 
coacervation at various pH was observed using a CLSM (Eclipse Ti, Nikon, Japan). WPI 
and GA were covalently labelled with fluorescein 5-isothiocyanate (FITC) and rhodamine 
B-isothiocyanate (RITC), respectively. Tuna oil was physically labelled with Bodipy-X-
Azide. Briefly, FITC solution (10 mg/100 ml ethanol) and RITC solution (10 mg/ 100 ml 
water) were prepared separately. Then 50 ml of FITC solution and 50 ml of RITC solution 
were used for the preparation of WPI (3%) and GA (1%) solutions and the 
microencapsulation procedure was carried out as per Section 2.4. Covalent labelling of 
WPI and GA was done in order to visualize these biopolymers in the mixture. A lens with 
40 X magnification and a laser with an excitation wavelength of 645 nm (for Bodipy-X- 
Azide), 488 nm (for FITC) and 561nm (for RITC) were used. 
 
3.2.4. Microencapsulation of tuna oil 
Firstly, 250 ml WPI solution (3%, w/w) was prepared at ambient temperature and 15 g of 
tuna oil was dispersed in this solution. The mixture was stirred using a mechanical stirrer 
(IKA® RW 20 digital overhead stirrer, Germany) at 800 rpm for 10 min and was further 
homogenized using a microfluidizer at 45 MPa for 3 passes (M110L, Microfluidics, 
Newton, USA) to produce an O/W emulsion. Then 250 ml GA solution (1%, w/w) was 
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added drop wise into this O/W emulsion and was stirred at 800 rpm. The pH of this 
emulsion was then adjusted to 3.75 by adding 1% citric acid drop wise in order to induce 
electrostatic interaction between WPI and GA. The microencapsulation procedure was 
carried out at 25o C, followed by cooling to 5o C at a rate of 5o C/h using a programmable 
water bath (PolyScience, Niles, Illinois, USA). A microscope (Eclipse 80 i, Nikon, Japan) 
was used to obtain optical images of the coacervates microcapsules. The morphology of 
the microcapsules was captured as a function of pH and temperature. Finally, the 
microcapsules were dried to produce solid or powder microcapsules. 
 
3.2.5. Drying of coacervate microcapsules  
A portion of suspension containing microcapsules produced as per Section 3.2.4 was spray 
dried (Mini spray dryer B-290, BÜCHI Labortechnik, Switzerland) using inlet and outlet 
temperatures of 180o C and 80±3 o C, respectively. The powdered microcapsules were 
collected and stored in an air tight desiccator for further characterization.  
The second portion of the liquid microcapsules was frozen at -20o C overnight and was 
freeze dried (Christ Alpha 2-4LD, Osterode, Germany). The temperature of the ice 
condenser was set at -500 C and the vacuum pressure was set to 0.04 mbar. The frozen 
samples were dried for 30 hrs and the dried product was collected, pulverized and stored in 
an air tight desiccator for further tests. 
 
3.2.6. Physicochemical properties of the microcapsules 
3.2.6.1. Oxidative stability 
Accelerated oxidation tests were carried out for the liquid oil and the solid or powdered 
microcapsules using a Rancimat (model 743, Metrohm, Herisau, Switzerland) (Mathaus, 
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1996). Four ml tuna oil or 1.5 g dried microcapsule powder was heated at 90o C under 
purified air (flow rate of 20L/h). Briefly, when the oxidation of oil takes place, the 
conductivity of Milli-Q water in the collection chamber increases due to the entrapment of 
the volatile products (formic acid) and this increase is plotted by the accompanied software 
(Rancimat Control, version 1.1,Metrohm, Herisau, Switzerland). Then the OSI value of the 
samples is graphically determined by locating tangential intersection point on experimental 
data as described by Läubli et al, (1986).The induction time (at which the conductivity of 
sample increases sharply due to oxidation) of the test sample was recorded and used as the 
oxidative stability index (OSI). Analyses were performed in duplicate. 
3.2.6.2. Microencapsulation efficiency 
Microencapsulation efficiency was calculated by measuring the surface oil (solvent 
extractable) and total oil of the microcapsules. Surface oil was determined by the washing 
method described by Liu et al (2010) with slight modification. Three grams of dried 
microcapsule sample was dispersed in 30 mL isohexane and this was shaken at 225rpm for 
5 minutes on an orbital shaker (Stuart SSL-1, Carl Roth, Karlsruhe, Germany). The slurry 
was then filtered through filter paper (Whatman, 5µm) and the solid particles caught on the 
filter were further washed three times with 10 ml of isohexane in each wash. The filtrate 
was dried under nitrogen followed by drying at 100o C for 1h in an oven. The sample dried 
in this way was placed in a fume hood overnight to remove the residual solvent.  The 
surface oil content was then measured gravimetrically. 
The total oil content in the dried microcapsules was determined by an acid digestion 
method using 4N HCl. Three grams of powdered microcapsule sample was dispersed in 30 
ml of 4N HCl and shaken at 225 rpm for 15 minutes on an orbital shaker (Stuart SSL-1, 
Carl Roth, Karlsruhe, Germany) in order to dissolve the shell materials. Fifteen ml of 
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isohexane was added to this mixture and then shaken for 18 h at ambient temperature to 
extract the oil. The mixture was centrifuged at 24,471 g at 20oC for 30 minutes. The 
hexane phase containing the dissolved oil was collected and dried by nitrogen under fume 
hood. This partially dried sample was further dried at 100o C in an oven and then placed 
under a fume hood to remove the residual solvent. The oil content was then determined 
gravimetrically. 
The percent surface oil (SO), total oil (TO) and microencapsulation efficiency (ME) were 
calculated using equations (2), (3) and (4), respectively. 
 (2) 
 (3) 
 (4) 
where wt and ws are the mass values (g) of total and surface oil of the microcapsules and 
wm is the mass (g) of the microcapsules. 
 
3.2.7. Surface morphology of the solid microcapsules 
A Scanning Electron Microscopy (JEOL JSM6300 SEM, Tokyo, Japan) was used to 
acquire the morphology of dried microcapsules. Samples were lightly gold sputter coated 
(Sputter coater, Agar Aids, England) for 45 seconds and imaged under scanning electron 
microscope operated at 7kV and low beam current. 
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3.2.8. Statistical Analysis  
All measurements were performed at least in triplicates and the results are reported as 
mean± standard deviation. The SPSS statistical package (Version 21, Lead Technologies, 
USA) was used for the analysis of variance (ANOVA) to determine whether or not 
significant difference existed between two mean values. The confidence level of 95% 
(p<0.05) was used.  
 
3.3. Results and discussion 
3.3.1. Optimal parameters for complex coacervation between WPI and GA 
3.3.1.1. Optimal pH for complex coacervation 
The zeta potentials of WPI and GA within the pH range of 3.0 - 7.0 are presented in Fig. 
3.1A. The zeta potentials of WPI within this pH range varied from positive (16.80 mV at 
pH 3.0) to negative (-20.21 mV at pH 7.0). The isoelectric point (IEP) at which the zeta 
potential becomes zero was found to be 4.4, which is in agreement with previous reports 
(Chen et al., 2012). 
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Fig. 3.1A: Effect of pH on zetapotential of WPI and GA dispersions. 
 
 
Fig. 3.1B: Turbidity values of WPI and GA mixed dispersions at different pH values at 
WPI to GA ratio = 3:1. 
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The zeta potential of GA is always negative independently of pH due to carboxylate groups 
being the only charged functionalities present in its globular-like random coil structure 
(Dickinson, 2003). If at least one of the macromolecules in a mixture is not a strong 
polyelectrolyte, then coacervation is likely to occur (de Kruif et al., 2004). Therefore, it can 
be inferred from the Fig. 3.1A that the pH at which complex coacervation between WPI 
and GA will occur is at or below pH 4.4. 
 
The turbidity test (Section 3.2.2.1) was carried out within the pH range of 3.0 -5.0 in order 
to locate the optimum pH value for complex coacervate formation. The absorbance values 
of the WPI and GA mixed dispersions are presented in Fig. 3.1B. As can be seen from this 
figure, formation of dense complex coacervates occurred within the pH range and 
formation of the complex coacervates was greatest at pH 3.75. Hence this pH value was 
chosen as the optimum pH for complex coacervate formation. 
 3.3.1.2. Optimal WPI-to-GA ratio for complex coacervation 
The ratio of protein to polysaccharide in the mixture influences the charge balance of 
polyions and consequently their complexation behaviour (Ye, 2008). Based on the work 
described in the previous section (Section 3.3.1.1) we used the optimum pH of 3.75 to 
study the binding between WPI and GA. As can be seen from Fig. 3.2A, the highest 
absorbance value was observed at a WPI-to-GA ratio of 3:1, which is due to the highest 
level of turbidity caused by the electrostatic interaction between WPI and to corroborate 
the data, the yield of complex coacervates was measured (Section 3.2.2.2) at different 
WPI-to-GA ratios and the data is presented in Fig. 3.2B. 
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Fig. 3.2A: Turbidity values at different WPI to GA ratios.  
 
Fig. 3.2B:  Yield of complex coacervates at different WPI to GA ratios. 
 
The highest coacervate yield of 71.26 % was obtained at the WPI-to-GA ratio of 3:1, 
which corroborates the turbidity data (Fig. 3.3.2A). Other WPI-to-GA ratios produced 
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lower coacervate yields, possibly due to the formation of soluble rather than insoluble 
complexes occurring when either of the biopolymer is in excess. Soluble complexes are 
formed due to the charge imbalance and produce weaker electrostatic interaction, which 
results in lower coacervate yield (Ye, 2008). The biopolymer ratio and dispersion pH are 
known to alter the charge density of the complexes (Espinosa-Andrews et al., 2013). At pH 
3.75 and WPI-to-GA ratio of 3:1, the electrostatic interaction between WPI and GA 
resulted in two phases specifically due to the formation of a soft dense coacervate phase 
rich in biopolymers and a dilute phase poor in biopolymer concentrations. Hence, this 
WPI-to-GA ratio of 3:1 was selected as the optimum ratio to produce complex coacervates. 
 
3.3.2. Observation of microcapsule formation 
Optical microscopy was used to study the formation of complex coacervates and their 
subsequent absorption onto oil droplets. As can be seen from Fig. 3.3A, 3.3B and 3.3C, no 
obvious complex coacervates were absorbed onto the oil droplets above pH 5.0. When the 
pH was further lowered to 4.5 (close to the IEP of WPI), the aggregation of oil droplets 
was observed (Fig. 3.3D). This may be due to weaker repulsion between negatively 
charged WPI and GA when the surface charge of WPI approaches neutral (Fig. 3.1A). 
Also, the steric repulsion between droplets was not enough to overcome the aggregation of 
the droplets. In this environment, the attractive interactions between the biopolymer 
molecules, such as van der Waals and hydrophobic, become dominant. Kulmyrzaev et al 
(2000) reported that excessive droplet aggregation occurs when the net charge on the 
droplet doesn’t generate stronger electrostatic repulsive force than the strength of the 
attractive forces in the emulsion. It can be observed from Fig. 3.3E to 3.3H that when the 
pH of the dispersion was lowered below the isoelectric point of WPI (IEP = 4.4), complex 
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coacervation occurred in the surrounding continuous phase, and these coacervates migrated 
to the surface of the oil droplets, and formed a coacervates layer. It was observed that 
complex coacervation occurred and aggregation of the oil droplets started to take place 
below pH 4.4. This is because WPI became positively charged below its IEP and 
electrostatic attraction with negatively charged GA started to occur. Finally, a smooth layer 
of WPI-GA complex coacervates was formed uniformly around the oil droplets (Fig. 3.3G) 
at pH 3.75, which is consistent with the turbidity and coacervate yield data (Fig. 3.1B and 
Fig. 3.2A, 3.2B). 
 
When the liquid microcapsules were cooled from ambient temperature to 5oC, the “free 
coacervates” which remained suspended in the continuous phase (at ambient temperature) 
began to absorb onto the surface of the aggregated oil droplets (Fig. 3.3H). This implies 
that cooling is an important step in stabilizing oil emulsions using complex coacervates. As 
can be seen from Fig. 3.3H, multicored microcapsules were formed due to the formation of 
WPI-GA complex coacervates. This may be partly due to homogenization occurring under 
high pressure when using a microfluidizer. Yeo et al (2005) reported that single core 
microcapsules were produced when a lower degree of homogenization was used while 
multi core microcapsules were produced under a higher degree of homogenization. 
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Fig 3.3: WPI-GA complex coacervates observed through light microscopy as a function of 
pH. (A) pH 6.0; (B) pH 5.5; (C) pH 5.0; (D) pH 4.5; (E) pH 4.0; (F) pH 3.8;(G) pH 3.75 
and  (H) pH 3.75 after cooling, scale bar = 10µm. 
 
Confocal laser scanning microscopy was used to visualize complex coacervate formation 
between WPI and GA and to confirm the optimized processing conditions (pH 3.75 and 
WPI-to-GA ratio 3:1) and also to assess whether tuna oil droplets were microencapsulated 
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in the WPI-GA complex coacervates. WPI (labelled green) and GA (labelled red) in the 
dispersion before complex coacervation are shown in Fig. 3.4A and Fig. 3.4B. These 
figures are similar to the optical micrographs of dispersion before complex coacervation 
(Fig. 3.3A). WPI and GA are clearly visible in the complex coacervate as shown in Fig. 
3.4C and Fig. 3.4D, respectively. The micrograph presented in Fig. 3.4C is WPI-GA 
complex coacervate (labelled WPI (green) only) formed under the optimized processing 
conditions. Similarly, Fig. 3.4D is the WPI-GA complex coacervate (labelled GA (red) 
only) formed under the same optimized conditions. Fig. 3.4E shows that WPI-GA complex 
coacervate (yellow in colour) was formed at pH 3.75 and at a WPI-to-GA ratio of 3:1, and 
neither WPI (green colour) nor GA (red colour) is dominant in Fig. 3.4E, indicating that 
complex coacervation has occurred between WPI and GA under the processing conditions 
used. These CLSM images are consistent with the optimum conditions for formation of 
complex coacervates between WPI and GA being pH 3.75 and a WPI-to-GA ratio of 3:1.  
 
       
A B 
75 
 
      
    
Fig 3.4: Confocal scanning laser micrographs of (A) WPI (green) in the dispersion before 
carrying out complex coacervation at pH 6.0, (B) GA (red) in the dispersion before 
carrying out complex coacervation at pH 6.0 (C) Complex coacervate with labelled WPI 
(green) at pH 3.75, (D) Complex coacervate with labelled GA (red) at pH 3.75 and (E) 
Complex coacervates of WPI and GA formed (yellow) at pH 3.75.  
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Fig. 3.5: Confocal scanning laser micrographs of (A) WPI in the coacervate microcapsules 
(green), (B)  GA in the coacervate microcapsules (red), (C) Oil droplets in the coacervate 
microcapsules (blue), (D) Mixture of WPI (green), GA (red), and oil (blue) before carrying 
A D 
B 
C 
E 
F 
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out complex coacervation at pH 6.0, (E) Coacervate microcapsules not showing (blue) oil 
droplets at pH 3.75 and (F) Coacervate microcapsules showing (blue) oil droplets at pH 
3.75.  
 
Multiple labelling CLSM was used to visualize the distribution of tuna oil droplets 
(labelled blue) in the WPI-GA microcapsules (Fig. 3.5). Microcapsules without and with 
visualisation of oil droplets are shown in Fig. 3.5E and Fig. 3.5F, respectively, to assess 
whether complexation has occurred between WPI and GA at pH 3.75 and at the WPI-to-
GA ratio of 3:1, and also to confirm the distribution of oil droplets in the microcapsules. 
The GA component in the microcapsule is shown in Fig. 3.5A (GA labelled red), the WPI 
component in Fig. 3.5B (WPI labelled green), and oil in Fig. 3.5C (oil droplets labelled 
blue). The mixture of oil, WPI and GA in the dispersion before carrying out complex 
coacervation process is presented in Fig. 3.5D. It can be clearly seen from Fig. 3.5D that 
no complex coacervates of WPI and GA was formed and oil droplets were just dispersed in 
the mixture at pH 6.0. An obvious formation of WPI-GA complex coacervate (yellow) and 
distribution of oil droplets in the coacervate can be clearly seen in Fig. 3.5E and Fig. 3.5F. 
The Z-average size of the oil droplets was 223.0 nm (polydispersity index (PdI) = 0.376) 
and these oil droplets are clearly microencapsulated in the WPI -GA matrix.  
 
3.3.3. Effect of drying methods on the physiochemical characteristics of the 
microcapsules  
Physiochemical properties (oxidative stability, surface oil, total oil, microencapsulation 
efficiency and morphological analysis through SEM) of spray and freeze dried tuna oil 
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microcapsules produced by microencapsulating with WPI-GA complex coacervates are 
discussed in this section.  
 
Fig. 3.6: Oxidative stability index of microcapsules measured by accelerated oxidation test 
using RancimatTM. 
 
The OSI values of blank tuna oil (control), freeze dried and spray dried solid microcapsules 
are presented in Fig. 3.6. These OSI data suggest that both freeze and spray dried tuna oil 
microcapsules exhibited significantly (p <0.05) better oxidative stability compared to the 
control (OSI = 3.1 h). The OSI value for freeze dried sample was 13.2 h compared to 22.1 
h for spray dried sample implying that the freeze dried microcapsules were less stable 
against oxidation compared to the spray dried ones. This may be due to the highly porous 
structure of the freeze dried powder (Sablani et al., 2007). The porous structure makes it 
easier for oxygen to diffuse through the porous shell structure to access the encapsulated 
oil and weakens the oxidative stability (Rahman et al., 2002; Ezhilarasi et al., 2013). This 
relatively poor oxidative stability in freeze dried microcapsules can also be explained by 
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their morphology identified by SEM (Fig. 3.7B). Freeze dried microcapsules possess 
irregular shape, are flake-like and have a highly porous structure.  
 
 
Fig. 3.7: SEM micrographs of spray dried (A) and freeze dried microcapsules (B). P 
indicates pores in the shell. 
 
The spray dried microcapsules were found to be significantly more stable (p < 0.05) 
against oxidation, as compared to freeze dried microcapsules, even though much higher 
temperature was used in the spray drying process. This relatively high OSI of spray dried 
microcapsules can be attributed to the compact structure of the spray dried solid 
microcapsules (Fig. 3.7A). The outer topography of the spray dried particles indicates that 
there is no shell rupture and the shell is much less porous compared to freeze dried 
microcapsules. The absence of pores/ cracks on the particle surface is very important for 
preventing the inward diffusion of oxygen and hence for better protection of the 
encapsulated oil. The SEM micrograph shows that the spray dried microcapsules have 
uniform size distribution below 5 µm (based on 100 microcapsules) with wrinkled 
spherical shape, resulting from the protein in the wall material. The wrinkled surface is 
typical characteristics of spray dried powders with protein in the matrix (Soottitantawat et 
B A 
P 
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al., 2005; Tonon et al., 2011; Xu et al., 2013). Moreover, this significantly enhanced 
oxidative stability for spray dried microcapsules compared to freeze dried ones is partly 
due to lower overall surface area and lower surface oil content.  
 
The surface oil and total oil contents, and microencapsulation efficiency of the freeze and 
spray dried microcapsules, are shown in Fig. 3.8. The freeze dried solid microcapsules had 
higher surface oil content (11.41%) as shown in Fig. 3.8, and lower microencapsulation 
efficiency. Surface oil is the unencapsulated oil found on the surface of the microparticles, 
and can trigger lipid oxidation and is a result of lower oil encapsulation efficiency (Hardas 
et al., 2000). The microencapsulation efficiency of freeze dried microcapsules was 72.95 
%, which is significantly (p<0.05) lower than that of spray dried microcapsules (Fig. 3.8). 
Similar result was also observed by Quispe-Condori et al (2011) when investigating the 
microencapsulation efficiency of freeze dried and spray dried flaxseed oil microcapsules.  
 
Fig. 3.8: Surface oil (SO), total oil (TO) and microencapsulation efficiency (ME) of spray 
dried and freeze dried complex coacervate microcapsules. 
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3.4. Conclusions 
The complex coacervation process between WPI and GA was optimised in terms of pH 
and WPI-to-GA ratio. The WPI-GA complex coacervates were used to microencapsulate 
omega-3 rich tuna oil. Solid microcapsules of tuna oil were produced through spray drying 
and freeze drying. The optimal complexation pH and WPI-to-GA ratio were found to be 
3.75 and 3:1, respectively. The spray dried microcapsules were found to be more stable 
against oxidation compared to those prepared by freeze drying. The spray dried 
microcapsules had the advantage of higher microencapsulation efficiency and lower 
surface oil content compared to the freeze dried samples. We conclude that WPI-GA 
complex coacervates can effectively microencapsulate omega-3 rich oils such as tuna oil 
and the solid microcapsules produced using spray drying will have high encapsulation 
efficiency and stability against oxidation. 
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Chapter 4 
Co-encapsulation and characterization of omega-3 fatty acids and probiotic bacteria 
in whey protein isolate-gum Arabic complex coacervates 
 
Abstract 
Omega-3 fatty acids and probiotic bacteria were co encapsulated in a single whey protein 
isolate (WPI)-gum Arabic (GA) complex coacervate microcapsule. Tuna oil (O) and L. 
casei 431 (P) were used as models of omega-3 and probiotic bacteria, respectively. The co 
microcapsules (WPI-P-O-GA) and L. casei containing microcapsules (WPI-P-GA) were 
converted into powder by using spray and freeze drying. The viability of L. casei was 
significantly higher in WPI-P O GA co microcapsules than in WPI-P-GA. The oxidative 
stability of tuna oil was significantly higher in spray dried co capsules than in freeze dried 
ones.  
 
Key words: Omega-3 fatty acids, Probiotic bacteria, Microencapsulation, Whey protein 
isolate-gum Arabic complex coacervates, Spray drying, Freeze drying 
89 
 
4.1. Introduction 
Probiotic bacteria are live microorganisms which when administered in adequate amounts 
confer a health benefit on the host (FAO/WHO, 2001). Interest in the consumption of 
foods that contain probiotic bacteria is increasing steadily and probiotic products account 
for approximately 65 % of the world functional food market (Agrawal, 2005; Burgain et 
al., 2011). Maintaining the viability of probiotic bacteria in food during manufacture, 
storage, and delivery to the targeted site of gastrointestinal tract is still a major challenge 
(Ross et al., 2005; Mattila-Sandholm et al., 2002). The viability of probiotic bacteria 
depends on many factors such as strain of the bacteria, composition of food in which they 
are incorporated, and the processing conditions used (Saarela et al., 2000). 
 
 Lactobacillus and Bifidobacterium are the most commonly studied probiotics because of 
their proven health benefits and also their long history of use in foods (Parvez et al., 2006). 
Lactobacillus casei 431 is used as a model probiotic bacterium in this study. It has been 
reported that Lactobacillus casei is beneficial to people suffering from perennial allergic 
rhinitis (Peng et al., 2005). Supplementation of L. casei 431 is shown to improve the 
immune function by augmenting systemic and mucosal immune responses (Rizzaridini et 
al., 2012). L. casei has been successfully used in a number of cheese varieties and other 
fermented food products because it is acid tolerant (Mishra et al., 2005).   
 
Omega-3 fatty acids are nutritionally essential for good health and are particularly 
recommended for individuals suffering from diseases such as cardiovascular disorders, 
Alzheimer’s disease, immune response disorders, diabetes and cancer (Luchtman et al., 
2013; Wen et al., 2014; McNamara et al., 2006; Rossmeisl et al., 2014). There is a high 
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commercial demand for omega-3 fatty acids; for example, the estimated global demand for 
omega-3 ingredients was worth USD 1595 million in 2010 and is  estimated to exceed 
USD 4000 million in 2018 (Transparency Market Research, 2012). Fish oil usually 
contains a higher amount of omega-3 fatty acids than seed oils and microalgae (Rubio-
Rodríguez et al., 2010).  Oils containing a high amount of omega-3 fatty acids are highly 
susceptible to oxidation. The oxidation of omega-3 fatty acids produces peroxides that later 
convert to volatile compounds, some of which produce off-flavours and ultimately 
decrease the nutritional value of omega-3 fatty acids (Miyashita et al., 1993). Therefore, 
technologies to improve the stability and prolong the shelf-life of fish oil are necessary to 
enable the use of these oils in the food industry (Kamal‐Eldin et al., 2002; Kaushik et al., 
2014). 
 
Microencapsulation is a technology used to protect bioactive unstable food materials. This 
technology retards or prevents rapid degradation and inactivation either by slowing down 
or by preventing degradation processes until the product is delivered to the desired site 
(Gouin, 2004; Barrow et al., 2009). The bioactive food compounds include not only 
polyunsaturated fatty acids, antioxidants, vitamins, peptides, phytosterols, lutein, lycopene 
but also living cells such as probiotic bacteria (Champagne et al., 2007; McClements et al., 
2009; de Vos et al., 2010). A review of current literature suggests that the 
microencapsulation of omega-3 fatty acids and probiotic bacteria has so far been carried 
out separately (Pedroso et al., 2012; Chen et al., 2013; Tonon et al., 2011; Capela et al., 
2006; Kim et al., 2008; Heinzelmann et al., 1999). Co-encapsulation of omega-3 fatty acids 
and probiotic bacteria in a single matrix has not been described. Halwani et al. (2008) 
reported that co-encapsulation of more than one core materials in an encapsulation system 
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that may enhance the bioactivity of individual components. Co-encapsulation concept has 
been widely used in pharmaceutical delivery systems, but the co-encapsulation of more 
than one bioactive component with different characteristics such as omega-3 oil 
(hydrophobic) and probiotic bacteria (hydrophilic) is challenging particularly using 
complex coacervation and has not been reported. 
 
When probiotic bacteria and omega-3 fatty acids are co-encapsulated in a single product, 
there may be synergistic health benefits. A synergetic effect between omega-3 fatty acids 
and probiotic bacteria during digestion has been reported, where omega-3 lipids help 
probiotic bacteria attach to the intestinal wall (Das, 2002). There may also be stability 
benefits of co-microencapsulation. This study represents the first systematic attempt to 
develop a single microcapsule capable of delivering omega-3 fatty acids and probiotic 
bacteria together in one particle. 
 
Microencapsulation by coacervation is carried out by phase separation of two or more 
biopolymers in a solution, followed by the subsequent deposition of the formed coacervate 
layer around the core material (Gouin, 2004). The liquid microcapsule obtained from the 
complex coacervation process can be dried using a variety of drying techniques. However, 
this step of the process is to remove the water and not to form the microcapsule. In 
complex coacervation, the size and type of particle formed is controlled during the wet 
process and not by the drying process, unlike spray dried emulsions. The 
microencapsulation of omega-3 rich tuna oil in whey protein isolate (WPI) – gum Arabic 
(GA) complex coacervates has been explored in detail (Eratte et al., 2014). The current 
work investigates on the microencapsulation of probiotic (P) bacteria L. casei 431 in WPI-
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GA complex coacervate matrix forming WPI-P-GA microcapsules and the co-
encapsulation of L. casei 431 and tuna oil (O) in WPI-GA matrix, forming WPI-P-O-GA 
microcapsules through complex coacervation. The novelty or significance of this study lies 
in the fact that it investigates whether probiotic bacteria and omega-3 fatty acids can be co-
encapsulated in WPI-GA complex coacervate and if such co-encapsulation contributes 
synergistically to the survival of bacteria and the oxidative stability of the omega-3 fatty 
acids. This study compares the viability of probiotic bacteria in co-microcapsules (WPI-P-
O-GA) with their viability in microcapsules containing only probiotic bacteria (WPI-P-
GA) and substantiates the benefits of using WPI-GA complex coacervates for co-
encapsulation of probiotic bacteria and omega-3 fatty acids. 
 
A dry powder is desirable for extending the shelf-life and broadening the range of food 
applications and is normally formed using spray drying or freeze drying (Gouin, 2004). 
Freeze drying is suitable for drying sensitive biological materials as it exerts less thermal 
stress on the materials being dried; but is very expensive, has low throughput and a long 
drying time. Compared to freeze drying, the operational and capital costs of spray drying 
are reportedly 1/6 and 1/9, respectively, per unit mass of the product (Chavez and 
Ledeboer, 2007). However, the spray drying process can cause high viability and vitality 
loss as a result of simultaneous dehydration, thermal, and oxygen stresses imposed to 
bacteria during the drying process (Fang et al., 2012; Ghandi et al., 2013). To date, the 
drying behaviour of liquid capsules containing probiotic bacteria and omega-3 fatty acids 
has not been reported. Moreover, physicochemical characteristics of WPI-P-GA and WPI-
P-O-GA microcapsules have not been studied in detail. 
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This study has the following key objectives: (1). To microencapsulate probiotic bacteria 
L.casei 431 in WPI-GA complex coacervates in order to produce probiotic bacteria 
containing microcapsules (WPI-P-GA). (2). To co-encapsulate probiotic bacteria L.casei 
431 and omega-3 rich tuna oil in WPI-GA complex coacervates to produce WPI-P-O-GA 
microcapsules. (3). To produce solid microcapsules of WPI-P-GA and WPI-P-O-GA 
through spray and freeze drying. (4). To compare the viability (of L.casei 431 ) and 
oxidative stability ( of omega-3 oil ) in WPI-P-GA and WPI-P-O-GA microcapsules. (5). 
Finally to determine the moisture content, water activity, amorphous/crystalline nature and 
the surface elemental composition of the above mentioned solid microcapsules and the 
WPI-GA complex coacervates. 
 
4.2. Materials and Methods 
4.2.1. Materials 
 L. casei 431 was kindly donated by Chr.Hansen (Horsholm, Denmark). Tuna oil 
(HiDHA), containing was a gift from NuMega Ingredients Ltd. (Melbourne, Australia) and 
stored at 4 oC until use. According to data provided by the supplier, the major fatty acids in 
this tuna oil were as follows: DHA (docosahexaenoic acid) 29.4%, EPA (eicosapentaenoic 
acid) 6.0%, decosapentaenoic acid (DPA) 1.2%, arachidonic acid 2.0%, stearidonic acid 
0.6%, linolenic acid 0.4%, linoleic acid 1.2%, oleic acid 12.8%, stearic acid 5.3%, palmitic 
acid 19.2%, myristic acid 2.4%. Whey protein isolate (WPI 895TM) was donated by 
Fonterra Cooperative (Melbourne, Australia). Gum Arabic was purchased from Sigma-
Aldrich Ltd. (Sydney, Australia). All other chemicals were purchased from Sigma–Aldrich 
Ltd. (Sydney, Australia) and were of analytical grade. 
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4.2.2. Preparation of L.casei 431 culture 
The L.casei 431 was cultured for 18 h in sterile MRS broth (1%, w/v) at 37o C. This culture 
was further sub-cultured (37o C, 18 h) twice in the same broth to activate bacteria and to 
allow them to adapt. All the inoculation works were done under sterile biological hoods 
with laminar air flow. Finally, 1000 mL of media were used for bulk culturing and cells 
were harvested at stationary growth phase by centrifuging at 2200 × g for 15 min at 5o C. 
The supernatant was discarded and the precipitated cell mass was washed twice with sterile 
peptone water (0.2%, w/v). The final wet cell mass was weighed and divided into two 
equal portions. One portion was used to prepare WPI-P-GA microcapsules and the second 
half was used to prepare WPI-P-O-GA in order to make a good comparative study. For cell 
enumeration, spread plating method was carried out at 37o C for 48 h under anaerobic 
conditions. MRS agar medium was used to determine the number of colony forming units 
(cfu/mL).  
 
4.2.3. Microencapsulation process 
The complex coacervation and microencapsulation procedures were carried out as detailed 
below: 
4.2.3.1. Preparation of WPI-P-GA liquid microcapsules 
WPI (7.5g; 3%, w/v) solution was prepared in deionised water at ambient temperature. One 
portion of the probiotic cell mass prepared as detailed in Section 4.2.2 was added slowly 
into this WPI solution. Then GA solution (2.5 g; 1%, w/v) was added drop wise into this 
dispersion with continuous stirring at 400 rpm. The pH of the mixed dispersion was then 
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adjusted to 3.75 by adding 1% citric acid drop wise in order to induce electrostatic 
interaction between WPI and GA. The microencapsulation procedure was carried out at 25o 
C, followed by keeping the liquid microcapsules at 5o C for 48 h to ensure the complete 
formation of complex coacervates. 
4.2.3.2. Preparation of WPI-P-O-GA liquid microcapsules 
Firstly, WPI solution (7.5 g; 3%, w/v) was prepared at ambient temperature and 15 g of 
tuna oil was dispersed in this solution. The mixture was stirred using a mechanical stirrer 
(IKA® RW 20, Staufen, Germany) at 800 rpm for 10 min and was further homogenized 
using a microfluidizer (M110L, Microfluidics, Newton, Massachusetts, USA) at 45 MPa 
for 3 passes to produce an O/W emulsion. The second half portion of probiotic cell mass 
prepared as detailed in Section 4.2.2 was added into this O/W emulsion. Then GA solution 
(2.5g; 1%, w/w) was added drop wise into this dispersion with continuous stirring at 400 
rpm. The pH of this emulsion was then adjusted to 3.75 by adding 1% citric acid drop wise 
in order to induce electrostatic interaction between WPI and GA. The microencapsulation 
procedure was carried out at 25o C, and the liquid microcapsules were kept at 5o C for 48 h 
to ensure complete formation of complex coacervates. A microscope (Vanox, Olympus 
Universal Research Microscope, Tokyo, Japan) was used to obtain optical images of the 
coacervates microcapsules.  
 
4.2.4. Drying of coacervate microcapsules  
A portion of suspension containing microcapsules produced as per Section 4.2.3 was spray 
dried (Mini spray dryer B-290, BÜCHI Labortechnik, Flawil, Switzerland) using inlet and 
outlet temperatures of 180 and 80 o C, respectively. The spray dried solid microcapsules 
were collected and stored at 5 o C for further characterization.  
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The second portion of the liquid microcapsules was frozen at -20o C overnight and was 
subsequently freeze dried (Christ Alpha 2-4LD, Osterode, Germany). The temperature of 
the ice condenser was set at -50o C and the vacuum pressure was set to 0.04 mbar. The 
frozen samples were dried for 30 h and the dried product was collected, pulverized and 
stored at 5o C for further tests. 
 
4.2.5. Determination of physicochemical characteristics of WPI-P-GA and WPI-P-O-
GA microcapsules 
4.2.5.1. Oxidative stability 
Accelerated oxidation tests were carried out on the oil and the solid WPI-P-O-GA 
microcapsules using a Rancimat (model 743, Metrohm, Herisau, Switzerland) (Mathäus, 
1996). Four ml tuna oil or 1.5 g dried microcapsule powder was heated at 90o C under 
purified air (flow rate of 20L/h).  The oxidative stability index (OSI) value of the samples 
is graphically determined by locating rapid change in slope of the conductivity versus time 
curve as described by Wang et al. (2014).  
4.2.5.2. Microencapsulation efficiency 
Microencapsulation efficiency was calculated by measuring the surface oil (solvent 
extractable) and total oil of the microcapsules. Surface oil was determined by the washing 
method described earlier by Liu et al. (2010) with slight modification as described in our 
previous paper (Eratte et al., 2014).  
The total oil content in the dried microcapsules was determined by an acid digestion 
method using 4M HCl according to Eratte et al. (2014). The percent surface oil (SO), total 
oil (TO) and microencapsulation efficiency (ME) were calculated using equations (2), (3) 
and (4), respectively. 
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 (2) 
 (3) 
 (4) 
where, wt and ws are the mass values (g) of total and surface oil of the microcapsules, 
respectively and wm is the mass (g) of the microcapsules. 
4.2.5.3. Surface morphology of the solid microcapsules 
A scanning electron microscope (JEOL JSM6300 SEM, Tokyo, Japan) was used to acquire 
the morphology of dried microcapsules. Samples were lightly gold sputter coated (Sputter 
coater, Agar Aids, Stansted, UK) for 45 seconds and imaged under scanning electron 
microscope operated at 7kV and low beam current. 
4.2.5.4. X-ray diffraction analysis 
X-ray diffraction (XRD) traces were obtained from the powdered samples using a Siemens 
(D500, Siemens, Karlsruhe, Germany) diffractometer. Ni-filtered CuK radiation was used 
and the operating conditions were 40kV/30mA, 0.02/(2) step scan at 1o (2)/min, 1o 
divergence and receiving slits and a 0.15o scatter slit. A scan range of 5° to 50° (2) was 
used. 
4.2.5.5. XPS analysis 
The X-ray photoelectron spectroscopy was performed with an AXIS Ultra-DLD 
spectrometer (Kratos Analytical Ltd., Manchester, UK) equipped with a monochromated 
Al Kα X-ray source and a hemispherical analyser (fixed analyser transmission mode).  
4.2.5.6. Moisture content and water activity 
The moisture content of powdered microcapsules was determined by drying the sample in 
a hot air oven at 105o C for 12 h. The water activity of the powdered microcapsules was 
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determined using a water activity meter (Novasina, Switzerland). The temperature during 
the water activity tests was maintained at 24 ± 0.5 o C. 
 
4.2.6. Statistical Analysis  
The Minitab 16 statistical software package (Minitab, Sydney, Australia) was used for the 
analysis of variance (ANOVA) to determine the significant differences. The confidence 
level of 95% (p<0.05) was used.  
 
4.3 Results and discussions 
4.3.1. Effect of WPI-GA complex coacervates, omega-3 oil and drying methods on the 
viability of L. casei 431 
The viability of L. casei 431 in WPI-P-GA and WPI-P-O-GA liquid and solid 
microcapsules are presented in Fig. 4.1. As can be observed,  there was about one log cycle 
loss of L. casei viable cells in liquid WPI-P-GA microcapsules (8.7 log cfu ml-1) compared 
to the control (9.5 log cfu ml-1) due to  complex coacervation in the absence of omega-3 
oil. This may be due to the stress on the L. casei 431 cells owing to the reduction of pH to 
3.75 at which optimum complex coacervation between WPI and GA occurs (Eratte et al., 
2014). Interestingly, there was no significant difference in viability (p < 0.05) of L. casei in 
liquid WPI-P-O-GA microcapsules (9.3 log cfu ml-1) from the initial cell count. 
 
The survival of L. casei in both liquid and solid microcapsules was much better in the 
presence of omega-3 oil (WPI-P-O-GA) than in its absence (WPI-P-GA).  In order to 
verify whether or not the better survival of L. casei in WPI-P-O-GA is due to the effect of 
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omega-3 fatty acids, we repeated the entire microencapsulation process using coconut oil 
which does not readily undergo oxidation. The viability of L. casei cells in the presence of 
the coconut oil was as high as the viability in omega-3 rich oil (data not shown). Thus, it 
can be concluded that the viability of L. casei in currently used encapsulation process can 
be improved in the presence of oil whether or not it is omega-3 rich. 
 
Fig. 4.1: Viability of  L. casei 431 in WPI-P-GA and WPI-P-O-GA in liquid microcapsules 
and in dried powders. 
a,b,c,d: Means followed by different letters are significantly different ( p <0.05). 
 
The possible reason for the better survival of L. casei cells in WPI-P-O-GA microcapsules 
than in WPI-P-GA microcapsules can be explained with the aid of phase contrast 
micrographs (Fig. 4.2).  As shown by the phase contrast micrographs, the composite 
microcapsules containing tuna oil and bacterial cells were formed at pH 3.75 in the case of 
WPI-P-O-GA microcapsules (Fig. 4.2F). The micrographs of WPI-P-GA (Fig 4.2A and 
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Fig. 4.2B) and WPI-P-O-GA microcapsules (Fig 4.2D and Fig. 4.2E) at pH 6.0 and pH 4.0 
are presented to provide the process of formation of complex coacervates and the liquid 
microcapsules. It can be observed from Fig. 4.2C that the rod shaped bacterial cells are 
dispersed in the WPI-GA complex coacervate matrix at the optimum pH (3.75). In the case 
of WPI-P-O-GA microcapsules, aggregation of oil droplets occurred and each oil droplet 
was covered with the WPI-GA complex coacervates. This assembly better embedded the 
bacterial cells in the WPI-GA matrix.  The embedding of the L.casei in the WPI-GA 
complex coacervates and the encapsulation of tuna oil in the L. casei embedded complex 
coacervate as capsule shell might have minimized the exposure of L. casei 431 cells to the 
acid stressor and this may have improved the cell viability. Lahtinen et al. (2007) reported 
a higher survival of bifidobacteria when immobilised in cocoa butter during storage. 
Pedroso et al. (2012) also reported a better survival of microorganisms encapsulated in 
lipid matrix than unencapsulated microorganisms in simulated gastric and intestinal fluids. 
Picot et al (2004) reported that diffusion of acid (H+ ions) and oxygen in lipid based 
capsules are restricted and thus can provide further protection to the probiotic bacteria. The 
same authors reported that the whey protein based microcapsules can improve the survival 
of bifidobacteria in high acidic condition. Thus, we can conclude here that the presence of 
tuna oil in the microcapsules improved the survival of L. casei 431 in the liquid 
microcapsules. 
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The viability of L. casei cells in WPI-P-GA and WPI-P-O-GA solid microcapsules 
produced through spray and freeze drying is also presented in Fig. 4.1. The viability of L. 
casei cells was found to be higher in the presence of tuna oil in solid microcapsules as 
well. Therefore, we can conclude here that viability of L. casei cells could be improved by 
co-encapsulating or formulating dry WPI-P-O-GA microcapsules. The viability of L. casei 
in spray dried microcapsules was significantly lower (p>0.05) as compared to their 
viability in freeze dried microcapsules. This lower survival rate can be attributed to the 
higher inlet (180o C) and outlet (80o C) temperatures used and the associated thermal and 
dehydration induced stresses.  These findings are similar to those reported by Rajam et al. 
(2012), Wang et al. (2004) and Chavez et al. (2007) who showed that the survival of 
bacterial cells was higher in freeze drying than in spray drying operations. However, Ying 
et al. (2010) reported that there was no difference in the loss of viability of Lactobacillus 
rhamnosus GG after spray and freeze drying whereas Perdana et al. (2013) reported that 
viability of probiotic bacteria in spray drying was higher than that in freeze drying.  
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Fig. 4.2: Phase contrast micrographs of WPI-P-GA and WPI-P-O-GA liquid microcapsules 
as a function of pH. (A) WPI-P-GA microcapsules at pH 6.0; (B) WPI-P-GA 
microcapsules at pH 4.0; (C) WPI-P-O-GA microcapsules at pH 3.75; (D) WPI-P-O-GA 
microcapsules at pH 6.0; (E) WPI-P-O-GA microcapsules at pH 4.0; (F) WPI-P-O-GA 
microcapsules at pH 3.75. The black arrow represents rod shaped L. casei cells and white 
arrow represents round shaped oil droplets. Scale bar represents 10 µm. 
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4.3.2. Effect of drying methods on the physicochemical characteristics of the solid 
microcapsules 
The physicochemical characteristics (moisture content, water activity, oxidative stability, 
surface oil, total oil, oil microencapsulation efficiency, survival of L. casei and 
morphological features) of spray and freeze dried WPI-P-GA and WPI-P-O-GA 
microcapsules are presented and discussed in this section.  
 
Table 4.1: Physiochemical properties of spray dried and freeze dried WPI-P-GA and WPI-
P-O-GA microcapsules. SD= spray dried, FD = Freeze dried, SO= Surface oil, TO = Total 
oil, ME = Microencapsulation efficiency 
 
Microcapsules 
Residual 
moisture 
content (%) 
Water 
activity SO (%) TO (%) Oil ME (%) 
Cell 
survival (%) 
SD WPI-P-GA 2.90± 0.2a 0.23± 0.004d       -    -     - 37.62d 
FD WPI-P-GA 3.94± 0.3a 0.29± 0.003b       -    -     - 70.23bc 
SD WPI-P-O-
GA 3.19± 0.2b 0.26± 0.014c 3.3± 0.66a 48.95± 2.2a 93.35± 3.01a 56.19cd 
FD WPI-P-O-
GA 4.03± 0.3b 0.32± 0.012a 11.3± 2.5b 47.57± 1.3a 76.28± 5.1b 84.95ab 
 a,b,c,d:Means followed by different letters within the same column are significantly 
different at p < 0.05. 
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The moisture content (Table 4.1) of both the spray and freeze dried microcapsules 
produced was lower than 4.03 % (w/w), and water activity was below 0.32. The moisture 
content and water activity values of freeze dried WPI-P-GA and WPI-P-O-GA 
microcapsules were slightly higher (p<0.05) than the corresponding values of spray dried 
microcapsules. On the other hand, WPI-P-O-GA microcapsules have higher moisture 
content (p>0.05) than that of WPI-P-GA microcapsules. It was reported that residual water 
contents of 4 % (w/w) or below improved the storability and stability of powders 
containing probiotic bacteria L. salivarius UCC 118  and L. paracasei NFBC 338 
(Gardiner et al., 2000). 
 
The OSI values of tuna oil (control), spray and freeze dried WPI-P-O-GA microcapsules 
are presented in supplementary data (Fig. 4.1S). As expected, the oxidative stability of 
WPI-P-O-GA microcapsules produced through both drying methods was higher than that 
of untreated tuna oil. However, there was a significant difference (p>0.05) in the oxidative 
stability between freeze and spray dried microcapsules. The spray dried WPI-P-O-GA 
microcapsules were more stable to oxidation (OSI= 14.2 h) than the freeze dried 
microcapsules (OSI= 7.5 h). Similar results were obtained in our previous work in which 
microencapsulation of omega-3 oil was carried out using WPI-GA complex coacervates in 
the absence of L. casei. The possible reason for this lower OSI in freeze dried WPI-P-O-
GA microcapsule could be due to the relatively higher surface oil content (11.3%, w/w) 
compared to that (3.3%, w/w) in spray dried WPI-P-O-GA microcapsules (Table 4.1). The 
larger pore size, the presence of microscopic pores and rougher surface morphology of 
freeze dried microcapsules compared to spray dried ones (Fig. 4.3) may have resulted in 
lower oxidative stability. The oil encapsulation efficiency of freeze dried WPI-P-O-GA 
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microcapsules (76.28%) was significantly (p>0.05) lower than that of spray dried WPI-P-
O-GA microcapsules (93.35%). However, the survival of L. casei in freeze dried 
microcapsules was higher than that in spray dried microcapsules. The survival of L. casei 
in WPI-P-O-GA microcapsules was higher than that in WPI-P-GA microcapsules, 
irrespective of the drying method (Table 4.1). 
 
Fig. 4.1S: Oxidative stability index (OSI) of microcapsules measured by accelerated 
oxidation test using RancimatTM. A represents blank tuna oil (* taken from our previous 
work for comparison), B represents freeze dried WPI-P-O-GA and C represents spray 
dried WPI-P-O-GA with their corresponding OSI values in h.  
 
The surface morphology of spray dried and freeze dried WPI-GA microcapsules, WPI-P-
O-GA and WPI-P-GA microcapsules are presented in Fig. 4.3. The freeze dried 
microcapsules showed flake like porous morphology, while the spray dried microcapsules 
showed more or less spherical shape in various size with concavities typical of materials 
produced by spray drying. The spray dried WPI-P-O-GA microcapsules (Fig 4.3E) were 
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smoother with less concavities compared to the spray dried WPI-GA (control) complex 
coacervates, as well as the WPI-P-GA microcapsules (Fig. 4.3A and 4.3C). This smoother 
and lesser concavity in the case of spray dried WPI-P-O-GA microcapsules indicated that 
the presence of oil droplets in the microcapsules might have reduced the extent of moisture 
evaporation and also the extent of shrinkage of particles during drying. This might have 
been one of the reasons for retention of higher moisture content in WPI-P-O-GA 
microcapsules than in WPI-P-GA microcapsules (Table 4.1). The formation of concavities 
on the surface of the spray dried particles can be attributed to the shrinkage of the particles 
during the drying process due to rapid evaporation of water (Saenz et al., 2009). Therefore, 
the presence of oil in the liquid microcapsules is able to make the surface morphology of 
spray dried microcapsules smoother with less concavities. 
 
The surface morphology of the freeze dried WPI-P-GA and WPI-P-O-GA microcapsules 
was quite similar (Fig. 4.3D and 4.3F). The SEM micrographs of freeze dried WPI-GA 
(control) microcapsules (Fig. 4.3B) showed much smoother surface compared to that in 
WPI-P-GA and WPI-P-O-GA microcapsules. The core materials were dispersed in the wall 
matrix which resulted into less smooth morphology in the case of freeze dried WPI-P-GA 
and WPI-P-O-GA microcapsules. The moisture content of freeze dried WPI-P-O-GA 
microcapsules was higher (p >0.05) than that of freeze dried WPI-P-GA microcapsules. 
Therefore, the presence of oil might have acted as a vapour transport barrier during the 
sublimation process. The SEM micrographs (Fig. 4.3) revealed that there were no bacterial 
cells on the surface of both spray and freeze dried microcapsules indicating that L. casei 
cells were embedded within the wall matrix. The  cross sectional SEM micrographs show 
that the composite matrix containing omega-3 oil and L. casei cells embedded in WPI-GA 
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coacervates was formed in the complex-coacervation followed by drying process (Fig. 
4.3G and 4.3H); therefore WPI-P-O-GA composite microcapsules can be represented 
graphically as in Fig. 4.3I.  
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Fig. 4.3: SEM micrographs of solid microcapsules. (A) Spray dried WPI-GA 
microcapsules (control); (B) Freeze dried WPI-GA microcapsules (control); (C) Spray 
dried WPI-P-GA microcapsules; (D) Freeze dried WPI-P-GA microcapsules; (E)  Spray 
dried WPI-P-O-GA microcapsules;   (F)  Freeze dried WPI-P-O-GA microcapsules; (G) 
Cross sectional images of  freeze dried WPI-P-O-GA microcapsules; (H) Cross sectional 
image of spray dried WPI-P-O-GA microcapsules. The black arrow represents rod shaped 
L. casei cells and white arrow represents round shaped oil droplets.  (I) Graphical 
representation of WPI-P-O-GA microcapsules inferred from SEM analysis. Scale bar 10 
G H 
I 
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µm and 50 µm for spray dried and freeze dried  microcapsules. Scale bar 5 µm for the 
cross sectional images.   
 
4.3.3. Crystallinity/amorphous nature of the solid microcapsules  
The crystalline/amorphous nature of the carrier materials (WPI and GA), spray dried and 
freeze dried microcapsules can be observed from supplementary data (Fig. 4.2S-A, Fig. 
4.2S-B and Fig. 4.2S-C, respectively).  It can be clearly seen from these figures that the 
carrier materials and microcapsules showed amorphous pattern irrespective of the drying 
methods used. Amorphous matrixes are known to be more soluble as well as more 
hygroscopic and they are able to release core material more readily (Botrel et al., 2014).  
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Fig. 4.2S: XRD patterns of: (A) Carrier materials (WPI and GA); (B) Spray dried 
microcapsules; (C) Freeze dried microcapsules (WPI-P-GA and WPI-P-O-GA). 
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 4.3.4. Surface elemental analysis of microcapsules 
XPS analysis was used to quantify the surface (20-100 Å) elemental and chemical 
composition of microcapsules, WPI, GA and freeze dried L. casei cells.  Table 4.2B and 
4.2C compares the oxygen and nitrogen concentrations as well as the concentrations of 
chemically different  carbon species (all relative to the total concentration of carbon) of 
spray dried and freeze dried microcapsules (WPI-P-GA, WPI-P-O-GA)  to those of WPI, 
GA and the L. casei cells (Table 4.2A). The concentration of different carbon species were 
determined by curve-fitting the high resolution C 1s spectra. The curve fit protocol is based 
on five components with the following assignments: C1+C2 (C-C, C-H), C3 (C-O, C-N), 
C4 (C=O, O-C-O, N-C=O), C5 (O-C=O). The relevant C 1s high resolution spectra are 
shown in Fig 4.4.  The XPS analysis of oil was not carried out as it is in liquid form and 
therefore not compatible with ultra-high vacuum. 
 
Table 4.2: Surface elemental composition (C, O, N) of (A) WPI, GA, L. casei, (B) spray-
dried and (C) freeze-dried microcapsules. Presented are the mean (± std. dev.) of two 
measurements (atomic concentrations relative to total concentration of carbon). 
 
Samples WPI GA L.casei FD cell pellets 
C1+C2 0.741 ± 0.004 0.168 ± 0.001 0.158 ± 0.011 0.411 ±  0.001 
C3 0.189 ± 0.006 0.591 ± 0.001 0.601 ± 0.015 0.412 ±  0.006 
C4 0.041 ± 0.005 0.212 ± 0.003 0.210 ± 0.000 0.137 ±  0.008 
C5 0.029 ± 0.003 0.030 ± 0.001 0.032 ± 0.004 0.039 ±  0.002 
O 0.215 ± 0.003 0.666 ± 0.000 0.680 ± 0.016 0.410 ±  0.001 
N 0.025 ± 0.000 0.014 ± 0.000 0.015 ± 0.001 0.075 ±  0.001 
(A) 
112 
 
Samples 
SD WPI-GA 
coacervates 
(control) 
SD WPI-P-
GA 
SD WPI-P-O-
GA 
C1+C2 0.456 ± 0.002 0.477 ± 0.002 0.837 ± 0.001 
C3 0.275 ± 0.003 0.273 ± 0.002 0.098 ± 0.003 
C4 0.169 ± 0.002 0.181 ± 0.005 0.014 ± 0.002 
C5 0.100 ± 0.003 0.068 ± 0.005 0.051 ± 0.000 
O 0.428 ± 0.006 0.377 ± 0.001 0.119 ± 0.001 
N 0.167 ± 0.001 0.175 ± 0.001 0.014 ± 0.002 
(B) 
Samples 
FD WPI-GA 
coacervates 
(control) 
FD WPI-P-
GA 
FD WPI-P-O-
GA 
C1+C2 0.292 ± 0.006 0.467 ± 0.015 0.838 ± 0.001 
C3 0.460 ± 0.001 0.339 ± 0.013 0.096 ± 0.006 
C4 0.150 ± 0.004 0.133 ± 0.002 0.013 ± 0.004 
C5 0.097 ± 0.003 0.060 ± 0.001 0.052 ± 0.001 
O 0.591 ± 0.008 0.407 ± 0.017 0.129 ± 0.007 
N 0.020 ± 0.001 0.035 ± 0.001 0.006 ± 0.001 
(C) 
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Fig. 4.4: C1s spectra of (A) shell material (WPI and GA) and freeze dried L. casei cells; 
(B) Spray dried microcapsules; (C) Freeze dried microcapsules. See text for details. 
 
The C 1s spectrum of WPI is characterised by a particularly strong CHx (C1+C2) 
contribution. This is not characteristic of proteins in general and indicates the presence of 
(most likely) lipids on the surface. This is confirmed by the very low level of nitrogen 
(uncharacteristic of proteins) as presented in Table. 4.2A. The C 1s of GA showed a typical 
polysaccharide spectrum, dominated by the C-O (C3) peak and a corresponding strong 
oxygen signal but almost no nitrogen (Fig. 4.4A). The data of freeze dried L. casei cells 
appear to combine characteristics of polysaccharides (prominent C-O peak together with 
high oxygen level) and proteins (presence of nitrogen) (Fig. 4.4A). 
 
C 
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The application of spray and freeze drying to the same formulation results into different 
surface composition in the dried microcapsules. The surface composition of WPI-GA 
(control) coacervates produced through spray and freeze drying showed characteristics of 
both WPI and GA (Fig. 4.4A and 4.4B). However, the O-C=O (C5) peak, indicative of 
acid/ester groups, is significantly more intense compared to the those of WPI and GA 
suggesting to some interaction between WPI and GA occurring during the complex 
coacervation process. Spray-dried microcapsules had higher protein concentration at the 
surface (high level of nitrogen) whereas the freeze dried microcapsules had higher 
concentration of polysaccharides (high levels of oxygen and C-O) on the surface. The 
former may be due to greater exposure of the air-droplet interface (very high surface to 
volume ratio) and also due to the inability of proteins to counter diffuse when the water is 
rapidly evaporated. Moreover, whey protein instantly forms a skin when it comes in 
contact with hot air (Adhikari et al., 2007). This difference between spray and freeze 
drying (spray-dried microcapsules consistently had much higher concentration of protein 
on the surface) was observed for all the microcapsules (WPI-O-GA, WPI-P-GA and WPI-
P-O-GA).  
 
The surface composition of WPI-P-GA microcapsules was similar to that of WPI-GA 
(control) produced by both drying methods. It indicates that the bacterial cells were 
embedded within the complex coacervates and were not exposed to the surface. In the case 
of oil containing microcapsules, the XPS data clearly shows that the surface of these 
microcapsules was coated with the oil. The C 1s spectra of all the oil containing 
microcapsules are almost identical showing shapes and peaks typical of lipids: a very 
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intense CHx peak (C1+C2), accompanied by two weaker peaks characteristic of ester 
groups (C-O and O-C=O). 
 
4.4. Conclusions 
Probiotic bacteria L. casei 431 was successfully encapsulated in WPI-GA complex 
coacervate matrix. L casei and omega-3 rich tuna oil were also successfully co-
encapsulated in WPI-GA complex coacervate matrix. The liquid capsules containing 
bacterial cells and also bacterial cells together with tuna oil were converted into powder 
form using spray and freeze drying. The viability of the L. casei bacteria was significantly 
(p>0.05) higher when co-encapsulated with tuna oil in WPI-GA complex coacervates 
rather than being encapsulated on its own in the same shell matrix. The oxidative stability 
of tuna oil was greatly improved in the WPI-GA complex coacervates in the presence and 
absence of the bacterial cells. The surface elemental composition showed that in the spray 
dried microcapsules had high surface protein while freeze dried microcapsules had high 
surface carbohydrate when oil was not incorporated in the formulation. In oil-containing 
microcapsules, the surface of both spray and freeze dried microcapsules was consistently 
found to be enriched in oil. All the microcapsules produced were amorphous in nature. 
Composite microcapsules containing omega-3 fatty acids and probiotic bacteria will be 
useful for the stabilised delivery of these two important functional ingredients together into 
functional food and nutraceutical applications. 
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Chapter 5 
Survival, oxidative stability and surface characteristics of spray dried 
co-microcapsules containing omega-3 fatty acids and probiotic bacteria 
 
Abstract 
The objective of the study was to determine optimum inlet and outlet air temperatures of 
spray process for producing co-microcapsules containing omega-3 rich tuna oil and 
probiotic bacteria L. casei. These co-microcapsules were produced using whey protein 
isolate and gum Arabic complex coacervates as shell materials. Improved bacterial 
viability and oxidative stability of omega-3 oil were used as two main criteria of this study. 
Three sets of inlet (130o C, 150o C and 170o C) and outlet (55o C, 65o C and 75o C) air 
temperatures were used in nine combinations to produce powdered co-microcapsule. The 
viability of L. casei, oxidative stability of omega-3 oil, surface oil, oil microencapsulation 
efficiency, moisture content, surface elemental composition and morphology of the 
powdered samples were measured. There is no statistical difference in oxidative stability at 
two lower inlet air temperatures (130o C and 150o C). However, there was a significant 
decrease in oxidative stability when higher inlet temperature (170o C) was used. The 
viability of L. casei decreased with the increase in the inlet and outlet air temperatures. 
There was no difference in the surface elemental compositions and surface morphology of 
powdered co-microcapsules produced under these nine inlet/outlet temperature 
combinations. Of the range of conditions tested the co-microcapsules produced at inlet-
outlet temperature 130-65o C showed the highest bacterial viability and oxidative stability 
of omega-3 and having the moisture content of 4.93 ± 0.05% (w/w). This research shows 
that powdered co-microcapsules of probiotic bacteria and omega-3 fatty acids with high 
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survival of the former and high stability against oxidation can be produced through spray 
drying. 
 
Key words 
Co-encapsulation, omega-3 fatty acids, probiotic bacteria, spray drying, surface 
composition and morphology 
 
5.1. Introduction 
The development of functional foods and nutraceuticals by incorporating bioactive 
ingredients, particularly omega-3 fatty acids, probiotic bacteria, and polyphenols is a 
significant focus of functional and nutritional food industries (Champagne et al., 2007; 
Olive Li et al., 2014). New nutraceutical and functional food products are being designed 
and manufactured to fulfil the growing demand for healthier foods (Earle, 1997; 
Annunziata et al., 2013). Two of the most widely utilised bioactive ingredients used in 
functional foods are probiotic bacteria (Nazzaro et al., 2012; Coman et al., 2012) and 
omega-3 fatty acids (Serfaty et al., 2014; Price Judge et al., 2014). The functional foods 
developed using probiotic bacteria and omega-3 oils have clinically proven health benefits 
(Kim et al., 2008; Nazzaro et al., 2012). Probiotic bacteria are a group of bacteria which 
are defined as ‘live microorganisms which when administered in adequate amounts confer 
a health benefit to the host’ (FAO/WHO, 2001). Lactobacillus and Bifidobacterium are the 
most commonly studied probiotic bacteria because of their proven health benefits (Parvez 
et al., 2006; Gomes et al., 1999). Lactobacillus (L.) casei 431 is used as a model probiotic 
(P) bacterium in this study. Omega-3 fatty acids also have clinically proven health benefits 
in humans (Dinnetz et al., 2013). Tuna oil (O) is used as the source of omega-3 fatty acids 
126 
 
in this study. Whey proteins isolate (WPI) possesses very high nutritional value and good 
emulsifying properties (Sousa et al., 2012; Adhikari et al., 2007). Gum Arabic (GA) is a 
complex polysaccharide and it is commonly used as thickener and emulsifier in food 
formulations (Williams et al., 2009). For these reasons, these two are used as encapsulating 
wall materials. 
 
Several functional foods are manufactured using microencapsulation technology which 
entraps potent and unstable core within relatively inert shell to enhance shelf-life and to 
achieve controlled release and targeted delivery (Desai et al., 2005; Sobel et al., 2014). 
Specifically, a number of microencapsulation techniques such as spray drying, fluidized 
bed drying, complex coacervation, extrusion, and emulsion have been used for the delivery 
of bioactive ingredients into food (Olive Li et al., 2014). Complex coacervation is 
generally regarded as a useful microencapsulation technology because it confers controlled 
and sustained release possibilities (Gouin, 2004). Complex coacervation based 
encapsulation technologies are utilized to protect bioactive ingredients such as omega-3 oil 
(Eratte et al., 2014), ascorbic acid (Comunian et al., 2013), sweet orange oil (Jun-Xia et al., 
2011) and probiotic bacteria (Oliveira et al., 2007). The benefits of co-encapsulation of 
omega-3 oil and probiotic bacteria in WPI-GA complex coacervate matrix were reported in 
our previous work in terms of survival and oxidative stability (Eratte et al., 2015). 
 
The liquid microcapsules produced through complex coacervation processes have to be 
converted into powder in order to increase shelf life, and to improve packaging, handling 
and storage properties (Anwar et al., 2011). Spray drying is one of the most hygienic and 
economical technologies used for microencapsulation and producing powders in food 
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industry (Re, 1998; Keshani et al., 2015). It is a thermally mild amongst the convective air 
drying methods because of its very short product residence time (Mazza et al., 2003). The 
spray drying is 4-7 times less expensive than that of freeze drying (Chavez et al., 2007). 
However, maintaining high viability of heat sensitive probiotic bacteria through spray 
drying is still a major challenge (Ghandi et al., 2012; Ghandi et al., 2013). Since spray 
drying is much more cost effective and it can process larger volumes and operate at higher 
energy efficiency compared to freeze drying, many studies endeavoured to optimize spray 
drying process parameters and product formulations towards highest probiotic viability and 
minimal activity losses (Knorr, 1998; Tripathi et al., 2014). 
 
In our previous study, we investigated the co-microencapsulation of omega-3 oil and L. 
casei produced through complex coacervation followed by freeze and spray drying. It was 
found that spray dried co-microcapsule powders had advantages in terms of oxidative 
stability of omega-3 oil; however, the freeze dried co-microcapsules had higher viability of 
L. casei.[24] This work endeavours to optimise the spray drying process parameters so that 
co-microcapsules with higher bacterial viability as well as higher oxidative stability are 
produced. In addition, this study investigates the effect of inlet/outlet air temperatures on 
the physico-chemical and surface characteristics of spray dried co-microcapsules for the 
first time. These findings will benefit both the industry and the general public because of 
the synergistic health benefits of these powdered co-microcapsules. These co-
microcapsules are robust enough to be incorporated in commonly used food items such as 
yoghurt and beverages. 
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This study had the following objectives: (1) To determine the optimum inlet/outlet air 
temperature combination to produce co-microcapsules (WPI-P-O-GA) with improved 
viability of probiotic bacteria and better oxidative stability of omega-3 oil. (2)  To evaluate 
the effect of spray drying inlet/outlet air temperatures on the physico-chemical properties 
(moisture content, surface oil, total oil, oil microencapsulation efficiency) and 
morphological features and surface composition of co-microcapsules.  
 
5.2. Materials and Methods 
5.2.1. Materials 
L. casei 431® was donated by Chr.Hansen (Horsholm, Denmark). Tuna oil (HiDHA), was 
obtained by courtesy of NuMega Ingredients (Melbourne, Australia) and stored at 4o C 
until used. According to data provided by the supplier, the major fatty acids in this tuna oil 
were as follows: DHA (docosahexaenoic acid) 29.4%, palmitic acid 19.2%, oleic acid 
12.8%, EPA (eicosapentaenoic acid) 6.0%, stearic acid 5.3%, myristic acid 2.4%, 
arachidonic acid 2.0%, decosapentaenoic acid (DPA) 1.2%, linoleic acid 1.2%, stearidonic 
acid 0.6%, and linolenic acid 0.4%. Whey protein isolate (WPI 895TM) was donated by 
Fonterra Cooperative (Melbourne, Australia). Gum Arabic was purchased from Sigma-
Aldrich (Sydney, Australia). All other chemicals were purchased from Sigma–Aldrich 
Australia and were of analytical grade and used without further purification. 
 
5.2.2. Preparation of probiotic cell pellets and co-microcapsules 
The bacterial cell pellets and co-microcapsules were prepared as described in our earlier 
work (Eratte et al., 2015). Briefly, the L. casei was cultured for 18 h in sterile MRS broth 
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(1%, w/v) at 37o C. This culture was further sub-cultured (37o C, 18 h) twice in the same 
broth to activate bacteria and to allow them to adapt. All the inoculation works were 
carried out under sterile biological hoods with laminar air flow (Auramini, Laftech, 
Australia). Finally, 1000 mL of media was used for bulk culturing and cells were harvested 
at stationary growth phase by centrifuging at 2200×g for 15 min at 5o C. The supernatant 
was discarded and the precipitated cell mass was washed twice with sterile peptone water 
(0.2%, w/v) and these cell pellets were used for co-encapsulation process. 
 
The co-encapsulation process was carried out as follows: Firstly, WPI solution (7.5 g; 3%, 
w/v) was prepared at ambient temperature and 15 g of tuna oil was dispersed in this 
solution. The mixture was stirred using a mechanical stirrer (IKA® RW 20, Staufen, 
Germany) at 800 rpm for 10 min and was further homogenized using a microfluidizer 
(M110L, Microfluidics, Newton, Massachusetts, USA) at 45 MPa for 3 passes to produce 
an O/W emulsion. The pure probiotic cell pellets prepared (wet mass 5g) as described 
above were then added into this O/W emulsion. Then GA solution (2.5 g; 1%, w/v) was 
added drop wise into this dispersion with continuous stirring at 400 rpm. The pH of this 
emulsion was then adjusted to 3.75 by adding 1% citric acid drop wise in order to induce 
complexation between WPI and GA. The co-microencapsulation procedure was carried out 
at 25o C, and the liquid co-microcapsules were kept at 5o C for 48 h to ensure complete 
formation of complex coacervates. Finally, the co-microcapsules were dried to produce 
solid or powder co-microcapsules (WPI-P-O-GA). 
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5.2.3. Spray drying of co-microcapsules  
The liquid co-microcapsule samples prepared as described in Section 5.2.2 were spray 
dried (Mini spray dryer B-290, BÜCHI Labortechnik, Flawil, Switzerland) using three 
different inlet (130o C, 150o C, 170o C) and outlet (55o C, 65o C, 75o C) temperatures in 
nine combinations. The flow rate of the drying air was 35m3/h at 100% fan aspiration. The 
pumping rate was adjusted to maintain the outlet air temperature (the feed rate varies from 
1.2 mL/min to 3.6 mL / min). The powdered co-microcapsules were collected and stored at 
5o C for further characterization. The entire process for the production of WPI-P-O-GA co-
microcapsules was performed in triplicates for each inlet/outlet temperature set and the 
samples taken from three batches were used to determine their physico-chemical 
characteristics. 
 
The thermal efficiency (ƞthermal) of the spray drying operation was approximated using 
equation (1) (Hui, 2008).  
 
 
 
100
T - T
T - T
 %η
ambientinlet
outletinlet
 thermal 
              (1) 
where Tinlet, Toutlet, and Tambient are inlet, outlet and ambient (25o C) air temperatures, 
respectively. 
 
5.2.4. Enumeration of bacterial viability in powdered co-microcapsules 
The viability of L. casei in the co-microcapsules was assessed in MRS agar (CM0361, 
Thermo scientific, Melbourne, Australia) using spread plating technique as described in 
our earlier work (Eratte et al., 2015). Briefly, 1g of powder was diluted in 9 mL of sterile 
peptone water (0.2%, w/v). The bacterial cells were released from the capsules to the 
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medium using a stomacher. The cell suspension was serially diluted and plated on MRS 
agar plate and incubated under anaerobic condition (OxoidTM AnaerojarTM, 
Thermoscientific, Australia) at 37o C for 48h. The plating and enumeration were performed 
in triplicate and expressed viability as log cfu/g.  
 
5.2.5. Assessment of oxidative stability 
Accelerated oxidation tests were carried out on the powdered WPI-P-O-GA co-
microcapsules using RancimatTM test (model 743, Metrohm, Herisau, Switzerland) 
(Mathaus, 1996). Two grams of dried powder was heated at 90o C under purified air (flow 
rate of 20L/h). Briefly, when the encapsulated oil is oxidized, the conductivity of Milli-Q 
water in the collection chamber increases due to the increased solubility of volatile 
products (formic acid). The oxidative stability index (OSI) of the samples is graphically 
determined by locating tangential intersection point on experimental data (Eratte et al., 
2014; Wang et al., 2014). The induction time (at which the conductivity of sample 
increases sharply due to oxidation) of the test sample was recorded and used as the OSI.  
 
5.2.6. Microencapsulation efficiency 
Microencapsulation efficiency (ME) was calculated by measuring the solvent extractable 
surface oil (SO) and total oil (TO) of the microcapsules. Surface oil was determined by the 
washing method (Eratte et al., 2014; Liu et al., 2010). 
The total oil content in the dried microcapsules was determined by an acid digestion 
method using 4M HCl according to Eratte et al., (2014). The SO, TO and ME were 
calculated using equations (2), (3) and (4), respectively. 
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where Wt  and Ws are the mass (g) values of total and surface oil of the microcapsules and 
Wm is the mass (g) of the microcapsules. 
 
5.2.7. Acquiring surface morphology of co-microcapsules 
Scanning electron microscope (SEM) (JEOL JSM6300 SEM, Tokyo, Japan) was used to 
acquire the morphology of liquid, solid and reconstituted solid co-microcapsules. Solid 
samples were lightly gold sputter coated (Sputter coater, Agar Aids, England) for 45 
seconds and imaged at 7kV and low beam current. The liquid co-microcapsules were 
subjected to additional treatment before gold sputter coating. Briefly, 20 mL of liquid co-
microcapsules was fixed with 2% (w/v) glutaraldehyde in phosphate buffer (0.1 M; pH 
7.2) for 12 h. The slurry containing the glutaraldehyde cross-linked co-microcapsules was 
dehydrated in ethanol at different concentrations (30%, 40%, 50%, 60%, 70%, 80%, 90%, 
100%), each for 30 min. The sample was transferred to a solution containing 
hexamethyldisilizane (HMDS) and 100% ethanol in the ratio of 1:2 and left undisturbed 
for 20 min. HMDS is used as an alternative of critical point drying. Then, the sample was 
transferred to a fresh solution with HMDS-to-100% ethanol ratio of 2:1 for another 20 min. 
Finally, the sample was transferred into 100% HMDS solution and capped loosely in the 
fume hood overnight. The HMDS evaporated and the resulting solid sample was gold 
sputter coated and imaged under SEM. 
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5.2.8. X-ray photoelectron spectroscopic (XPS) analysis 
The surface chemical analysis was performed using an AXIS Ultra-DLD spectrometer 
(Kratos Analytical Ltd., UK) equipped with a monochromatic Al Kα X-ray source and a 
hemispherical analyser (fixed analyser transmission mode). Elemental compositions were 
determined from low-resolution survey spectra. High resolution C1s spectra were acquired 
to obtain detailed information about chemical map on the surface of the co-microcapsules. 
 
5.2.9. Moisture content  
The moisture content of powdered co-microcapsules was determined by drying the sample 
in a hot air oven at 105o C for 12 h. The dried samples were allowed to cool to room 
temperature in a desiccator containing silica gel before measuring sample mass.  
 
5.2.10. Statistical analysis  
All measurements were performed at least in triplicates unless otherwise stated and the 
results are reported as the mean ± standard deviation. The Minitab 17 statistical software 
package (University Park, Pennsylvania, United States) was used for the analysis of 
variance (ANOVA). The significant difference between any two means values was 
determined using Turkey test. A 95% (p<0.05) confidence level was used in all the cases.  
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5.3. Results and discussion 
5.3.1. Effect of inlet-outlet air temperatures on the physico-chemical properties of 
co-microcapsules 
In order to determine the optimal spray drying parameters of producing powdered 
co-microcapsules, the highest possible survival of encapsulated L. casei, highest oxidative 
stability (highest OSI) of encapsulated tuna oil and residual moisture content of 5% (w/w) 
were set as three overarching criteria. 
   
5.3.1.1. Viability of co-encapsulated probiotic bacteria 
The viability of L. casei in these powdered co-microcapsules produced at various 
inlet/outlet air temperature combinations is presented in Fig. 5.1. For a given inlet 
temperature, it was observed that there was a decrease in the viability of L. casei, when the 
outlet temperature increased from 55o C to 75o C. Various studies have indicated the 
importance of outlet air temperature associated with the bacterial viability (Knorr., 1988; 
Koc et al., 2010). As the droplet and particles are exposed to the outlet temperature in most 
of their residence time; hence, low outlet air temperatures better protect cells from being 
over-heated and thus improve the viability (Fu et al., 2013). Fig. 5.1 shows that the 
survival of L. casei in the co-microcapsules is lower at higher inlet temperatures. Similar 
findings on the effect of inlet temperatures on bacterial viability have been reported by 
others (Ghandi et al., 2012; Atalar et al., 2015). Therefore, it can be concluded here that the 
viability of L. casei in these co-microcapsules decreased with increase in inlet as well as 
outlet air temperatures. The highest bacterial survival in these co-microcapsules was 
observed at inlet/outlet temperature combination of 130/55o C (7.3 log cfu/g) followed by 
at 130/65o C and 150/55o C (7.1 log cfu/g). The survival of bacteria at these temperature 
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combinations was not significantly different (p>0.05) (Fig. 5.1). The lowest viability of L. 
casei was obtained at inlet/outlet temperature combination of 170/75o C (5.5 log cfu/g). 
These observations indicate that both inlet and outlet temperatures of spray dryer affect the 
survival of L. casei in WPI-P-O-GA co-microcapsules and that higher inlet and outlet air 
temperatures are detrimental to the viability of L. casei in these co-microcapsules. 
 
 
Fig. 5.1: Survival of L. casei in spray dried WPI-P-O-GA co-microcapsules at different 
inlet/outlet air temperature combinations. The labelled data corresponds to the viability in 
log (cfu/g). The bars with different letter in superscript indicate significant difference (p < 
0.05). 
 
5.3.1.2. Oxidative stability of co-encapsulated omega-3 oil 
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The OSI values of powders produced at different inlet/outlet temperature combinations are 
presented in Fig. 5.2. The OSI values of pure tuna oil (control) was measured as 3.1 h 
(Eratte et al., 2014). The oxidative stability of co-microcapsules produced at different 
inlet/outlet temperature combinations was significantly higher than that of untreated tuna 
oil. As can be observed, there is no statistical difference in OSI values at two lower inlet 
air temperatures (130o C and 150o C). However, there was a significant decrease in OSI 
value when higher inlet temperature (170o C) was used.  
 
 
Fig. 5.2: Oxidative stability index (OSI) of encapsulated tuna oil in spray dried WPI-P-O-
GA co-microcapsules at different inlet/outlet air temperature combinations. The labelled 
data indicates the oxidative stability index (OSI). Different lower case letters in superscript 
indicate significant difference (p <0.05). 
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A large temperature gradient between the droplet/particle and the drying air can occur at 
high inlet temperature, resulting into faster heat, and moisture transfer rates.  Faster 
outward diffusion of vapour when resisted by microcapsule shell of low moisture 
diffusivity can create higher number of cracks for unit surface area which can increase the 
inward diffusion or permeation of the oxygen. It was previously reported that high inlet air 
temperatures cause excessive bubble growth and surface imperfections (Jafari et al., 2008). 
This perhaps is the reason for lower OSI values in co-microcapsules dried at higher inlet 
temperature. Thus, so far it is technically and economically feasible, lower inlet air 
temperatures should be selected to produce oxidatively stable co-microcapsule powders. 
The highest and lowest OSI values of 21.2 h and 15.12 h were obtained at inlet/outlet 
combinations of 130/65o C and 170/55o C, respectively. The OSI values of the co-
microcapsules increased with increase in the outlet air temperatures, for each inlet 
temperature tested except for 130o C (Fig. 5.2). 
 
 5.3.1.3. Physico-chemical characteristics of co-microcapsules  
The residual moisture content, surface oil, total oil, and oil microencapsulation efficiency 
of spray dried co-microcapsules produced at different inlet/outlet air temperatures are 
shown in Table 5.1. As expected, the residual moisture content of powder decreased with 
increase in the inlet as well as outlet air temperatures in all the cases. This is due to the fact 
that the relative humidity decreases substantially at higher temperature, and it creates 
higher vapour gradient between the bulk air and the droplet/particle surface. The effect of 
higher dryer inlet and outlet temperatures showed similar trend in residual moisture content 
and bacterial survival. For example, the lowest residual moisture content and the lowest 
bacterial survival were observed at inlet/outlet temperature combination of 170/75o C. 
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Similarly the highest residual moisture content and the highest bacterial survival was 
observed at inlet/outlet temperature combination of 130/55° C. Given the residual moisture 
content of powders obtained from all these temperature combinations was close to 5% 
(w/w), due to highest bacterial survival and highest oxidative stability the inlet/outlet 
temperature combination of 130/65o C appeared to be optimal to produce WPI-P-O-GA co-
microcapsule powder. The thermal efficiency calculated at the inlet/outlet temperature 
combination of 130/65o C was found to be 61.90% (Table 5.1). 
 
There was no significant difference in surface oil (SO), total oil (TO) and oil 
microencapsulation efficiency (ME) in the spray dried WPI-P-O-GA co-microcapsules 
produced at different inlet/outlet temperature combinations (Table 5.1). This suggests that 
the complex coacervate matrix rather than the spray drying process determines the amount 
of surface oil on the WPI-P-O-GA co-microcapsules. This observation agrees with earlier 
findings that the surface oil in spray dried powders is not affected by outlet (Danviriyakul 
et al, 2002) and inlet (Klinkesorn et al., 2006) air temperatures. The ME depends on the 
amount of surface oil of the microcapsules in addition to the degree to which the wall 
matrix can hold or store the oil within (Hogan et al., 2001). Therefore, we can conclude 
here that surface oil and, hence, the microencapsulation efficiency of these co-
microcapsules were mainly affected by the complex coacervate wall matrix rather than the 
inlet and outlet air temperatures used.  
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Table 5.1: Physico-chemical properties of spray dried WPI-P-O-GA co-microcapsules and 
thermal efficiency of spray drying process at different inlet/outlet air temperatures. SO = 
Surface oil, TO = Total oil, ME = Oil microencapsulation efficiency, ƞ thermal = Thermal 
efficiency of spray drying process. 
 
Inlet/outlet 
temperature 
(° C) 
Residual moisture 
content (%) SO (%) TO (%) Oil ME (%) ƞthermal (%) 
130/55 5.03 ± 0.07a 2.85 ± 0.28a 48.25 ± 1.11a 94.08 ± 0.60a 71.43 
130/65 4.93 ± 0.05ab 2.68 ± 0.70a 47.57 ± 2.09a 94.32 ± 1.68a 61.90 
130/75 4.72 ± 0.05abc 2.80 ± 0.73a 48.74 ± 1.40a 94.24 ± 1.59a 52.38 
150/55 4.66 ± 0.33abcd 2.83 ± 0.87a 48.86 ± 0.85a 94.23 ± 1.69a 76.00 
150/65 4.27 ± 0.28bcde 2.96 ± 0.43a 48.63 ± 1.50a 93.91 ± 0.81a 68.00 
150/75 4.07 ± 0.51cdef 2.61 ± 1.05a 47.62 ± 1.50a 94.49 ± 2.35a 60.00 
170/55 3.96 ± 0.30def 3.14 ± 1.27a 47.81 ± 1.27a 93.39 ± 2.84a 79.31 
170/65 3.69 ± 0.23ef 3.07 ± 1.07a 48.66 ± 0.57a 93.69 ± 2.18a 72.41 
170/75 3.32 ± 0.20f 2.97 ± 0.79a 47.87 ± 1.70a 93.81 ± 1.46a 65.52 
 
Considering the bacterial viability, OSI and moisture content, it appears that the inlet 
temperatures >130o C and <170o C and outlet temperatures >55o C and < 75o C will 
produce high quality WPI-P-O-GA co-microcapsules in terms of viability of probiotic 
bacteria and oxidative stability of omega-3 fatty acids. The co-microcapsules produced at 
the inlet/outlet air temperatures of 130/65° C satisfied the three criteria of the highest 
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possible survival of the L. casei cells, improved oxidative stability of microencapsulated 
tuna oil and residual moisture content of <5% (w/w). 
 
5.3.2. Morphology and surface characteristics of WPI-P-O-GA co-microcapsules 
5.3.2.1. Morphology of co-microcapsules 
Many important properties of microcapsules, such as protection of core materials, powder 
stability depend on their surface characteristics and surface morphology (Klinkesorn et al., 
2006). The morphology of liquid co-microcapsules observed under phase contrast and 
SEM microscope (scale bar = 5 µm) is shown in Fig. 5.3A and Fig. 5.3B, respectively. The 
reconstituted spray dried co-microcapsules with additional biological treatment (Section 
5.2.7) was observed under SEM to investigate the morphological change of rod shaped 
bacteria after drying, which is shown in Fig. 5.3C. The rod shaped bacteria (represented by 
white circles) and spherical oil droplets (represented by white arrows) are clearly 
distinguishable in the matrix (Fig. 5.3B and 5.3C). We observed that the morphology of the 
liquid co-microcapsules changed when observed under SEM (Fig. 5.3B) compared to the 
one observed under phase contrast (Fig. 5.3A), probably due the pre-treatment required 
before SEM imaging (Section 5.2.7). The sample pre-treatment was carried out in order to 
observe the structural change of bacterial cell before and after spray drying. There was no 
noticeable alteration in the bacterial cell structure (rod shape) in liquid co-microcapsules 
(Fig. 5.3B) and in reconstituted spray dried co-microcapsules (Fig. 5.3C). This can be 
attributed to the mild drying condition (inlet/outlet combination of 130/65o C), strong 
evaporative cooling effect, short residence time and resultant lower extent of bacterial 
denaturation (Arpagaus et al., 2012; Perdana et al., 2013; Eratte et al., 2016). Preservation 
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of structural integrity of bacteria during drying is important for preservation of their 
viability and vitality.  
 
The SEM micrographs of spray dried WPI-P-O-GA solid co-microcapsules produced at 
different inlet/outlet temperature combinations are shown in Fig. 5.4 (scale bar = 20 µm). 
The solid microcapsules obtained are more or less spherical in shape and no bacterial cell 
was observed on the surface, indicating that L. casei cells were fully encapsulated within 
the shell matrix. This absence of bacterial cells on the surface of these co-microcapsules is 
also supported by the surface elemental composition data which will be presented shortly. 
In addition, there was no observable sign of fissures or cracks on the surface of these WPI-
P-O-GA co-microcapsules. This observation further confirms good structural integrity of 
the co-microcapsule surface which corroborates to the low permeability of oxygen and 
better microencapsulation efficiency as observed in Table 5.1. The SEM micrograph of 
reconstituted WPI-P-O-GA co-microcapsules (Fig. 5.3C) substantiates the presence of L. 
casei cells and oil droplets inside the co-microcapsules after drying. There was no 
noticeable difference on the surface morphology in WPI-P-O-GA co-microcapsules 
produced at different inlet/outlet temperature combinations (Fig. 5.4). 
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Fig. 5.3: Morphology of WPI-P-O-GA co-microcapsules: (A) Liquid co-microcapsules 
observed under phase contrast microscope; (B) Liquid co-microcapsules observed under 
SEM; (C) Reconstituted spray dried co-microcapsules obtained under SEM, scale bar = 
5µm. 
 
 
Fig. 5.4: SEM micrographs of WPI-P-O-GA co-microcapsules produced at different 
inlet/outlet temperature combinations (o C): (A) 130/55; (B) 130/65; (C) 130/75; (D) 
150/55; (E) 150/65; (F) 150/75; (G) 170/55; (H) 170/65; (I) 170/75; scale bar = 20µm. 
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5.3.2.2. Surface characteristics of co-microcapsules 
XPS analysis was used to quantify the surface (20-100 Å) elemental composition of 
WPI-P-O-GA co-microcapsules. The C1s spectra of these co-microcapsules at various 
inlet/outlet temperature combinations are shown in Fig. 5.5. The corresponding surface 
elemental composition in terms of carbon (C), oxygen (O), nitrogen (N) of these 
co-microcapsules are presented in Table 5.2.  
Table 5.2: Surface elemental compositions [Carbon (C), Oxygen (O), and Nitrogen (N)] of 
spray-dried WPI-P-O-GA co-microcapsules produced at varying inlet/outlet air 
temperatures.  
Inlet/outlet 
temperature (° 
C) C1+C2 C3 C4 C5 O N 
130/55 0.716 ± .002 0.156 ± .000 0.064 ± .000 0.064 ± .002 0.215 ± .003 0.072 ± .001 
130/65 0.736 ± .007 0.145 ± .002 0.058 ± .002 0.061 ± .003 0.196 ± .010 0.062 ± .003 
130/75 0.714 ± .004 0.159 ± .005 0.067 ± .000 0.060 ± .001 0.209 ± .003 0.073 ± .001 
150/55 0.733±  .004 0.145 ± .002 0.058 ± .002 0.064 ± .000 0.202 ± .006 0.061 ± .003 
150/65 0.720 ± .004 0.154 ± .003 0.067 ± .000 0.060 ± .001 0.209 ± .003 0.071 ± .002 
150/75 0.715 ± .003 0.156 ± .004 0.068 ± .003 0.061 ± .002 0.214 ± .004 0.072 ± .001 
170/55 0.726 ± .000 0.148 ± .003 0.064 ± .005 0.062 ± .001 0.208 ± .003 0.065 ± .000 
170/65 0.719 ± .001 0.149± .001 0.070± .002 0.062 ± .000 0.220 ± .002 0.071 ± .001 
170/75 0.716 ± .002 0.152 ± .001 0.071 ± .001 0.061 ± .001 0.218 ± .006 0.074 ± .005 
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The concentration of carbon atoms bonded differently or bonded with different elements 
was determined by curve-fitting the high resolution C1s spectra. The curve fitting protocol 
was based on five components with the following notations: C1+C2 (C-C, C-H), C3 (C-O, 
C-N), C4 (C=O, O-C-O, N-C=O), C5 (O-C=O).  As can be seen from Fig. 5, the C1s 
spectra of all the co-microcapsules are overlapping with each other. This means that the 
spray dried WPI-P-O-GA co-microcapsules produced at different inlet/outlet temperature 
combinations had identical surface elemental composition and that the drying parameters 
made no difference on the surface composition. This observation also corroborates with the 
surface oil data (Table 5.1) which showed that there was no significant difference (p>0.05) 
in the surface oil content in WPI-P-O-GA co-microcapsules produced at different 
inlet/outlet temperature combinations. Furthermore, there was no significant difference in 
oxygen and nitrogen content on the surface of co-microcapsules produced at different 
inlet/outlet air temperature combinations (Table 5.2). However, the least oxygen content 
(0.196) was found on the surface of co-microcapsules produced at inlet/outlet temperature 
combination of 130/65o C. This observation also corroborates with the oxidative stability 
index data (Fig. 5.2) which showed that co-microcapsules produced at inlet/outlet 
temperature combination of 130/65o C exhibited highest oxidative stability (21.2 h) than 
those produced at other inlet/outlet temperature combinations.  
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Fig. 5.5: C1s spectra of spray dried WPI-P-O-GA co-microcapsules produced at different 
inlet/outlet air temperature combinations (o C): (A) 130/55; (B) 130/65; (C) 130/75; (D) 
150/55; (E) 150/65; (F) 150/75; (G) 170/55; (H) 170/65; (I) 170/75.  
 
5.4. Conclusions 
The probiotic bacteria L. casei and omega-3 rich tuna oil were co-encapsulated using 
WPI-GA complex coacervate as shell material and subsequently converted into powder 
using spray drying. Nine sets of spray dryer inlet/outlet temperature combinations were 
used to determine the effects of these temperature combinations on properties such as 
bacterial survival, stability of oil against oxidation, moisture content, surface oil, total oil, 
oil microencapsulation efficiency as well as surface morphology and surface elemental 
composition of these co-microcapsules. High inlet and outlet air temperatures decreased 
the survival of L. casei. High inlet air temperature also decreased oxidative stability of 
microencapsulated tuna oil. Surface oil content and hence the oil microencapsulation 
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efficiency of WPI-P-O-GA co-microcapsules was not affected by the inlet and outlet 
temperatures. The shape and the morphology of L. casei cells were not affected by the 
chosen spray drying temperatures. The surface morphology of co-microcapsules produced 
at different inlet/outlet temperature combinations was not significantly different.  The inlet 
air temperatures from 130o C to 170o C and outlet temperatures between 55o C and 75o C 
different did not alter the surface elemental composition of these spray dried co-
microcapsules. This study identified that the inlet/outlet temperature combination of 
130/65o C produced WPI-P-O-GA co microcapsules with highest bacterial survival and 
highest oxidative stability under moisture content less than 5%. These findings of this 
study will benefit many potential applications in functional food, nutraceutical and 
pharmaceutical industries. 
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Chapter 6 
Survival and fermentation activity of probiotic bacteria and oxidative stability of 
omega-3 oil in co-microcapsules during storage 
 
Abstract 
Tuna oil (O) and probiotic bacteria L. casei (P) were co-microencapsulated in whey protein 
isolate (WPI)-gum Arabic (GA) complex coacervate. The co-microcapsules (WPI-P-O-
GA), L. casei microcapsules (WPI-P-GA) and tuna oil microcapsules (WPI-O-GA) were 
converted into powder using spray and freeze drying. The interaction between probiotic 
bacteria and omega-3 oil in co-microcapsules, particularly in terms of oxidative stability of 
omega-3 oil and vitality/viability of probiotic bacteria and any synergistic outcome were 
studied. The effect of storage temperature (5 and 25o C) and time (90 days) on the survival 
and fermentation activity of L. casei and oxidative stability of tuna oil in the 
microcapsules/co-microcapsules were determined. A synergism between oxidative stability 
of omega-3 oil and vitality of probiotic bacteria was observed, when they were co-
microencapsulated and spray dried. These co-microcapsules will likely have utility in 
functional food formulations due to simple and cost effective stabilisation and delivery of 
two important functional ingredients. 
 
Key words: Probiotic bacteria, Omega-3 fatty acids, Co-microencapsulation, Viability, 
Vitality, Oxidative stability 
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6.1. Introduction 
There is growing interest in producing functional foods containing encapsulated probiotic 
bacteria that provide health benefits to consumers (Mattila-Sandholm et al., 2002; Burgain 
et al., 2011). Probiotic bacteria are live microorganisms which when administered in 
adequate amounts confer health benefits to the host (FAO/WHO, 2001). These health 
benefits include the enhancement of gastrointestinal and immune functions (Macfarlane et 
al., 1999). Microencapsulation of probiotic bacteria has been investigated comprehensively 
including the strains, methods and matrix of microencapsulation, and the effect of drying 
and storage conditions in order to maintain their viability and vitality during manufacture, 
storage, and delivery to the targeted site of gastrointestinal tract (Tripathi et al., 2014). 
 
The polyunsaturated fatty acid requirement of the human brain is substantial during the 
neonatal period and remains high throughout life, in order to preserve the integrity of cell 
membranes and their function. However, these very long chain fatty acids are poorly 
synthesised in our bodies from shorter precursors obtained from food (Bourre, 2004). 
Maintaining adequate levels of omega-3 content in brain cell membranes is crucial for 
memory-processing which may diminish with age and due to certain chronic brain 
disorders (Stough et al., 2012). Omega-3 fatty acids are considered as good fatty acids 
(Shahidi, 2015) and hence it is essential to take omega-3 fatty acids through food (Kris-
Etherton et al., 2002). The broader consumption of omega-3 rich foods has been hindered 
because of their poor compatibility in water-based products and susceptibility to oxidative 
degradation, which can lead to off-flavours, off-odours, and loss in bioactivity (Barrow et 
al., 2007). Therefore, stabilisation of omega-3 rich oils using suitable microencapsulation 
technology is essential for successful incorporation of omega-3 rich oils in a broad 
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spectrum of food products and beverages (Sanguansri et al., 2006; Augustin et al., 2015). 
A remarkable emergent interest to enrich food products with omega-3 fatty acids has been 
observed in the last few decades (Lemahieu et al., 2015; de Camargo Talon et al., 2015). 
 
We reported in an earlier work that the survival of probiotic bacteria is improved when 
they are co-microencapsulated with omega-3 in a single matrix (Eratte et al., 2015). Co-
microencapsulation of omega-3 fatty acids and probiotic bacteria in whey protein isolate 
(WPI) - gum Arabic (GA) complex coacervate matrix significantly improved the survival 
of probiotic bacteria and stability of omega-3 rich tuna oil (Eratte et al., 2014; Eratte et al., 
2015). In this study, we investigate the viability/vitality of probiotic bacteria and oxidative 
stability of omega-3 in co-microcapsules during specific storage conditions. For this 
purpose the viability/vitality of probiotic bacteria (P) and oxidative stability of tuna oil (O) 
in co-microcapsules (WPI-P-O-GA) and individual microcapsules containing either 
probiotic bacteria (WPI-P-GA) or tuna oil (WPI-O-GA) were studied during storage. 
Changes in viability/vitality and oxidative stability over time have not been previously 
reported for microcapsules containing both probiotic bacteria and omega-3 fatty acids. 
 
Probiotic bacteria are dried and converted into powder for use in food and pharmaceutical 
applications, as the powder is easy to handle, transport and store (Ghandi et al., 2013a). 
Probiotic bacteria, particularly lactic acid bacteria (LAB), are added in fermented milk 
products in order to impart the desired physico-chemical, sensory and microbiological 
attributes in such products (Casarotti et al., 2014). Consumption of fermented probiotic 
milk provides health benefits such as alleviation of undesirable gastric and abdominal 
symptoms (Gomi et al., 2015), improved immune response (Bogsan et al., 2014), reduction 
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of total cholesterol (Ejtahed et al., 2011), and enhancement of intestinal microbiota (Wang 
et al., 2012).  
 
For these reasons, we studied the vitality (fermentation ability) of microencapsulated and 
co-microencapsulated model probiotic bacteria (L. casei) in reconstituted skim milk 
powder. The fermentation activity of the probiotic bacteria was also determined in co-
microcapsules as a function of storage temperature and time using microcapsules 
containing only the probiotic bacteria as a control. To date, no published study has 
addressed the viability and vitality of any probiotic bacteria in co-microcapsules containing 
omega-3 fatty acids as a function of storage temperature and time. Similarly, no study has 
been reported on the oxidative stability of omega-3 oil in co-microcapsules containing 
probiotic bacteria as a function of storage temperature and storage time by measuring and 
comparing different oxidation parameters, such as oxidative stability index (OSI) by 
Rancimat, peroxide value (PV), p-Anisidine value (AV) and total oxidation value 
(TOTOX). The novelty of this study lies in the facts that it is a further improvement of the 
concept of co-microencapsulation of omega-3 fatty acids and probiotic bacteria in one 
single matrix through a detailed examination of the viability/vitality of microencapsulated 
bacteria and the oxidative stability of the microencapsulated omega-3 at different storage 
temperatures and times.  
 
Co-microcapsules provide the benefits of both omega-3 fatty acids and probiotic bacteria 
in one serving. This has cost and convenience advantages over individual 
microencapsulation of each ingredient. The cost of spray drying is six times lower per 
kilogram of water removed than the cost of freeze-drying (Knorr, 1998) and result in a 
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relatively stable powder that can be transported and stored in a stable form. Therefore, co-
microcapsules can be preferred in functional foods where both quality and low cost are key 
parameters for commercial success. 
 
This study had the following key objectives: (1) To compare the survival and fermentation 
activity of L. casei as a model probiotic bacteria in freeze and spray dried co-microcapsules 
(WPI-P-O-GA) as a function of storage temperature and time, in comparison with a 
control, of freeze and spray dried microcapsules containing only L. casei (WPI-P-GA). (2) 
To compare the oxidative stability of omega-3 rich tuna oil in the co-microcapsules (WPI-
P-O-GA) as a function of storage temperature and time, in comparison with a control of 
freeze and spray dried microcapsules containing only tuna oil (WPI-O-GA). 
 
6.2. Materials and Methods 
6.2.1. Materials 
L. casei 431 was used as the model of probiotic bacteria and was kindly donated by Chr. 
Hansen (Horsholm, Denmark). Tuna oil (HiDHA) (NuMega Ingredients Ltd, Melbourne, 
Australia) is rich in omega-3 fatty acids and was used as an omega-3 rich oil for this study. 
Tuna oil was stored at 4o C until used. According to data provided by the supplier, the 
major fatty acids in this tuna oil were as follows: DHA (docosahexaenoic acid) 29.4%, 
palmitic acid 19.2%, oleic acid 12.8%, EPA (eicosapentaenoic acid) 6.0%, stearic acid 
5.3%, myristic acid 2.4%, arachidonic acid 2.0%, decosapentaenoic acid (DPA) 1.2%, 
linoleic acid 1.2%, stearidonic acid 0.6%, and linolenic acid 0.4%. Whey protein isolate 
(WPI 895TM) was donated by Fonterra Cooperative (Melbourne, Australia). Gum Arabic 
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was purchased from Sigma-Aldrich Ltd. (Sydney, Australia). All other chemicals were 
purchased from Sigma–Aldrich Ltd. (Sydney, Australia) and were of analytical grade. All 
of the above ingredients and chemicals were used as received without further purification 
or alteration. 
 
6.2.2. Preparation of L. casei culture 
The L. casei was cultured for 18 h in sterile MRS broth (1%, w/v) at 37o C. This culture 
was sub-cultured (37o C, 18 h) twice in the same broth to activate bacteria and to allow 
them to adapt. All the inoculation works were carried out under sterile biological hoods 
with laminar air flow (Auramini, Laftech, Melbourne, Australia). Finally, 1000 mL of 
media volume was used for bulk culturing and cells were harvested at stationary growth 
phase by centrifuging at 2200×g for 15 min at 5o C. The supernatant was discarded and the 
precipitated cell mass was washed twice with sterile peptone water (0.2%, w/v). The final 
wet cell mass was weighed and divided into two equal portions. One portion (wet mass 5g) 
was used to prepare WPI-P-GA microcapsules and the second half (wet mass 5g) was used 
to prepare WPI-P-O-GA co-microcapsules in order to facilitate a good comparative study 
(Eratte et al., 2015).  
 
6.2.3. Microencapsulation process 
The complex coacervation and microencapsulation procedures were performed as below, 
using a previously published methods with some modifications (Eratte et al., 2014; Eratte 
et al., 2015). 
6.2.3.1. Microencapsulation of tuna oil 
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A solution of 15 g tuna oil and 250 mL WPI solution (12%, w/v) were stirred (IKA® RW 
20 digital overhead stirrer, Staufen, Germany) at 800 rpm for 10 min and then 
homogenized using a microfluidizer at 45 MPa for 3 passes (M110L, Microfluidics, 
Newton, MA, USA) to produce an O/W emulsion. Then a 250 mL GA solution (4%, w/v) 
was added drop wise into this O/W emulsion with continuous stirring at 400 rpm and the 
pH adjusted to 3.75 by adding 1% citric acid drop wise in order to induce complexation 
between WPI and GA.  
6.2.3.2. Microencapsulation of L. casei  
Similar to above, the previously prepared probiotic cell mass was added slowly into a WPI 
solution, and a GA solution was then added drop wise with continuous stirring, after which 
the pH was adjusted to 3.75 as above. 
6.2.3.3. Co-microencapsulation of omega-3 oil and L. casei  
As above, tuna oil (15 g) was dispersed into a WPI solution and stirred for 10 min, 
followed by homogenizing using a microfluidizer to produce an O/W emulsion. Previously 
prepared probiotic cell mass was then added into this O/W emulsion and GA solution was 
added with continuous stirring at 400 rpm, and the pH adjusted to 3.75 as above. 
The microencapsulation procedure in all the three cases were carried out at 25o C, and the 
liquid microcapsules/co-microcapsules were kept at 5o C for 48 h to ensure complete 
formation of complex coacervates. Finally, the microcapsules/co-microcapsules were dried 
to produce solid or powder co-microcapsules (WPI-O-GA, WPI-P-GA and WPI-P-O-GA). 
 
6.2.4. Drying of coacervate liquid microcapsules  
A portion of liquid microcapsules produced as per Section 6.2.3 was spray dried (B-290, 
BÜCHI Labortechnik, Flawil, Switzerland) using an inlet temperature of 130o C and outlet 
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temperature 65o C (Eratte et al., 2016). The second portion of the liquid microcapsules was 
frozen at -20o C overnight and was subsequently freeze dried (Christ Alpha 2-4LD, 
Osterode, Germany). The temperature of the ice condenser was set at -50o C and the 
vacuum pressure was set to 0.04 mbar. The frozen samples were dried for 48 h and the 
dried product was collected, pulverized and stored. This procedure is also adapted from our 
earlier work (Eratte et al., 2015). 
 
6.2.5. Storage studies 
The freeze dried and spray dried microcapsule powder containing tuna oil only (WPI-O-
GA) and bacteria only (WPI-P-GA) and co-microcapsule powder (WPI-P-O-GA) were 
first flushed with nitrogen and stored for 90 days at two different temperatures (5  and 25o 
C) in dark airtight vials. They were further placed in aseptic plastic bags, vacuum sealed 
and kept in air-tight desiccator containing silica gel beads. Bacterial survival was measured 
at an interval of 15 days during 90 days of storage. Fermentation activity and oxidative 
stability by RancimatTM analysis were evaluated at an interval of 30 days (Läubli et al., 
1986). The primary and secondary oxidation products such as peroxide value (PV) and p-
Anisidine value (AV) were measured at intervals of 15 days during the storage. 
 
6.2.6. Determination of bacterial survival during storage 
The viability of L. casei in the microcapsules/co-microcapsules was assessed in MRS agar 
(CM0361, Thermoscientific, Melbourne, Australia) using spread plating. Briefly, 1g of 
powder was diluted in 9 mL of sterile peptone water (0.2%, w/v). The bacterial cells were 
completely released from the microcapsules to the medium within 15 min using a 
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stomacher. Maximum cell release was confirmed by testing cell viability over time (up to 
20 min) in the preliminary test. The cell suspension was serially diluted and plated on MRS 
agar plate. The plates were then incubated under anaerobic condition (OxoidTM 
AnaerojarTM, Thermoscientific, Melbourne, Australia) at 37o C for 48h. The plating was 
performed in triplicate. Results are expressed as log colony forming units per gram of the 
powder used (log cfu/g powder).   
 
The viability of the bacteria (L. casei) during storage was expressed as a logarithmic value 
(to the base 10) of the ratio of cell count at a particular storage time (N t) to the cell count at 
the beginning of storage (N0). Equation (1) was fitted to the experimental log (N t/N0) 
against storage time (t) in days for each temperature in order to determine the inactivation 
rate constant k (day-1) during storage (Foerst et al., 2012).  
kt
N
N
log
0
t
                                                                                (1) 
The survival percentage (S) of bacterial cells was calculated using equation (2) given 
below. 
100
N
N
(%) S
0
t
                                                                       (2) 
 
6.2.7. Fermentation process 
The reconstituted skim milk (RSM) was prepared according to Casarotti et al., (2014) with 
slight modification. The skim milk powder- Regular High Heat (protein 32.9g/100g) 
(Fonterra, Melbourne, Australia) was reconstituted to 10% (w/v) in double distilled water. 
The RSM was thermally treated in sterile bottles at 90o C for 5 min in a water bath, cooled 
in ice bath and transferred to a sterile glass flask sealed with a screw-cap sealed lid, all 
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inside a laminar flow chamber. The amounts of WPI-P-GA microcapsules and WPI-P-O-
GA co-microcapsules powders added into 100 mL of sterile RSM are given in Table 6.1. 
These formulations provide the same initial cell count of 8 log cfu/g of microcapsules in 
100 mL RSM for a good comparative study. These fermentation experiments were carried 
out using a shaking (100 rpm) incubator under sterile condition at 37o C for 72 h. The 
incubator was disinfected with 70% ethanol and all the glassware used were autoclaved 
before fermentation. These fermentation tests were carried out in triplicate. 
 
6.2.8. Measurement of fermentation activity 
The fermentation activity was determined in terms of change in pH and lactic acid 
production. The change of pH during fermentation was monitored intermittently over a 
period of 72 h using a pH meter (TPS WP-80M, Melbourne, Australia). The electrode was 
disinfected with 70% (v/v) ethanol, rinsed with sterile distilled water and placed in the 
fermentation flask under aseptic conditions in each measurement. 
The following parameters were used to characterize the fermentation  kinetics: (a) 
maximum acidification rate (Vmax) which was calculated by differentiating the pH–time 
curve with respect to time (dpH/dt) and expressed in absolute values (10-3  pH units /min) 
(De Souza Oliveira et al., 2009); (b) the time at which pH 4.6 was reached (tpH 4.6, h); (c) 
lactic acid productivity (Pmax, g/L/h) was calculated by dividing the final lactic acid 
concentration by the total fermentation time (Dembczynski et al., 2002).  
The fermented RSM was sampled at different time intervals (0h, 24h, 48h, 72h) to 
determine the amount of lactic acid produced. Briefly, the collected samples were 
centrifuged at 13,000 x g for 10 min. The supernatant was collected and further filtered by 
passing through 0.45 µm nylon syringe filter. The lactic acid concentration was then 
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determined by using ultra high performance liquid chromatography (LCMS-8030, 
Shimazdu, Columbia, Maryland, USA) with photodiode Array detector at λ=210 nm. An 
organic acid column (AllTech OA-1000 cat. No 9046; 300 × 7.8 mm) was used to 
determine the lactic acid content.  The mobile phase (0.005M H2SO4) was vacuum filtered 
and fed using an isocratic elution with a flow rate of 0.6 mL/min and the oven temperature 
was kept at 65o C (Nazzaro et al., 2009).  
 
6.2.9. Oxidative stability 
6.2.9.1. Determination of oxidative stability index 
Accelerated oxidation tests were carried on the solid WPI-P-O-GA co-microcapsules and 
WPI-O-GA microcapsules using a Rancimat (model 743, Metrohm, Herisau, Switzerland) 
(Mathäus, 1996). Dried microcapsule powder (1.5 g) was heated at 90o C under purified air 
flow rate of 20L/h.  The oxidative stability index (OSI) value of the samples was 
graphically determined by locating the rapid change of slope of the conductivity versus 
time curve. These tests were carried out in triplicate. 
 
6.2.9.2. Primary and secondary oil oxidation products 
Primary oxidation products in the extracted oil were measured by peroxide value (PV) 
according to the methodology described by Karaca et al. (2013). Secondary oxidation 
products, specifically the aldehydes produced from the breakdown of oil peroxides, were 
measured by p-Anisidine value (AV) according to Lee et al. (2007). The total oxidation 
(TOTOX) value was calculated using equation (3) given below (Ifeduba et al., 2015). 
AV2PVTOTOX                                                                (3) 
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6.2.10. Statistical Analysis  
All the experiments were carried out either in duplicate or triplicate, as stated. The Minitab 
16TM statistical software package (University Park, PA, USA) was used for the analysis of 
variance (ANOVA) to determine the significant differences. The confidence level of 95% 
(p<0.05) was used to determine significant difference between mean values. 
 
6.3. Results and discussion 
In this section, the viability and vitality (fermentation activity) of the microencapsulated 
probiotic bacteria and the oxidative stability of microencapsulated omega-3 oil during 
storage are discussed based on four parameters: Microencapsulation process; drying 
method used (spray and freeze drying); storage time (up to 90 days); and storage 
temperature (5 and 25o C). 
 
6.3.1. Survival of L. casei in WPI-P-GA microcapsules and WPI-P-O-GA co-
microcapsules 
The initial cell count, final survival percentage, and inactivation rate constant of L. casei in 
freeze dried and spray dried WPI-P-GA microcapsules (control) and WPI-P-O-GA co-
microcapsules are presented in Table 6.1. We had reported earlier that the count of viable 
cells (viability) of L. casei in WPI-P-O-GA co-microcapsules was greater than that of 
WPI-P-GA microcapsule powders obtained from both spray and freeze drying (Eratte et 
al., 2015). The initial viability data obtained in this study (Table 6.1) confirmed those 
findings. The initial cell count was found to be greater in FD WPI-P-O-GA (8.47 log cfu/g) 
than all the other solid microcapsules. However, after storage for 90 days, the highest 
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bacterial survival (45.72 %) was measured in spray dried (WPI-P-O-GA) co-microcapsules 
stored at 5o C. Some denaturation and aggregation of whey protein occurred during spray 
drying, enhancing adsorption at the interface and resulting in the formation of a thin gel-
like protective layer (Adhikari et al., 2007). This has resulted in enhanced protection of the 
bacterial cells during storage for the spray dried co-microcapsules compared to the freeze 
dried co-microcapsules. Lian et al, (2002) reported that GA can act as a thermo-protectant 
to bacterial cells during spray drying and help to preserve cell viability on storage. 
Moreover, the presence of more oxidation-sensitive lipids in the co-microcapsules appears 
to further protect bacterial cells during spray drying and storage, resulting in greater 
viability of L. casei in spray dried WPI-P-O-GA during storage. The less porous nature of 
the outer surface (skin) and lower surface oil content of spray dried microcapsules 
compared to freeze dried microcapsules has resulted in greater storage stability for spray 
dried microcapsules (Eratte et al., 2014). 
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Fig. 6.1:  The survival of L.casei in freeze (FD) and spray (SD) dried WPI-P-GA 
microcapsules and WPI-P-O-GA co-microcapsules as a function of storage temperature (5o 
C and 25o C) and storage time. Data represent survival percentage in mean ± SD of three 
replicate. 
 
It can be seen from Table 6.1 that the survival of L. casei decreased with storage time in all 
the cases. Bacterial death was more rapid when the powders were stored at 25o C than at 5o 
C. The highest survival percentage of L. casei was found in spray dried WPI-P-O-GA at 
both temperatures when stored for 90 days. The lowest survival percentage was found in 
freeze dried WPI-P-O-GA (1.44 %) stored at 25o C. Thus, it can be concluded that the 
upstream drying methods significantly (p<0.05) affect the survival of microencapsulated 
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bacteria during storage. The bacterial cells in spray dried co-microcapsules had higher 
survival percentage whereas the bacterial cells in the freeze dried co-microcapsules had the 
lowest survival percentage compared to survival in their respective controls (microcapsules 
containing only bacteria) during storage. The presence of omega-3 rich oil in the liquid 
microcapsules resulted in improved survival of bacterial cells in spray dried WPI-P-O-GA 
compared to when the oil was absent (i.e. in spray dried WPI-P-GA). To the contrary, the 
presence of omega-3 rich oil in freeze dried WPI-P-O-GA hindered the survival of 
bacterial cells during storage when compared to its control (freeze dried WPI-P-GA). The 
mechanism behind this observation is assumed to be related to the oxidative stability of co-
microencapsulated omega-3 oil, which will be discussed in detail in the Section 6.3.4. 
 
The bacterial survival data over storage time is presented in Fig. 6.1. The survival of L. 
casei in the microcapsules was significantly (p<0.05) lower in the samples stored at room 
temperature. The viability of dried cells in WPI-P-GA microcapsules and WPI-P-O-GA 
co-microcapsules during storage is clearly reflected on the inactivation rate constant (k) 
(Table 6.1). This constant also enables the comparison of viability of L. casei cells at 
different storage temperature. It is observed that k values increased with increase in the 
storage temperature, indicating poorer survival at higher temperatures. As indicated by 
these k values, the type of microcapsules, drying methods used, and the choice of storage 
temperature all affected the viability of encapsulated bacteria. The drying methods 
impacted the viability of bacterial cells in WPI-P-GA microcapsules and WPI-P-O-GA 
co-microcapsules in different ways. The spray dried WPI-P-O-GA co-microcapsules had 
lower inactivation rate constants than that of spray dried WPI-P-GA microcapsules, 
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whereas the freeze dried WPI-P-GA microcapsules have lower inactivation rate constant 
than that of freeze dried WPI-P-O-GA co-microcapsules on storage. 
 
It was observed clearly that spray dried WPI-P-O-GA co-microcapsules had the lowest k 
both at 5o C and 25o C, indicating that the co-microencapsulation of bacterial cells with 
omega-3 rich oil can have higher survival during storage than when they are encapsulated 
without it. Interestingly, the freeze dried WPI-P-O-GA co-microcapsules had a higher k 
value than that of the freeze dried WPI-P-GA microcapsules. Therefore, it is concluded 
that although the initial viability of bacterial cells in freeze dried WPI-P-O-GA co-
microcapsules was the highest, they had the poorest viability during storage at both 
temperatures (5 and 25o C). The porous structure of freeze dried microcapsules might have 
enhanced the moisture and oxygen diffusion inward and this might have reduced the 
viability of probiotic cells upon storage. 
 
6.3.2. Fermentation activity of L. casei in WPI-P-GA microcapsules and WPI-P-O-
GA co-microcapsules 
The panels A, B, C, and D in Fig. 6.2 show the acidification profile of L.casei in WPI-P-
GA microcapsules and WPI-P-O-GA co-microcapsules. These microcapsules were stored 
at 5o C and 25o C for a period of 0, 30, 60 and 90 days before these fermentation tests were 
carried out. The fermentation was carried out for 72 h at 37o C. The change in the pH over 
the fermentation time due to the production of lactic acid was measured as an indicator of 
fermentation activity (Ghandi et al., 2013a). It was observed that (Fig. 6.2) the 
fermentation activity (decrease in pH value) was affected by type of microcapsules, drying 
methods used, time and temperature of storage of microcapsules. The different 
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acidification profile of L. casei in different microcapsules, when the initial bacterial count 
was kept identical, may be due to the different extent of injury or shock caused by different 
upstream drying methods in the case of microcapsules which were subjected to 
fermentation tests immediately after they were produced (zero days of storage). Although 
significant differences were noticed in pH versus time profiles, the acidification profile of 
all of the microcapsules exhibited three distinct and noticeable phases. Firstly, there was an 
initial lag phase in which the pH did not decrease or decreased only insignificantly 
(p>0.05). The lag phase was followed by a second period at which pH values decreased 
rapidly, and finally the pH decreased only slightly or stopped, indicating completion or 
termination of the fermentation process. This phenomenon is due to the chemical and 
biochemical reactions that take place in bacterial cytoplasm during the lactic acid 
production process (Kashket, 1987). 
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Fig. 6.2: The fermentation activity (pH versus time) profile of freeze (FD) and spray (SD) 
dried WPI-P-GA microcapsules and WPI-P-O-GA co-microcapsules in RSM. (A) 
Microcapsules immediately after drying; (B) Microcapsules stored for 30 days; (C) 
Microcapsules stored for 60 days; (D) Microcapsules stored for 90 days. Data represent pH 
in mean ± SD of three replicate. 
 
The acidification kinetics of bacterial cells contained within different microcapsules was 
further evaluated in terms of the maximum acidification rate (Vmax), the time taken to reach 
pH 4.6 (T pH 4.6), which represents the isoelectric point of bovine casein, and the maximum 
rate of production of lactic acid (Pmax). These results are shown in Table 6.1. In general, 
Vmax of all the microcapsules decreased with increase in storage time and temperature. This 
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may be due to the decrease in the reproductive rate or vitality of the bacterial cells in the 
fermentation medium during storage. An opposite trend was noted in the case of time taken 
to reach pH 4.6 (Table 6.1), which increased with the storage time and temperature. 
Curdling of medium was observed at and below pH 4.6 in all cases due to coagulation of 
casein. The highest Vmax after 90 days storage was observed in the encapsulated cells in 
spray dried WPI-P-O-GA and the lowest value was obtained in the case of freeze dried 
WPI-P-O-GA indicating that the vitality of L. casei in the freeze dried co-microcapsules 
was the lowest in this study. These findings are consistent with the viability data (Fig. 6.1). 
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Table 6.1: Survival and fermentation kinetics of L. casei in freeze (FD) and spray (SD) 
dried WPI-P-GA microcapsules and WPI-P-O-GA co-microcapsules 
Microcapsules/    
co-microcapsules
Storage  
Temperature 
( 
o 
C )
Storage  
days
Initial cell count 
(cfu/g) Final survival (%)
Inactivation 
rate constant   
(k, day
-1 
)
Samples taken/ 
100 ml of RSM (g)
Vmax (x10
-3
 pH 
units/min) tpH (4.6) (h) Pmax (g/L/h)
0 2.49 ± 0.07
a
18.50 ± 0.71
o
0.45 ± 0.01
a
30 2.14 ± 0.02
b
20.00 ± 0.00
no
0.35 ± 0.00
bcd
60 1.49 ± 0.01
efgh
35.00 ± 0.00
hi
0.33 ± 0.02
def
90 1.32 ± 0.01
ghi
36.50 ± 0.71
hi
0.25 ± 0.01
ghi
30 1.61 ± 0.03
de
20.38 ± 0.53
no
0.40 ± 0.00
ab
60 1.37 ± 0.04
ghi
36.50 ± 0.71
hi
0.22 ± 0.01
ijk
90 1.22 ± 0.01
ijk
36.25 ± 0.35
hi
0.21 ± 0.01
ijk
0 1.51 ± 0.03
defg
32.50 ± 0.71
k
0.29 ± 0.02
efg
30 1.10 ± 0.01
jkl
37.75 ± 0.35
gh
0.28 ± 0.00
fgh
60 1.08 ± 0.02
jkl
65.50 ± 0.71
c
0.23 ± 0.01
hijk
90 1.05 ± 0.03
kl
68.75 ± 1.06
b
0.22 ± 0.01
ijk
30 1.09 ± 0.03
jkl
32.00 ± 0.00
k
0.23 ± 0.00
hij
60 1.09 ± 0.04
jkl
36.25 ± 0.35
hi
0.19 ± 0.01
jkl
90 1.02± 0.01
 l
72.00 ± 0.56
a
0.07 ± 0.00
m
0 1.70 ± 0.01
d
23.15 ± 0.21
m
0.30 ± 0.00
efg
30 1.57 ± 0.03
def
28.25 ± 0.35
l
0.29 ± 0.00
efg
60 1.40 ± 0.02
fghi
38.20 ± 0.28
fgh
0.19 ± 0.01
jkl
90 0.99 ± 0.04
l
68.35 ± 0.49
c
0.17 ± 0.01
klm
30 1.35 ± 0.03
ghi
22.05 ± 0.07
mn
0.29 ± 0.01
efg
60 1.27 ± 0.04
ij
28.25 ± 0.35
l
0.14 ± 0.01
lm
90 0.98 ± 0.02
l
40.25 ± 0.35
ef
0.13 ± 0.01
m
0 2.60 ± 0.01
a
23.50 ± 0.71
m
0.40 ± 0.01
ab
30 2.06 ± 0.02
bc
24.00 ± 0.00
m
0.39 ± 0.00
bc
60 1.63 ± 0.06
de
33.50 ± 0.71
jk
0.34 ± 0.01
cde
90 1.61 ± 0.21
de
39.45 ± 0.78
fg
0.29 ± 0.01
efg
30 1.92 ± 0.02
c
24.00 ± 1.41
m
0.35 ± 0.05
bcd
60 1.32 ± 0.01
ghi
42.50 ± 0.71
e
0.27 ± 0.01
gh
90 1.31 ± 0.03
hi
48.00 ± 0.00
d
0.20 ± 0.01
jk
Table 1: Survival and fermentation kinetics of L. casei  in freeze (FD) and spray (SD) dried WPI-P-GA microcapsules and WPI-P-O-GA co-microcapsules on storage.
1.00
1.00
1.13
SD WPI-P-O-GA
5 7.98 ± 0.04
b
45.72 ± 1.48
a
0.0002 
(0.9949)
25 7.98 ± 0.04
b
12.80 ± 3.30
c
0.0006 
(0.9885)
0.0015 
(0.8779) 0.94
1.72 ± 0.08d
0.0017 
(0.9920) 1.22SD WPI-P-GA
5 6.55 ± 0.07
d
25.77 ± 2.51
b
0.0004 
(0.9611) 1.22
25 6.55 ± 0.07
d
FD WPI-P-O-GA
5 8.47 ± 0.07
a
12.06 ± 2.93
c
0.0005 
(0.9866) 0.94
25 8.47 ± 0.07
a
1.44 ± 0.59
d
FD WPI-P-GA
5 7.10 ± 0.01
c
35.63 ± 4.62
b
0.0003 
(0.9916) 1.13
25 7.10 ± 0.01
c
7.13 ± 1.15
cd
0.001 
(0.9634)
 
 
The decrease in pH in the RSM medium is due to the production of lactic acid as a 
consequence of the metabolic activity of L. casei (fermentation of lactose). The amount of 
lactic acid produced by the microencapsulated bacteria in freshly freeze dried and spray 
dried WPI-P-GA microcapsules and WPI-P-O-GA co-microcapsules in RSM as a function 
of time is plotted in Fig. 6.3A. The lactic acid content-time profiles of microcapsules 
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stored at 5 and 25o C for a period of 30, 60, and 90 days are shown in Fig. 6.3B, 6.3C, 
6.3D, respectively. The lactic acid production was found to vary across the different 
microcapsule types. The quantity of lactic acid produced by L. casei was higher in spray 
dried WPI-P-O-GA compared to its control (spray dried WPI-P-GA) at 90 days of storage. 
This can be attributed to the fact that highest survival and preservation of metabolic 
activity of L. casei was observed in spray dried WPI-P-O-GA on storage (Table 6.1). The 
amount of lactic acid production was lower in freeze dried WPI-P-O-GA compared to its 
control (freeze dried WPI-P-GA). This can also be attributed to the lower percentage of 
survival of L. casei in freeze dried WPI-P-O-GA upon storage (Table 6.1). Injury or 
damage of cell wall and cell membrane due to membrane lipid oxidation would decrease 
the vitality of the bacterial cells and may play a role in this result (Edward et al., 2011; 
Ghandi et al., 2013b). To confirm that storage stability is adequate for commercial use 
more extensive accelerated storage studies showing up to 2 years shelf-life of the 
ingredient, and storage studies specific to each food application, will be required. 
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Fig. 6.3: Fermentation activity [Lactic acid content (g lactic acid/g microcapsule solid) 
versus time] of freeze (FD) and spray (SD) dried WPI-P-GA microcapsules and WPI-P-O-
GA co-microcapsules in RSM: (A) Microcapsules immediately after drying; (B) 
Microcapsules stored for 30 days; (C) Microcapsules stored for 60 days; (D) 
Microcapsules stored for 90 days. Data represent lactic acid in mean ± SD of two replicate. 
 
The lactic acid production by encapsulated L. casei decreased with increase in the storage 
time and storage temperature. The highest lactic acid production was observed in the spray 
dried WPI-P-O-GA stored at 5o C. Therefore, it can be concluded that co-
microencapsulation of omega-3 rich oil and L. casei in WPI-GA complex coacervates 
followed by spray drying of the resultant co-microcapsules results in improved viability 
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and vitality. As expected, storing these microcapsules at 5o C better preserves the viability 
and vitality of L. casei than storing at 25o C up to the maximum 90 days tested. The freeze 
drying of WPI-P-O-GA co-microcapsules resulted in lower viability and fermentation 
activity during storage, even though it had the highest initial cell count. The mechanism 
behind this phenomenon is also related to the oxidative stability of co-microencapsulated 
omega-3 oil and this will be discussed in detail in the Section 6.3.4. 
 
6.3.3. Oxidative stability of omega-3 oil in WPI-O-GA microcapsules and WPI-P-O-
GA co-microcapsules 
6.3.3.1. Oxidation stability index (OSI) on storage 
The OSI graphs of freeze dried and spray dried solid microcapsules and co-microcapsules 
stored at 5o C and 25o C for 90 days are presented in Fig. 6.4. The OSI value for freeze 
dried samples was significantly lower than that of spray dried samples, implying that the 
freeze dried microcapsules and co-microcapsules were less stable against oxidation when 
compared to the spray dried ones. This relatively poor oxidative stability in freeze dried 
microcapsules is attributed to the highly porous structure of freeze dried sample that allow 
easier diffusion of oxygen through to the encapsulated oil and also increases the amount of 
surface oil (Eratte et al., 2014). The relatively high OSI value of spray dried 
microcapsules/co-microcapsules can be attributed to the compact structure of the spray 
dried solid microcapsules, less pores on the shell and lower surface oil content (Eratte et 
al., 2014).  
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Fig. 6.4: Oxidative stability index (OSI) of freeze (FD) and spray (SD) dried 
microcapsules/ co-microcapsules on storage measured by accelerated oxidation test using 
RancimatTM. (A) Microcapsules immediately after drying; (B) Microcapsules stored for 30 
days; (C) Microcapsules stored for 60 days; (D) Microcapsules stored for 90 days. Data 
represents OSI in mean ± SD of three replicate.  
 
The OSI value was found to decrease with increasing storage temperature and time and 
was found to be higher in co-microcapsules (containing both L. casei and tuna oil) than in 
microcapsule (containing only tuna oil) obtained from spray drying. There was no 
statistically significant (p>0.05) difference between OSI values of freeze dried WPI-O-GA 
and freeze dried WPI-P-O-GA. It has been reported that lactic acid bacteria do not have 
pro-oxidant properties but do provide some antioxidant benefits to unsaturated free fatty 
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acids (Talon et al., 2000). In general, the spray dried co-microcapsule containing L. casei 
and tuna oil had better oxidative stability during storage compared to that of spray dried 
microcapsules containing only tuna oil. This could be due to the presence of probiotic 
bacterial cells on the encapsulation matrix and subsequent denser packaging of co-
microcapsule particles compared to that of microcapsules, thereby minimizing the 
diffusion of oxygen and moisture and enhancing oxidative stability.  
 
6.3.3.2. Primary and secondary oxidation products on storage 
Both the primary and secondary oxidation products were analysed as indicators of lipid 
oxidation of the microencapsulated tuna oil. Primary oxidation of microencapsulated tuna 
oil was determined by measuring peroxide value (PV). Changes in the PVs of encapsulated 
omega-3 in co-microcapsules and microcapsules at 5 and 25o C for the entire storage period 
are plotted in Fig. 6.5A. These PV results reveal that the oxidation gradually increased 
with increasing storage time. AV indicates the amount of secondary oxidation products 
such as α and β-alkenals and related compounds that react with p-Anisidine. Fig. 6.5B 
shows AV values for microencapsulated omega-3 during storage. Storage temperature also 
exerted notable effect on the lipid oxidation as the microcapsules were more oxidative 
stable at 5 than at 25o C. A comparison of Fig. 6.5A (PV values) with Fig. 6.5B (AV 
values) shows that both the primary and secondary oxidation products are produced 
simultaneously. This is because oxidation is triggered by the presence of free radicals that 
abstract a hydrogen atom from the carbon atoms adjacent to the double bond (Vandamme 
et al., 2015). Reactive oxygen species then react with these lipid radicals and produces 
lipid hydroperoxide, which eventually gets degraded into secondary lipid oxidation 
products (Frankel, 1991).  
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Fig. 6.5: Oxidation profile of freeze (FD) and spray (SD) dried microcapsules of omega-3 
rich tuna oil when stored for 90 days at 5o C and 25o C: (A) Peroxide value (PV); (B) p-
Anisidine value (AV); (C) Total oxidation value (TOTOX) after 90 days of storage at 5o C 
and 25o C. Data represent oxidation profile in mean ± SD of three replicate. 
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In general, the freeze dried WPI-O-GA and WPI-P-O-GA powders had significantly 
(p<0.05) higher PV and AV values than that of corresponding spray dried ones. These 
results are consistent with the OSI data (Fig. 6.4). The highly porous structure, larger 
surface area and comparatively greater surface oil have likely caused the decrease in the 
oxidative stability of freeze dried microcapsules (Eratte et al., 2014).  
 
Total oxidation (TOTOX) values of microencapsulated omega-3 at 90 days of storage at 
both storage temperatures are shown in Fig. 6.5C. TOTOX provides information on the 
production of both primary and secondary oxidation products (Abramovic et al., 2005). 
TOTOX values were found to be significantly lower in spray dried WPI-P-O-GA co-
microcapsules stored at both temperatures compared to those of other microcapsules. 
Limits on the amount of primary and secondary oxidation products are based on the 
palatability rather than health impacts (Albert et al., 2015). We set limits for the spray 
dried WPI-P-O-GA stored at 5o C for 30 days at PV, AV and TOTOX values of 
< 5 meq/kg, < 20 and < 26, respectively.  
 
6.3.4. Correlation between the viability of L. casei and oxidative stability of omega-3 
oil in WPI-P-O-GA co-microcapsules during storage  
Synergism was observed between the oxidative stability of omega-3 oil and 
vitality/viability of L. casei in the freshly prepared WPI-P-O-GA co-microcapsules 
produced by both spray and freeze drying. However, these drying techniques affected the 
storage stability in different ways. Spray dried WPI-P-O-GA was found to have the highest 
oxidative stability at the tested storage temperature (5 and 25o C) and the storage time (90 
days). Similarly, the vitality and viability of L. casei were highest in spray dried WPI-P-O-
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GA. To the contrary, the oxidative stability of omega-3 oil was significantly (p<0.05) 
lower in freeze dried WPI-P-O-GA co-microcapsules. The storage stability and vitality of 
L. casei were poor in freeze dried WPI-P-O-GA. The viability and vitality of L. casei in 
freeze dried WPI-P-GA was higher than that of freeze dried WPI-P-O-GA, indicating that 
the presence of omega-3 rich oil in the freeze dried co-microcapsules negatively affects the 
viability and vitality of bacteria due to greater access of oxygen through the porous 
structure. The spray dried co-microcapsules (WPI-P-O-GA) had higher oxidative stability 
compared to that of spray dried capsules containing only the omega-3 rich oil (WPI-O-GA) 
or the control, which indicates that the presence of bacterial cells in microcapsule shell 
provides protection against oil oxidation. The vitality of L. casei in spray dried WPI-P-O-
GA was higher than that in the spray dried WPI-P-GA (control) due to the protective effect 
of omega-3 oil on the bacterial cells. Therefore, co-encapsulation of omega-3 oil and L. 
casei in WPI-GA matrix followed by spray drying provides a synergistic effect in terms of 
oxidative stability of omega-3 oil and survival and vitality of L. casei on storage.  The co-
microencapsulation of omega-3 oil and L. casei in WPI-GA matrix followed by freeze 
drying exhibited synergism in the freshly prepared co-microcapsules; however, this 
synergism was lost during storage.  
 
6.4. Conclusions 
The effects of storage temperature and time on the survival and fermentation activity of L. 
casei and oxidative stability of omega-3 rich oil when they were microencapsulated 
together in whey protein isolate (WPI)-gum Arabic (GA) complex coacervate solid co-
microcapsules (WPI-P-O-GA) were determined, and compared with results from 
microencapsulation of omega-3 rich oil and the probiotic alone. Synergistically enhanced 
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oxidative stability of omega-3 rich tuna oil and viability and vitality of L. casei was 
observed in these co-microcapsules during storage in those produced through spray drying. 
Thus, the co-encapsulation of omega-3 oil and L. casei in WPI-GA complex coacervate 
followed by spray drying produces co-microcapsules with higher fermentability of bacteria 
and higher oxidative stability of omega-3 oil. The mechanism for improved stability of the 
oil in co-microcapsules is unclear, but may involve shielding of oil by the probiotic rich 
WPI-GA complexed shell matrix and resultant denser packing providing an improved 
oxygen barrier. Further work is required to determine the mechanisms involved. Whatever 
the mechanism, it appears that a synergetic interaction occurs between omega-3 oil and 
probiotic bacteria in co-microcapsules that enhances the stability of the omega-3 oil and 
the viability and vitality of the probiotic bacteria. These co-microcapsules provide the 
potential benefit of both omega-3 fatty acids and probiotic bacteria in a single functional 
food ingredient, providing compatible shell matrix for these two quite different materials 
functional ingredients for delivery to be incorporated in functional foods.  
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Chapter 7 
In-vitro digestion of probiotic bacteria and omega-3 oil co-microencapsulated in whey 
protein isolate-gum Arabic complex coacervates 
 
Abstract 
Solid co-microcapsules of omega-3 rich tuna oil (O) and probiotic bacteria L. casei (P) 
were produced using whey protein isolate (WPI)–gum Arabic (GA) complex coacervate as 
wall material. The in-vitro digestibility of the co-microcapsules (WPI-P-O-GA) and 
microcapsules (WPI-P-GA and WPI-O-GA) was studied in terms of survival of L. casei 
and release of oil in sequential exposure to simulated salivary (SSF), gastric (SGF) and 
intestinal (SIF) fluids. Co-microencapsulation significantly increased the survival and 
surface hydrophobicity and the ability of L. casei to adhere to the intestinal wall. No 
significant difference in the assimilative reduction of cholesterol was observed between the 
microencapsulated and co-microencapsulated L. casei. The pattern of release of oil from 
the microcapsules and co-microcapsules was similar. However, the content of total 
chemically intact omega-3 fatty acids was higher in the oil released from co-microcapsules 
than the oil released from microcapsules. The co-microencapsulation can deliver bacterial 
cells and omega-3 fatty acids to human intestinal system with less impact on their 
functional properties.  
Key words: 
Co-microencapsulation, Omega-3 oil, Probiotic bacteria, In-vitro digestion, Survival, 
Simulated digestive fluids 
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7.1. Introduction 
There is a significant commercial interest for functional foods containing long chain 
omega-3 polyunsaturated fatty acids (PUFAs), especially eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA). The estimated global demand for omega-3 ingredients was 
1.6 billion USD in 2010 and is expected to be greater than 4.0 billion USD in 2018 
(Transparency Market Research, 2013). Long chain PUFAs play an important role in 
human health (Shahidi, 2015). The dietary intake of these fatty acids has been associated 
with improving cardiovascular health (Bonafini et al., 2015), combating neural disorders 
(Blondeau, 2016), helping in infant brain and vision development (Wu et al., 2015), and 
combating some forms of cancer (Rose et al., 1999). However, omega-3 fatty acids are 
highly susceptible to oxidative degradation due to high degree of unsaturation (Jacobsen, 
2010). Lipid oxidation impairs flavour and nutritional value, and shortens the shelf-life of 
products containing omega-3 fatty acids (Kaushik et al., 2015). Microencapsulation is 
effective in stabilizing omega-3 fatty acids and for masking the inherent fishy odour of fish 
oils (Nickerson et al., 2014). Microencapsulated omega-3 fatty acids have been used to 
fortify a range of food products such as breads, milk, fruit juices, tortillas, chocolate, and 
yogurt drinks (Kaushik et al., 2015; Kadam et al., 2010). 
 
Alternatively, probiotic bacteria are live microorganism which provide numerous health 
benefits in human (Salminen et al., 2016). These benefits include control of serum 
cholesterol levels and intestinal infection, positively influencing the immune system (de 
Roos et al., 2000), improving lactose utilization (Post, 2013) and providing 
anticarcinogenic activities (Maleki et al., 2016). Many studies report on various aspects of 
incorporation of probiotic bacteria into a range of food products (Farnworth et al., 2016; 
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Shori, 2016). One of the major challenges regarding the application of probiotic bacterial 
cultures in functional foods is the maintenance of their viability during processing and 
passage through the host’s gastrointestinal system (De Prisco et al., 2016). 
Microencapsulation is a promising technology for introducing viable probiotic bacteria in 
various foods as the encapsulating shell material provides protection to the encapsulated 
bacterial cells against environmental stressors such as temperature, pH and mechanical 
shear (Mattila-Sandholm et al., 2002). The microcapsules containing bacterial cells, if 
properly designed, are able to maintain their integrity during passage through the 
gastrointestinal tract until they reach their target destination (colon), where they should 
break down and release the probiotic bacteria (Del Piano et al., 2011).  
 
In our previous work, we reported the co-microencapsulation of omega-3 rich tuna oil and 
probiotic bacteria L. casei in whey protein isolate-gum Arabic complex coacervate matrix 
and detailed the synergistic effect of this co-encapsulation to bacterial survival and stability 
against oxidation during storage (Eratte et al., 2015; Eratte et al., 2016b). In this study, 
address the in-vitro digestion of co-microcapsules containing omega-3 oil and probiotic 
bacteria when they are sequentially exposed to simulated salivary (SSF), gastric (SGF) and 
intestinal (SIF) fluids. In-vitro digestion behaviour of individual microcapsules containing 
probiotic bacteria (WPI-P-GA) or tuna oil (WPI-O-GA) distinctly were also studied as 
controls. To date, there is no study which reports the digestion behaviour of co-
microcapsules containing two distinct bioactive ingredients such as omega-3 oil and 
probiotic bacteria. 
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The site-specific delivery of bioactive ingredients to a targeted site in the gastrointestinal 
tract is of great interest (Hirsch et al., 1999; Kosaraju et al., 2009). Hence, in order to 
ensure the delivery of co-microencapsulated omega-3 oil and probiotic bacteria to targeted 
sites of the human digestive system, it is important to test the stability and release of both 
omega-3 and probiotic bacterial cells either in-vivo or in-vitro using simulated digestive 
fluids. In the human digestive system, food is first exposed to salivary enzymes at pH ~ 7.0 
and then digested by gastric pepsin at low pH of ~ 3.0, and eventually reaches the intestine 
having pH ~ 7.0 (Minekus et al., 2014). To understand the possible release of omega-3 oil 
and survival of probiotic bacteria during their passage through the human gastrointestinal 
digestion system, the co-microcapsules were subjected to SSF, SGF and SIF and the 
survival of L. casei and release of omega-3 oil were evaluated. The novelty of this study 
lies in that it advances the concept of co-microencapsulation of probiotic bacteria and 
omega-3 fatty acids by quantifying viability of the former and release of the latter in-vitro 
using SSF, SGF and SIF. 
   
In this context, this study addresses two major research objectives. Firstly, to quantify the 
survival of L. casei in co-microcapsules (WPI-P-O-GA) when sequentially exposed to 
SSF, SGF and SIF, in comparison to microcapsules containing only L. casei (WPI-P-GA). 
Secondly, to quantify and compare the release properties of major omega-3 fatty acids 
from co-encapsulated tuna oil (WPI-P-O-GA) when sequentially exposed to SSF, SGF and 
SIF with that of microcapsules containing only tuna oil (WPI-O-GA). 
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7.2. Materials and Methods 
7.2.1. Materials 
L. casei 431 was used as a model probiotic bacteria and was kindly donated by Chr.Hansen 
(Horsholm, Denmark). Tuna oil (HiDHA) was donated by NuMega Ingredients Ltd. 
(Melbourne, Australia). Tuna oil is rich in omega-3 fatty acids particularly DHA. The oil 
samples were stored at 4±0.5o C until use. Whey protein isolate (WPI 895TM) was donated 
by Fonterra Cooperative (Melbourne, Australia). Gum Arabic was purchased from Sigma-
Aldrich Ltd. (Sydney, Australia). Enzymes including α-amylase from human saliva (Type 
1X-A, 1000-3000 units/mg protein), pepsin from porcine gastric mucosa (3200–4500 
units/mg protein), pancreatin from porcine pancreas, bile salt (B8756) were obtained from 
Sigma–Aldrich Ltd. (Sydney, Australia). All other chemicals were purchased from Sigma–
Aldrich and were of analytical grade. All of the above ingredients and chemicals were used 
as received without further purification or alteration. 
 
7.2.2. Preparation of L. casei culture 
L. casei was cultured for 18 h in sterile MRS broth (1%, w/v) at 37±0.5o C. This culture 
was further sub-cultured (37±0.5o C, 18 h) twice in the same broth to activate bacterial 
cells and to allow them to adapt. All inoculation works were carried out under a sterile 
biological hoods with laminar air flow (Auramini, Laftech, Australia). Finally, 1000 mL of 
media was used for bulk culturing and cells were harvested at the stationary growth phase 
by centrifuging at 2200 × g for 15 min at 5o C. The supernatant was discarded and the 
precipitated cell mass was washed twice with sterile peptone water (0.2%, w/v). The final 
wet cell mass was weighed and divided into two equal portions. One portion (wet mass ~5 
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g) was used to prepare WPI-P-GA microcapsules and the second equal half was used to 
prepare WPI-P-O-GA co-microcapsules (Eratte et al., 2015).  
 
7.2.3. Microencapsulation process 
The complex coacervation and microencapsulation procedures were carried out according 
to the following procedures described in our previous works (Eratte et al., 2014; Eratte et 
al., 2015) with slight modification. These processes are briefly presented in subsections 
7.2.3.1, 7.2.3.2 and 7.2.3.3. 
7.2.3.1. Microencapsulation of tuna oil 
A solution of 15 g tuna oil and 250 mL WPI solution (12%, w/v) were stirred (IKA® RW 
20 digital overhead stirrer, Staufen, Germany) at 800 rpm for 10 min and then 
homogenized using a microfluidizer at 45 MPa for 3 passes (M110L, Microfluidics, 
Newton, MA, USA) to produce an O/W emulsion. Then a 250 mL GA solution (4%, w/v) 
was added drop wise into this O/W emulsion with continuous stirring at 400 rpm and the 
pH adjusted to 3.75 by adding 1% citric acid drop wise in order to induce complexation 
between WPI and GA.  
7.2.3.2. Microencapsulation of L. casei  
Similar to above, the previously prepared probiotic cell mass (Section 7.2.2) was added 
slowly into a WPI solution, and a GA solution was then added drop wise with continuous 
stirring, after which the pH was adjusted to 3.75. 
7.2.3.3. Co-microencapsulation of omega-3 oil and L. casei  
As above, tuna oil (15 g) was dispersed into a WPI solution and stirred for 10 min, 
followed by homogenizing using a microfluidizer to produce an O/W emulsion. Previously 
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prepared probiotic cell mass was then added into this O/W emulsion and GA solution was 
added with continuous stirring at 400 rpm, and the pH adjusted to 3.75 as above. 
The microencapsulation procedure in all the three cases were carried out at 25o C, followed 
by keeping the liquid microcapsules at 5o C for 24 h to ensure the complete formation of 
complex coacervates. After maintaining the sample at 5° C for 24 h, 100 mL of 4% (w/w) 
transglutaminase dispersion was added to induce the crosslinking. The slurry was heated to 
25° C to activate the enzyme and was kept at 25° C for 2 h to allow complete crosslinking. 
Finally, the microcapsules/co-microcapsules were dried to produce solid or powder co-
microcapsules (WPI-O-GA, WPI-P-GA and WPI-P-O-GA). 
   
7.2.4. Drying of coacervate liquid microcapsules  
The liquid microcapsules produced as detailed in Section 7.2.3 were spray dried (B-290, 
BÜCHI Labortechnik, Flawil, Switzerland) using inlet and outlet temperatures of 130o C 
and 65o C, respectively. The flow rate of the drying air was 35 m3/h at 100% fan aspiration. 
The powdered microcapsules/co-microcapsules were collected and stored at 5o C for 
further characterizations. 
 
7.2.5. Preparation of simulated digestive fluids and in-vitro digestion of microcapsules 
Simulated salivary fluid (SSF), simulated gastric fluid (SGF) and simulated intestinal fluid 
(SIF) were prepared according to the method proposed by Minekus et al., (2014) with 
slight modification as presented in Table 7.1 and includes the details of the stock solutions 
used. The pH of the stock solution was adjusted using 1.0 M NaOH and 1.0 M HCl. 
Calcium chloride (CaCl2) stock solution was prepared by dissolving 44.1g/L. CaCl2(H2O)2 
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was not added to the electrolyte stock solutions to avoid  precipitation. Instead, it was 
added to the final mixture of simulated digestive fluid and microcapsule/ co-microcapsule 
powder (Table 7.1). 
 
Table 7.1: Detailed composition of stock solutions used to prepare simulated digestive 
fluids. The final volume was adjusted to 500 mL with distilled water for each simulated 
fluid. SSF = Simulated Salivary Fluid, SGF = Simulated Gastric Fluid, SIF = Simulated 
Intestinal Fluid 
Components 
  
Stock 
concentration 
(g/L) 
  
SSF (pH 7.0) SGF (pH 3.0) SIF (pH 7.0) 
Volume of stock 
(mL) 
Volume of stock 
(mL) 
Volume of 
stock (mL) 
KCl 37.3 20.1 6.9 6.8 
KH2PO4 68 8.7 0.9 0.8 
NaHCO3 84 11.8 12.5 42.5 
NaCl 117 - 11.8 9.6 
MgCl2(H2O)6 30.5 1.0 0.4 1.1 
(NH4)2CO3 48 0.12 0.5 - 
 
7.2.5.1. In-vitro digestion in the oral phase 
Five grams of microcapsule/co-microcapsule powder was mixed with 7 mL of SSF 
electrolyte stock solution. Then, 0.5 mL salivary α-amylase solution (1500 units/mL) 
prepared with SSF electrolyte stock solution was added. This was followed by addition of 
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50 µL 0.3 M CaCl2 and 2 mL water and was thoroughly mixed. The pH was adjusted to 7.0 
and the oral bolus thus prepared was kept at 37o C for 2 min.  
7.2.5.2. In-vitro digestion in the gastric phase 
The oral bolus obtained was mixed with 7.5 mL of SGF electrolyte stock solution. Then, 
1.6 mL porcine pepsin stock solution (25000 units/ mL) prepared with SGF electrolyte 
stock solution was mixed thoroughly followed by addition of 5 µL 0.3 M CaCl2, and 0.695 
µL water. Then, the pH was adjusted to 3.0 with HCl. The gastric chime thus prepared was 
kept at shaking incubator at 100 rpm at 37o C for 2h.  
7.2.5.3. In-vitro digestion in the intestinal phase 
The gastric chime obtained was mixed with 11 mL of SIF electrolyte stock solution, 5.0 
mL of a pancreatin solution (800 units/ mL) prepared with SIF electrolyte stock solution, 
2.5 mL fresh bile (160 mM in fresh bile), 40 µL of 0.3 M CaCl2, and 1.5 mL of water. The 
pH of the mixture was adjusted to 7.0 using NaOH. The intestinal phase thus prepared was 
kept at shaking incubator at 100 rpm at 37o C for 3h.  
 
7.2.6. Enumeration of bacterial viability 
The viability of L. casei was assessed in MRS agar (CM0361, Thermo scientific, 
Melbourne, Australia) using the spread plating technique as described in our earlier work 
(Eratte et al., 2015). Samples were taken from SSF every 30 seconds and every 30 min 
from SGF and SIF. Briefly, the sample (1 mL) was diluted in 9 mL of sterile peptone water 
(0.2%, w/v) and placed in a stomacher for 30 sec. The cell suspension was then serially 
diluted and plated on MRS agar plate and incubated under anaerobic condition (OxoidTM 
AnaerojarTM, Thermoscientific, Australia) at 37o C for 48 h. The plating and enumeration 
were performed in triplicate. 
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7.2.7. Assimilation of cholesterol by microencapsulated and co-microencapsulated L. 
casei 
7.2.7.1. Preparation of cholesterol micelles 
The cholesterol micelles were prepared according to the methodology given by Kim et al., 
(2008). Briefly, cholesterol (9.1 mg) and α-lecithin (0.2 mL) were inoculated in 1.0 mL 
chloroform. A stream of nitrogen gas was used to facilitate the evaporation of solvent and 
then 10.0 mL of 0.4 mole/L sucrose solution was added. The samples were ultra-sonicated 
(M220 Focused-ultrasonicator™, Massachusetts, USA) for 15 min and cooled for 5 min. 
Once the ultra-sonication was repeated for five times, the samples were centrifuged at 
24,471 × g at 20o C for 30 min. The supernatant was sterile-filtered through a filter (0.45 
mm, Minisart® high flow syringe filters) and was then used for cholesterol assimilation 
study. 
 
7.2.7.2. Determination of cholesterol assimilation ability 
The cholesterol assimilation ability of microencapsulated and co-microencapsulated L. 
casei was carried out according to the method described by Kim et al., (2008). Firstly, 
MRS broth supplemented with 0.2 g/100 mL of thioglycolate and 0.3 g/100 mL of oxgall 
was prepared and sterilized at 121o C for 20 min. Each of the microencapsulated and co-
microencapsulated probiotic bacteria preparations (~ 107 cfu/g) were inoculated into a 
mixture (9:1) of MRS broth and cholesterol–phosphatidylcholine micelles and incubated at 
37o C for 18 h under anaerobic condition. After incubation, probiotic bacteria were 
removed by centrifugation for 10 min at 2000 × g at 4o C. The supernatant (1 mL) was 
placed into two clean sterile test tubes. Three mL of 95% ethanol and 2 mL of 50% 
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potassium hydroxide were added to each tube and were thoroughly mixed. Both test tubes 
were heated at 60o C for 10 min in a water bath and then cooled down to room temperature 
(25o C). Five millilitres of hexane was dispensed into each tube and mixed with aliquots for 
30 s. The test tubes were allowed to stand for 15 min at room temperature to permit phase 
separation. Then 2.5 mL of the hexane layer was transferred into a clean test tube. The 
hexane was evaporated by the flow of nitrogen gas and subsequently by heating at 60o C. 
Four millilitres of o-phthalaldehyde reagent containing 0.55 mg of o-phthalaldehyde per 
millilitre of glacial acetic acid was added to each tube and allowed stand for 10 min at 
ambient temperature. Two millilitres of sulfuric acid was pipetted slowly down the inside 
of each tube. Each tube was immediately mixed and was allowed to stand at ambient 
temperature for 10 min. The absorbance was measured at 550 nm using a UV 
spectrophotometer (UV-1800, Shimadzu, Kyoto, Japan). Triplicate runs were carried out 
for each sample. The cholesterol assimilation rate was calculated using equation (1): 






 100  
B
A
 100(%)  C                  (1) 
whereas C indicates the percentage (%) of cholesterol reduction, A indicates optical 
density of microencapsulated or co-microencapsulated probiotic bacteria after incubation 
for 18 h at 37o C and B indicates optical density of control in MRS broth supplemented 
with cholesterol–phosphatidylcholine micelles. 
 
7.2.8. Surface hydrophobicity 
The measurement of surface hydrophobicity was carried out according to the method given 
by Vinderola et al., (2003). Bacterial cells were released from microcapsules/co-
microcapsules using 0.4 M sodium phosphate buffer. The released bacterial cells were 
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centrifuged at 14000 × g for 5 min at 4o C, washed twice with 50 mM K2HPO4 (pH 7.0), 
and then resuspended in 50 mM K2HPO4 to realise an absorbance value of 0.5 at 560 nm. 
Five millilitre of the suspension was mixed with 1 mL of n-hexadecane by vortexing for 
120 s and was incubated for 1 h at room temperature. Changes in the absorbance (A) of 
probiotic bacterial suspension were recorded using a UV–Vis spectrophotometer. The 
surface hydrophobicity was determined using the equation (2), given below. 
100
A
A)(A
(%) SH
0
0


                                                                 (2) 
where SH, A0 and A are the surface hydrophobicity (%),  absorbance before and after 
extraction with n-hexadecane, respectively. 
 
7.2.9. Estimation of released oil and omega-3 fatty acids during in-vitro digestion 
The release of omega-3 oil before and after subjecting the microcapsules/co-microcapsules 
to the digestion fluids was estimated using the method reported (Kosaraju et al., 2009) with 
slight modification. Briefly, petroleum ether (75 mL) was added to the release medium 
containing microencapsulated/co-microencapsulated omega-3 oil and the mixture was 
shaken thoroughly on an orbital shaker (Stuart SSL-1, Carl Roth, Karlsruhe, Germany). 
The solvent phase was then filtered using filter papers (Whatman, 5 µm) and the solid 
particles caught on the filter were washed three times with 20 mL of petroleum in each 
wash. The filtrate was dried under nitrogen followed by drying at 100o C for 1 h in an oven 
to remove the residual solvent. The amount of oil released from the sample was expressed 
as % of total oil present in the microcapsule sample. 
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The omega-3 fatty acid profile of the released oil was determined using gas 
chromatography. Before undertaking the chromatographic experiments, the oil samples 
were transesterified to their respective fatty acids methyl esters (FAMEs) according to 
Kolanowski (2010). The resulting FAMEs were analysed using a GC column BPX70, (60 
m × 0.22 mm ×0.25µm) installed in a gas chromatograph system (Agilent 7890A GC, 
California, USA) equipped with a flame ionisation detector. The initial oven temperature 
was 180o C, which was maintained for 5 min before increasing to 210o C at a rate of 1o 
C/min and then maintained at 210o C for 60 minutes. Helium was used as the carrier gas 
and the column head pressure was 76 kPa. The split ratio used was 20:1. Peaks were 
identified using retention times obtained for standard FAME mixture. The major omega-3 
fatty acids such as hexadecatrienoic acid (HTA, 16:3w3), α-linolenic acid (ALA, 18:3w3), 
stearidonic acid (SDA, 18:4w3), eicosatetraenoic acid (ETA, 20:4w3), eicosapentaenoic 
acid (EPA, 20:5w3), docosapentaenoic acid (DPA, 22:5w3), and docosahexaenoic acid 
(DHA, 22:6w3) in the released oil were expressed as mg/ g of oil.  
 
7.2.10. Statistical Analysis  
All the experiments were carried out in duplicate or triplicate, as stated. The Minitab 16TM 
statistical software package (University Park, Pennsylvania, United States) was used for 
the analysis of variance (ANOVA) to determine the significant differences. The confidence 
level of 95% (p < 0.05) was used to determine significant difference between any two 
mean values. 
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7.3. Results and discussion 
7.3.1. Survival of unencapsulated, microencapsulated and co-microencapsulated L. 
casei in simulated digestive fluids 
The survival or viability of the unencapsulated (P), microencapsulated (WPI-P-GA) and 
co-microencapsulated (WPI-P-O-GA) L. casei in simulated digestive fluids (SSF, SGF, 
and SIF) is shown in Fig. 7.1. This strain showed a steady loss in viability when exposed to 
simulated digestive fluids; however, its susceptibility to SSF, SGF and SIF was quite 
different. No significant (p>0.05) decrease in probiotic cell counts was detected after 
exposure to simulated mouth conditions (SSF) for both microencapsulated and co-
microencapsulated L. casei (Fig. 7.1: inset). There was a significant loss of viability (~ 0.5 
log cfu/mL) of unencapsulated free bacterial cells when exposed to SSF. This indicates that 
microencapsulation of L. casei in complex coacervate shell material helps to improve its 
survival in SSF. 
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Fig. 7.1: Survival of unencapsulated, microencapsulated and co-microencapsulated L. casei 
upon sequential exposure to simulated salivary fluid (SSF) for 2 min, simulated gastric 
fluid (SGF) for 2 h and simulated intestinal fluid (SIF) for 3h. The inset represents the 
survival of cells when exposed in SSF for 2 min.  
 
 When the samples were exposed to the gastric condition, the number of viable cells 
significantly (p < 0.05) decreased in all three cases. The unencapsulated or free bacterial 
cells lost all viability within 1.5 h in SGF. There was a significantly (p<0.05) greater 
decrease in the viability of microencapsulated cells (4.8 log cfu/mL), when compared to 
the co-microencapsulated cells (1.5 log cfu/mL) in the SGF condition. This result indicate 
that the presence of omega-3 oil together with the bacterial cells provides better protection 
to the latter during the gastric simulation.  
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No viable cells of L. casei managed to reach the SGF when they were not protected. The 
co-microencapsulated bacterial cells survived better in SIF than the microencapsulated 
bacterial cells. This indicates that the presence of omega-3 oil in general greatly improves 
the survival of bacterial cells in SIF. It has been shown recently that the dietary PUFAs, 
particularly eicosapentaenoic acid (EPA), promoted the secretion of immune signalling 
protein TGF-β1 (Transforming Growth Factor β1) by gut bacteria and thus improved their 
viability (Bentley‐Hewitt et al., 2015). Our results, as articulated above, strongly support 
that the co-microencapsulation of omega-3 oil and probiotic bacteria improves the survival 
of probiotic bacteria in the human digestive system. 
 
7.3.2. Assimilation of cholesterol by microencapsulated and co-microencapsulated L. 
casei 
The cholesterol assimilation study was undertaken to access the degree to which co-
microencapsulation preserves the health promoting properties of probiotic bacteria in the 
human digestive system. The percentage of cholesterol reduction by microencapsulated 
and co-microencapsulated L. casei is shown in Fig. 7.2. No significant difference (p >0.05) 
in the extent of cholesterol assimilation was observed between the microencapsulated and 
co-microencapsulated L. casei. These results show that co-microencapsulation of omega-3 
oil with L. casei improved the survival but did not improve the degree of cholesterol 
assimilation. It has been reported that non-viable cells of probiotic bacteria can also act as 
cholesterol reducing agents (Miremadi et al., 2014). This could explain the similar 
cholesterol reducing effects of microencapsulated and co-microencapsulated L. casei.  
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Fig. 7.2: The percentage assimilation of cholesterol by microencapsulated and co-
microencapsulated L. casei. 
 
7.3.3. Surface hydrophobicity of microencapsulated and co-microencapsulated L. 
casei 
The surface hydrophobicity of bacterial cells is an indirect measure of the ability of these 
cells to adhere to the intestinal lining. The surface hydrophobicity of microencapsulated 
and co-microencapsulated L. casei is shown in Fig. 7.3. It was reported that surface 
hydrophobicity correlated with the ability of bacterial cells to adhere to the intestinal wall 
(Botes et al., 2008). The surface hydrophobicity of co-microencapsulated L. casei cells 
(43.7%) was significantly (p<0.05) greater than that of microencapsulated cells (31.3%). It 
has also been reported that the higher the surface hydrophobicity of probiotic bacteria, the 
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greater is its ability to adhere to the epithelial cells of intestines (Duary et al., 2011). 
Higher surface hydrophobicity in co-microencapsulated L. casei cells also indicated that 
the structural integrity of cell membrane (phospholipids and glycolipids) was better 
preserved in co-microcapsules than in microcapsules. Thus, the better preserved 
hydrophobic components of the membrane, such as fatty acids or S-protein, could better 
promote the adherence of cells to hydrophobic components of intestinal lining. 
 
Fig. 7.3: Surface hydrophobicity as a measure of intestinal lining ability of 
microencapsulated and co-microencapsulated L. casei. Different lower case letters in 
superscript indicate significant difference (p <0.05). 
 
7.3.4. In-vitro release of omega-3 from microcapsules and co-microcapsules 
It is essential to evaluate the release behaviour of omega-3 oil from microcapsules and co-
microcapsules during gastrointestinal transit in order to estimate the effectiveness of these 
microcapsules and co-microcapsules to deliver it to the targeted site of the gastrointestinal 
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tract. The percentage of oil released upon sequential exposure to SSF, SGF and SIF is 
shown in Fig. 7.4. As shown, there was no significant difference (p >0.05) in the 
percentage of oil released from WPI-O-GA microcapsules and WPI-P-O-GA co-
microcapsules in all the simulated digestive fluids. However, there was a significant 
difference in the percentage of oil released among SSF, SGF, and SIF. These differences 
can be attributed to the different pH and the presence of different enzymes in these 
different digestive fluids. 
 
Fig. 7.4: Release of omega-3 oil from WPI-O-GA microcapsules and WPI-P-O-GA co-
microcapsules upon sequential exposure to simulated salivary fluid (SSF) for 2 min, 
simulated gastric fluid (SGF) for 2 h and simulated intestinal fluid (SIF) for 3h.  
 
 It is expected that the presence of different digestive enzymes and different prevailing pH 
degrade WPI-GA complex coacervate wall matrix. This different degree of degradation of 
encapsulating shell releases significantly different amounts of encapsulated oil. As 
expected, the lowest amount of oil was released in SSF and the highest amount of oil was 
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released in SIF. The much lower amount of oil released in SSF and SGF compared to SIF 
may be attributed to the much lower extent of degradation of WPI-GA complex coacervate 
shell material by the salivary and gastric enzymes. It has been reported that chemical 
crosslinking of protein in complex coacervates slowed down the proteolytic activity of 
gastric enzyme and resulted in slower release of oil in simulated gastric conditions 
(Kosaraju et al., 2009). Interestingly, the low pH (pH=3.0) does not seem to erode the 
WPI-GA matrix significantly, and we postulate this may be due to stability of these 
crosslinked complex coacervates at this pH. The larger amount of oil release in SIF (pH 
7.0) compared to SGF (pH 3.0) can be attributed to the breaking down of both protein and 
polysaccharide by pancreatin present in SIF. The breaking down of WPI-GA complex 
coacervate matrix in SIF facilitated the extraction of oil in solvent.  
 
7.3.5. Evaluation of major omega-3 fatty acids in the released oil  
The amount of major omega-3 fatty acids such as hexadecatrienoic acid (HTA, 16:3w3), α-
linolenic acid (ALA, 18:3w3), stearidonic acid (SDA, 18:4w3), eicosatetraenoic acid 
(ETA, 20:4w3), eicosapentaenoic acid (EPA, 20:5w3), eicosapentaenoic acid (DPA, 
22:5w3), and docosahexaenoic acid (DHA, 22:6w3) in the unencapsulated or control tuna 
oil, and the oil extracted from solid WPI-O-GA microcapsules and released from WPI-O-
GA microcapsules upon sequential exposure to SSF, SGF and SIF, are presented in Table 
7.2A. The major omega-3 fatty acids in the oil extracted from WPI-P-O-GA co-
microcapsules and in the released oil obtained from sequential exposure of WPI-P-O-GA 
co-microcapsules to SSF, SGF and SIF are given in Table 7.2B.  
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Table 7.1A: The major omega-3 fatty acids in the blank tuna oil, in the oil extracted from 
WPI-O-GA microcapsules and in the released oil from WPI-O-GA microcapsules during 
in-vitro digestion; SSF = Simulated Salivary Fluid, SGF = Simulated Gastric Fluid, SIF = 
Simulated Intestinal Fluid. Different lower case letters in superscript indicate significant 
difference (p <0.05). 
Omega-3 fatty acids 
Blank tuna oil         
(mg/g of oil) 
WPI-O-GA                        
(mg/g of 
oil) 
SSF                
(mg/g of oil)         
SGF            
(mg/g of oil)           
SIF              
(mg/g of oil)            
16:3w3 9.70 ± 0.0no 9.7 ± 0.1no 8 ± 0.7no  7.1 ±  0.1op  6.9 ±  0.1pq  
18:3w3         ALA 4.10 ± 0.1rst 3.35 ± 0.2t 3.5 ± 0.7t 3.25 ± 0.3t 3.05 ± 0.1t 
18:4w3 6.05 ± 0.1pqr 5.9 ± 0.1qrs 4.75 ± 0.4rst 4.65 ± 0.5rst 4.45 ± 0.1rst 
20:4w3 4.60 ± 0.0rst 3.95 ± 0.1st 3.65 ± 0.2t 3.4 ± 0.1t 3.05 ± 0.1t 
20:5w3         EPA 59.81 ± 0.0j 53.3 ± 0.4k 48.88 ± 0.2l 48.65 ± 0.2l 47.85 ± 0.4l 
22:5w3 12.05 ± 0.1m 11 ± 0.1mn 10 ± 0.3n 10 ± 0.0n 9.85 ± 0.2no 
22:6w3         DHA 294.21 ± 0.0f 280.5 ± 0.7g 269 ± 1.4h 266.8 ± 0.3i 265.75 ± 0.4i 
Sum   Omega-3 -
PUFAS 390.52 ± 0.3a 367.7 ± 0.7b 347.78 ± 1.2c 343.85 ± 1.3d 340.9 ± 0.4e 
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Table 7.2B: The major omega-3 fatty acids in the oil extracted from WPI-P-O-GA co 
microcapsules and in the released oil from WPI-P-O-GA co-microcapsules during in-vitro 
digestion; SSF = Simulated Salivary Fluid, SGF = Simulated Gastric Fluid, SIF = 
Simulated Intestinal Fluid. Different lower case letters in superscript indicate significant 
difference (p <0.05). 
Omega-3 fatty acids 
WPI-P-O-GA           
(mg/g of oil) 
SSF             
(mg/ g of oil)     
SGF                
(mg/g of oil)         
SIF             
(mg/g of oil)              
16:3w3 9.65 ± 0.1jk  9.65 ± 0.1jk  7.04 ± 0.1kl  7.04 ± 0.1kl  
18:3w3         ALA 3.95 ± 0.1lm 3.91 ± 0.0lm 3.67 ± 0.2lm 3.04 ± 0.1m 
18:4w3 5.98 ± 0.0lm  5.93 ± 0.1lm 5.87 ± 0.1lm 5.86 ± 0.0lm 
20:4w3 4.60 ± 0.0lm  4.57 ± 0.1lm  3.06 ± 0.1m  3.02 ± 0.0m  
20:5w3         EPA 55.65 ± 0.8g 55.2 ± 0.1gh 52.10 ± 1.4hi 51.74 ± 1.1i 
22:5w3 11.95 ± 0.1j  11.95 ± 0.0j 10.00 ± 0.3jk 10.00 ± 0.3jk 
22:6w3         DHA 290.00 ± 1.4d  289.5 ± 0.7d 277.30 ± 2.4e 273.25 ± 0.4f 
Sum   Omega-3 -
PUFAS 381.78 ± 2.1a 380.68 ± 0.7a 359.04 ± 1.3b 353.94 ± 1.8c 
                                                                                                                                                          
In general, there is a decrease in the omega-3 fatty acid content in the oil extracted from 
WPI-O-GA microcapsules and WPI-P-O-GA co-microcapsules when compared to that 
amount in unencapsulated or control tuna oil. There was also a significant decrease in EPA 
and DHA contents in the oil extracted from microcapsules and co-microcapsules from their 
content in the original tuna oil. The complex coacervation and spray drying processes 
might have caused this drop, possibly due to oxidative degradation. The total identified 
omega-3 fatty acids content also decreased upon microencapsulation (367.7 mg/g of oil) 
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and co-microencapsulation (381.78 mg/g of oil) compared to that in unencapsulated 
sample (390.52 mg/g of oil). This suggests that the PUFAs present in the encapsulated oil 
underwent some oxidative damage, which is not unexpected (Czerniak et al., 2015). 
However, a significant (p < 0.05) retention of total omega-3 fatty acids were observed from 
the oil released from co-microcapsules compared to that from microcapsules. This is 
probably due to the greater oxidative stability of co-microcapsules as compared to that of 
microcapsules (Eratte et al., 2016a). 
 
There was no significant drop (p >0.05) in total omega-3 fatty acids in the released oil 
from SSF digesta of WPI-P-O-GA microcapsules (380.68±0.7 mg/g of oil) when compared 
to that in oil released from undigested WPI-P-O-GA co-microcapsules (381.7± 2.1 mg/g of 
oil). However, there was a significant (p<0.05) drop in total omega-3 fatty acids content in 
the SSF digesta of WPI-O-GA microcapsules (347.78 ± 1.2 mg/g of oil). Salts contained in 
the SSF might not have interacted with co-microencapsulated PUFAs to the same extent as 
with microencapsulated PUFAs. There was a decrease in the total omega-3 fatty acids in 
the oil released from the digesta of SGF and SIF in both microcapsules and co-
microcapsules. However, the decrease was comparatively higher for WPI-O-GA 
microcapsules. A significant decrease in DHA in the released oil was observed from 
microcapsules and co-microcapsules in all digestive fluids, compared to that of other 
omega-3 fatty acids tested. Retention of total omega-3 fatty acids in the oil extracted from 
WPI-P-O-GA co-microcapsules (90.63%) was significantly (p<0.05) higher than that in 
WPI-O-GA microcapsules (87.29%). The above observations show that although there was 
no significant effect of co-microencapsulation on the release properties of oil from 
microcapsules/co-microcapsules, there was a significantly (p<0.05) higher retention of 
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omega-3 fatty acids in co-microcapsules compared to that in microcapsules during oral, 
gastric and intestinal digestion phases. This may be due to the co-microencapsulation of 
omega-3 oil with probiotic bacteria providing better oxidative stability to omega-3 oil 
(Eratte et al., 2016b). 
 
7.4. Conclusions 
The in-vitro release and oxidative stability of omega-3 oil in co-microcapsules containing 
L. casei were determined. The co-microcapsules were prepared using WPI-GA complex 
coacervates. The co-microcapsules (WPI-P-O-GA) were sequentially subjected to 
simulated digestive fluids (SSF, SGF, and SIF) in vitro. The in-vitro digestion behaviour of 
microcapsules containing only L. casei (WPI-P-GA) and omega-3 rich tuna oil (WPI-O-
GA) was also determined. The viability, cholesterol assimilation ability and cell surface 
hydrophobicity of L. casei in the microcapsules and co-microcapsules were determined. 
Co-microencapsulation was found to significantly improve the viability of probiotic 
bacteria during digestion; however, the cholesterol assimilation ability of L. casei did not 
improve. The cell surface hydrophobicity, which measures the ability of bacteria to adhere 
to the intestinal wall, was found to significantly improve when co-microencapsulated. No 
significant difference in the release properties of encapsulated omega-3 oil was observed 
between the microcapsules and co-microcapsules during the in-vitro digestion. However, 
the retention of total omega-3 fatty acids in the released oil was significantly higher in co-
microencapsulated samples. This study shows that the co-microencapsulation of omega-3 
rich oil with probiotic bacteria improved the survival and intestinal adhering ability and 
also helped to retain a higher proportion of omega-3 fatty acids in the human digestive 
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system. In-vivo clinical studies are required to further evaluate the survival/oxidative 
stability/ bioavailability of co-encapsulated probiotic bacteria and omega-3 fatty acids. 
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Chapter 8 
General Discussion, Conclusions and Recommendations 
 
8.1. Introduction 
The overarching goal of this research was to successfully co-encapsulate omega-3 rich tuna 
oil (O) and probiotic bacteria L. casei (P) in whey protein isolate (WPI) - gum Arabic (GA) 
complex coacervate matrix. Further studies on the interaction (synergistic/ competitive) 
between encapsulated omega-3 oil and encapsulated bacterial cells in terms of oxidative 
stability of the former and cell viability of the latter until it reached the human gastro-
intestinal tracts were carried out. This thesis describes the detailed investigations on the 
underpinning science involved in the design, production and characterisation of physico-
chemical properties of composite microcapsule comprising omega-3 fatty acids and 
probiotic bacteria in a single microcapsule. The outcomes contribute to both fundamental 
science and technological aspects in the body of knowledge of functional foods.  
 
The co-encapsulation concept has been widely used in pharmaceutical delivery systems; 
however, co-encapsulation of more than one bioactive components with different 
characteristics such as omega-3 oil (hydrophobic) and probiotic bacteria (hydrophilic) is 
challenging and illustrates the novelty of this research. Powdered co-microcapsules 
containing omega-3 oil (tuna oil) and probiotic bacteria (L. casei) were produced through 
spray and freeze drying and their physico-chemical properties were studied during storage. 
Simulated digestion studies were also carried in these solid co-microcapsules to investigate 
the applicability of these co-microcapsules to the food industry. The outcomes of the 
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research contribute to the body of knowledge related to complex coacervation and co-
encapsulation in food science. The importance of key findings obtained from the above 
mentioned investigations is articulated in the ensuing sections. The contributions made by 
this study to the body of knowledge are also presented. Finally, recommendations for 
future studies are outlined towards the end of this chapter. 
 
8.2. Research Aspects and Key Findings 
The research was designed in a systematic way by first developing and optimising the 
microencapsulation of omega-3 fatty acids and probiotic bacteria separately. The 
knowledge gained from these individual encapsulation experiments was used to optimise 
the combined encapsulation of these two components in single matrix. The key findings 
obtained from the research study and their significances are articulated in the ensuing 
sections: 
 
8.2.1. Complex coacervation of WPI and GA 
The process of complex coacervate formation between cationic whey protein isolate and 
anionic gum Arabic was explored in detail and key aspects are presented in Chapter 3. WPI 
is prepared from whey which is a by-product of cheese making and it has been widely used 
in the food processing industry due to its nutritional qualities and unique physio-chemical 
properties, such as emulsion stabilization and gel formation.  WPI is effective in lowering 
interfacial tension at the oil-water interface, promptly migrates to the interface from bulk 
solution, and possesses good skin forming ability when it is dried. GA is one of the most 
commonly used stabilizers in the food and pharmaceutical industries. The complex 
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coacervation process between WPI and GA was optimised in terms of pH, and WPI-to-GA 
ratio, using zeta potential and turbidity measurements, and acquiring morphology of the 
microcapsules. The optimum pH and WPI-to-GA ratio for complex coacervation was 
found to be 3.75 and 3:1, respectively. Confocal laser scanning microscopy (CLSM) and 
optical microscopy were used to visualize process of complex coacervate formation 
between WPI and GA and to confirm the optimized processing conditions. 
8.2.2. Co-encapsulation of omega-3 oil and probiotic bacteria in WPI-GA complex 
coacervates 
Microencapsulation of omega-3 rich tuna oil (Chapter 3) and probiotic bacteria L. casei  
(Chapter 4) in WPI-GA complex coacervate were carried out separately followed by co-
encapsulation of both (Chapter 4).  
 
Omega-3 rich tuna oil and probiotic bacteria L. casei 431 were successfully encapsulated 
individually in WPI-GA complex coacervate matrix. L casei and omega-3 rich tuna oil 
were also successfully co-encapsulated in WPI-GA complex coacervate matrix. The liquid 
capsules containing bacterial cells, tuna oil and bacterial cells together with tuna oil were 
converted into powder form using spray and freeze drying. The viability of bacterial cells 
and oxidative stability of tuna oil were studied in detail in microcapsules and co-capsules. 
Furthermore, the morphology and surface elemental composition of microcapsules were 
compared. The viability of the L. casei bacteria was significantly higher when co-
encapsulated with tuna oil in WPI-GA complex coacervates rather than being encapsulated 
on its own in the same shell matrix both in liquid and dried microcapsules. Freeze dried 
WPI-P-O-GA microcapsules exhibited greater survival compared to that in spray dried 
microcapsules. The higher inlet and outlet temperatures (180/80o C) resulted into lower 
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viability of bacterial cells. The oxidative stability of tuna oil was greatly improved in the 
WPI-GA complex coacervates in the presence of the bacterial cells. However, spray dried 
WPI-P-O-GA microcapsules exhibited greater oxidative stability than that of freeze dried 
microcapsules. The surface elemental composition showed that the spray dried 
microcapsules had high surface protein content while freeze dried microcapsules had high 
surface carbohydrate when oil was not incorporated in the formulation. The freeze dried 
microcapsules showed flake like porous morphology, while the spray dried microcapsules 
showed more or less spherical shapes in various size with concavities typical of polymeric 
materials produced by spray drying. All the microcapsules produced were amorphous in 
nature. In conclusion, we found that spray dried co-microcapsule powders had advantages 
in terms of oxidative stability of omega-3 oil; however, the freeze dried co-microcapsules 
had higher viability of L. casei. Since spray drying is one of the most hygienic and 
economical technologies used for microencapsulation and production of powders in food 
industry and is also less expensive than that of freeze drying, the spray drying process 
parameters were optimised so that co-microcapsules with higher bacterial viability as well 
as higher oxidative stability could be produced (Chapter 5). The effect of three sets of inlet 
(130o C, 150o C and 170o C) and outlet (55o C, 65o C and 75o C) air temperatures on the 
physico-chemical and surface characteristics of spray dried co-microcapsules were 
determined. The viability of L. casei decreased with increase in the inlet and outlet air 
temperatures. There was no difference in the surface elemental compositions and surface 
morphology of powdered co-microcapsules produced under these nine inlet/outlet 
temperature combinations. The co-microcapsules produced at inlet-outlet air temperature 
130-65o C had better bacterial viability and oxidative stability of omega-3 at moisture 
content 4.93 % (w/w). This research shows that powdered co-microcapsules of probiotic 
225 
 
bacteria and omega-3 fatty acids with high survival of the former and high stability against 
oxidation can be produced through spray drying, which confirms the commercial 
suitability of production of these composite microcapsules. 
 
8.2.3. Is the interaction synergistic or competitive in co-capsules? 
The complex coacervation process, co-encapsulation and drying parameters to produce co-
capsules with highest possible bacterial cell viability and better oxidative stability for tuna 
oil have been optimized. Further, the storage stability of co-capsules were tested and key 
results are presented in Chapter 6. Whether or not the interaction between probiotic 
bacteria and omega-3 oil in co-microcapsules, particularly in terms of oxidative stability of 
omega-3 oil and vitality/viability of probiotic bacteria was synergistic outcome was tested. 
The effect of storage temperature (5 and 25o C) and time (90 days) on the survival and 
fermentation activity of L. casei and oxidative stability of tuna oil in the microcapsules/co-
microcapsules were determined. 
 
Synergism was observed between the oxidative stability of omega-3 oil and 
vitality/viability of L. casei in the freshly prepared WPI-P-O-GA co-microcapsules 
produced by both spray and freeze drying. However, these drying techniques affected the 
storage stability in different ways. Spray dried WPI-P-O-GA was found to have the highest 
oxidative stability at the tested storage temperature (5 and 25o C) and the storage time (90 
days). Similarly, the vitality and viability of L. casei were highest in spray dried WPI-P-O-
GA. The oxidative stability of omega-3 oil was significantly lower in freeze dried WPI-P-
O-GA co-microcapsules. The storage stability and vitality of L. casei were poor in the 
freeze dried WPI-P-O-GA. The viability and vitality of L. casei in freeze dried WPI-P-GA 
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was higher than that of freeze dried WPI-P-O-GA, indicating that the presence of omega-3 
rich oil in the freeze dried co-microcapsules negatively affected the viability and vitality of 
bacteria due to greater access of oxygen through the porous structure. The spray dried co-
microcapsules (WPI-P-O-GA) had higher oxidative stability compared to that of spray 
dried capsules containing only the omega-3 rich oil (WPI-O-GA) or the control, which 
indicated that the presence of bacterial cells in microcapsule shell provided protection 
against oil oxidation. The vitality of L. casei in spray dried WPI-P-O-GA was higher than 
that in the spray dried WPI-P-GA (control) due to the protective effect of omega-3 oil on 
the bacterial cells. Therefore, co-encapsulation of omega-3 oil and L. casei in WPI-GA 
matrix followed by spray drying provided a synergistic effect in terms of oxidative stability 
of omega-3 oil and survival and vitality of L. casei on storage.  The co-microencapsulation 
of omega-3 oil and L. casei in WPI-GA matrix followed by freeze drying exhibited 
synergism in the freshly prepared co-microcapsules; however, this positive effect was lost 
during storage.  
8.2.5. In vitro digestion of microcapsules and co-microcapsules (in vitro) 
The in-vitro digestibility of the co-microcapsules (WPI-P-O-GA) and microcapsules (WPI-
P-GA and WPI-O-GA) was studied in terms of survival of L. casei and release of oil in 
sequential exposure to simulated salivary, gastric and intestinal fluids. Co-
microencapsulation significantly increased the survival and surface hydrophobicity and the 
ability of L. casei to adhere to the intestinal wall. No significant difference in the 
assimilative reduction of cholesterol was observed between the microencapsulated and co-
microencapsulated L. casei. The pattern of release of oil from the microcapsules and co-
microcapsules was similar. However, the content of total chemically intact omega-3 fatty 
acids was higher in the oil released from co-microcapsules than the oil released from 
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microcapsules. The co-microencapsulation was able to deliver bacterial cells and omega-3 
fatty acids to human intestinal system with less negative impact on their functional 
properties.  
 
8.3. Contributions made by this Thesis 
This thesis has made significant contributions to the body of knowledge as follows: 
It demonstrated that it is possible to co-encapsulate omega-3 oil and probiotic bacteria in a 
single capsule. 
It showed that synergism between viability/vitality and oxidative stability occurs in in 
spray dried co-microcapsules. 
Co-encapsulation of omega-3 promoted the survival of probiotic cells in simulated gut 
system. 
The amount of total omega-3 fatty acids in the released oil was higher in co-microcapsules. 
A total of six peer reviewed journal papers were generated from this work out of which 
five are published. The review chapter (Chapter 2) is currently under peer-review.  
 
In summary, the findings of this study paves the way for co-encapsulation of omega-3 and 
probiotic bacteria into one matrix, and this technology may have a wide range of 
applications in functional powder formulations. Consumers can get a two-fold health 
benefits in one serving, which has commercial potential. Furthermore, the delivery of 
stable multiple bioactive ingredients through a single product can facilitate the 
incorporation of these ingredients into functional foods.  
 
8.4. Recommendations for further research 
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Food industry is increasingly interested in developing microencapsulated bioactive 
products to incorporate into processed foods. In this study, WPI-GA complex coacervate 
matrix was used as wall material to co-encapsulate omega-3 oil and probiotic bacteria L. 
casei 431. Further investigations on different wall materials and probiotic bacterial strains 
could broaden the scope of this technology. 
 
In this study, WPI and GA were successfully complexed and crosslinked to produce a wall 
material to protect tuna oil and probiotic bacteria. However, the cross linker used in this 
study is transglutaminase. There is an increasing interest in application of plant 
polyphenols as cross linker due to their unique health benefits.  Hence, further work using 
polyphenols as crosslinking agent can add value to the research done in this study.  
 
The mechanism for improved stability of the oil in co-microcapsules is not yet clearly 
understood. This may involve shielding of oil by the probiotic rich WPI-GA complex 
coacervate shell matrix and resultant denser packing providing an improved oxygen 
barrier. Further work is required to determine the mechanisms involved. Similarly, the 
trend on the fermentation ability of encapsulated probiotic bacteria and the mechanism of 
lactic acid generation during much prolonged storage period and higher temperature need 
to be explored further. 
 
It is of industrially important to investigate the incorporation aspect this co-microcapsules 
in many commercial food products. These co-microcapsules can be used in a variety of 
food products such as bakery products, beverages, dairy products, baby foods, nutrition 
bars, soups and salad dressings. The performance of the encapsulated oil and encapsulated 
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probiotic bacteria in these food products can be investigated by employing simulated 
digestive conditions and subsequently testing its bioavailability. In-vivo and clinical 
human studies will further confirm the bioavailability and health benefits of these co-
microcapsules.  
 
  
 
 
 
 
 
 
 
 
